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Abstract 
Background: Cancerous tumours are characterised by areas of insufficient blood supply, 
with resulting hypoxia and nutrient deprivation. The mechanisms by which cancer cells adapt 
to these conditions are of interest due to potential clinical relevance. Although immortalised 
cell lines have been used extensively in cancer research, a primary cancer cell model could 
potentially shed additional light on cancer biology. Protein phosphatase 2A (PP2A) is a 
Serine/Threonine protein phosphatase which has been implicated in hypoxia, although 
contradictory reports regarding its involvement has been published.  
 
Aims: 
1. To establish a primary cell culture model using fine needle aspiration (FNA) for cell 
collection. 
2. To investigate the effect of hypoxia on these primary cells.  
3. To investigate the effect of hypoxia on PP2A expression, post-translational 
modification and activity in MDA-MB-231 cells.  
 
We hypothesized that hypoxia would induce a reduction in PP2A activity, thereby favouring 
the phosphorylation and activation of enzymes associated with survival and proliferation. 
 
Methods: Nine FNA samples were collected from patients at Tygerberg Hospital. Samples 
were subjected to processing and cultured at 37°C in suitable growth medium containing 
HEPES and epidermal growth factor. Cells were maintained in culture for 1.5–6 weeks and 
medium was refreshed initially after 3-4 days, and there after every second day. Although 
cells appeared to attach and survive initially, numbers dwindled until none were visible. We 
are therefore as of yet unable to establish a primary cancer cell model. Potential variables 
which could be of importance in future attempts to culture primary cells, include using a 
suitable attachment matrix, as well as optimizing the culture medium. 
 
Concerning PP2A in hypoxia in standard cell culture: MDA-MB-231 cells were cultured in a 
gas mixture of 5%CO2, 0.5%O2 for varying lengths of time, in growth medium containing 
only 1% FBS, where after cells were harvested and the following primary end-points 
investigated: (1.) The expression, phosphorylation and methylation of the catalytic subunit 
of PP2A; (2.) PP2A activity; and (3.) cell viability.  
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Results: Following 72 hours hypoxia, Western blotting showed a decrease in total PP2A 
(control: 1.00±0.1426 arbitrary units (AU) vs hypoxia: 0.3513±0.07558 AU; n=3; p≤0.05), as 
well as unexpectedly a decrease in the relative phosphorylation of both PKB (phospho-to-
total (p/t) ratio: control: 1.211±0.1820 AU vs hypoxia: 0.2088±0.03583 AU; n=3; p≤0.05) and 
ERK  (control: 1.00±0.1519 AU vs hypoxia: 0.3493±0.05206 AU; n=3; p≤0.05). This led us 
to investigate shorter durations of hypoxia, specifically in the range between 2 and 8 hours. 
No significant changes in PP2A expression, post-translational modification or activity were 
observed, although there was a trend in increasing PP2A activity associated with hypoxia, 
which was highlighted by a significant increase in cells exposed to 6 hours of chemically 
stabilized HIF1ɑ (characteristic of hypoxia) (control: 134.7±33.74 AU vs positive control: 
193.6±35.31 AU; n=2; p≤0.05). Four and six hours of hypoxia were consistently associated 
with a significant decrease in ATP.  
 
Discussion and Conclusion: Although we observed an interesting pattern of increased 
PP2A activity associated with hypoxia, our results failed to show a convincing link. Based 
on this, as well as literature, further research is needed: It would be interesting to investigate 
intermediate durations of less strenuous hypoxia (1% O2 instead of 0.5%). Modulating the 
activity of PP2A in hypoxia, followed by assessment of cell viability and pro-survival 
signalling would also contribute value. 
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Opsomming 
Agtergrond: ‘n Tekort aan genoegsame bloedvoorsiening, met gepaardgaande hipoksie en 
‘n tekort aan voedingstowwe, is kenmerkend van kankeragtige tumore. Die meganismes ter 
sprake by die aanpassing van kankerselle by hierdie kondisies is van belang as gevolg van 
moontlike kliniese toepaslikheid. Alhoewel onsterflike sellyne ekstensief gebruik is in 
kanker-navorsing, kan ‘n primêre kankersel-model moontlik bykomende inligting aangaande 
kankerbiologie oplewer. Proteïen fosfatase 2A (PP2A) is ‘n Serien/Threonien proteïen 
fosfatase wat vantevore betrek is by hipoksie, alhoewel teenstrydige inligting aangaande sy 
deelname gepubliseer is.  
 
Doelstellings: 
1. Om ‘n primêre selkultuur model daar te stel deur selle te gebruik wat deur 
fynnaaldaspirasie (FNA) versamel is. 
2. Om die effek van hipoksie op hierdie primêre selle te ondersoek.  
3. Om die invloed van hipoksie op PP2A uitdrukking, post-sintese modifikasie en 
aktiwiteit in MDA-MB-231 selle te ondersoek.  
 
Ons hipotese was dat hipoksie ‘n afname in PP2A aktiwiteit tot gevolg sou hê om sodoende 
die fosforilering en aktivering van ensieme wat betrokke is by oorlewing en selvermeerdering 
te bevoordeel. 
 
Metodes: Nege FNA monsters is versamel by pasiënte in Tygerberg Hospitaal. Hierdie 
monsters is verwerk en in kultuur geplaas teen 37°C in gepaste groeimedium wat beide 
HEPES en epidermale groeifaktor bevat het. Selle is in kultuur onderhou vir tussen 1.5 en 
6 weke. Medium is inisieel eers vervang na 3-4 dae en daarna elke tweede dag. Alhoewel 
dit eers voorgekom het of die selle geheg en oorleef het, het die getal selle uiteindelik 
afgeneem totdat niks sigaar was nie. Ons is dus tot op hede onsuksesvol in ons pogings om 
‘n primêre kankersel-model daar te stel. Veranderlikes wat in aggeneem kan word in 
toekomstige pogings om primêre selle in kultuur te onderhou sluit in die gebruik van ‘n 
gepaste hegtings-matriks, asook optimalisering van die groeimedium. 
 
Aangaande die effek van hipoksie op PP2A in standaard selkultuur: MDA-MB-231 selle is 
onderhou in ‘n gasmengsel van 5%CO2, 0.5%O2 tesame met groemedium wat slegs 1% 
FBS bevat het vir wisselende tydsdure. Selle is daarna versamel en die volgende eindpunte 
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ondersoek: (1.) Die uitdrukking, fosforilering en metilering van die katalitiese subeenheid 
van PP2A; (2.) PP2A aktiwiteit; en (3.) seloorlewing. 
Resultate: Western-kladanalise na 72 uur hipoksie het ‘n afname in totale PP2A (Kontrole: 
1.00±0.1426 arbitrêre eenheide (AE) vs hipoksie: 0.3513±0.07558 AE; n=3; p≤0.05), asook 
‘n onverwagse afname in die relatiewe fosforilering van beide PKB (fosfo-tot-totaal (p/t) 
verhouding: kontrole: 1.211±0.1820 AE vs hipoksie: 0.2088±0.03583 AE; n=3; p≤0.05) 
asook ERK  (kontrole: 1.00±0.1519 AE vs hipoksie: 0.3493±0.05206 AE; n=3; p≤0.05) 
getoon. Hierdie resultate het ons genoop om korter periodes van hipoksie te ondersoek, 
spesifiek tussen 2 en 8 ure. Geen beduidende verskille in die uitdrukking, post-sintese 
modifikasie of aktiwiteit van PP2A is egter waargeneem nie, alhoewel PP2A aktiwiteit geneig 
het om toe te neem in assosiasie met hipoksie. Hierdie is uitgelig deur ‘n beduidende 
toename in PP2A aktiwiteit in selle blootgestel aan 6 uur van die chemiese stabilisering van 
HIF1ɑ (wat kenmerkend is van hipoksie) (kontrole: 134.7±33.74 AE vs positiewe kontrole: 
193.6±35.31 AE; n=2; p≤0.05). Vier en ses uur van hipoksie was konstant geassosieer met 
‘n afname in ATP.  
 
Bespreking en gevolgtrekking: Alhoewel ons ‘n interessante patroon van toenemende 
PP2A aktiwiteit in assosiasie met hipoksie waargeneem het, het ons resultate geen 
oortuigende verwantskappe getoon nie. In die lig hiervan, asook die literatuur, word verdere 
ondersoek vereis: Dit sal interessant wees om intermediêre tydsdure met minder ingrypende 
hipoksie (1% O2 instede van 0.5%) te ondersoek. Dit sal ook van waarde wees om die 
aktiwiteit van PP2A in hipoksie te moduleer, gevolg deur analises van sel-oorlewing en pro-
oorlewings seintransduksie. 
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Chapter 1: Literature Review 
 
1.1 The Burden of Breast Cancer 
Statistics concerning the rapidly increasing global incidence of breast cancer sees this 
unrelenting disease account for 23% per annum, of new cancer cases around the world, 
and it has been stated to be overall leading cause of cancer related deaths among women 
worldwide (Shibuya et al., 2002; Parkin et al., 2005). According to Cancer Research UK, 
approximately 1 in 8 women will develop breast cancer within their lifetime (World Cancer 
Research Fund International, 2017). It is the most common neoplastic disease in women 
the world over, accounting for a staggering 22.9% of all global cases, and 13.7% of cancer 
related deaths (Jemal et al., 2011). There are however, variations in incidence, mortality and 
survival between predominantly Western, industrialised countries and the developing world, 
with more than three quarters of breast cancer related deaths reported to be occurring in 
‘third world’ developing countries (Hortobagyi et al., 2005). This discordance has been 
reported to be largely related to the lack of preventative screening methods available leading 
to diagnosis at a late stage of cancer progression, along with poor access to patient care 
with below standard treatment (Vorobiof et al., 2001; Walker et al., 2004). The highest 
incidences of the disease have been reported in well developed, urbanised countries and 
regions, yet it presents a more favourable survival rate in comparison to incidences in the 
developing world (Hortobagyi et al., 2005; Ferlay et al., 2010). South Africa also follows the 
global cancer trend, with breast cancer presenting the primary cancer in women (Vorobiof 
et al., 2001). It has been reported that the incidence of breast cancer in South Africa is far 
higher in white South African women than compared to black women. However the 
occurrence of the disease in black South Africans appears to increase among women living 
in urban areas (Walker et al., 2004). African women from traditionally rural areas have been 
reported to show characteristic protective factors against the development of breast cancer, 
such as a later onset of menstruation, a younger age at birth of first child usually with 
prolonged lactation, and increased levels of physical activity in comparison to their non-
African counterparts. However, these favourable factors appear to decrease with a direct 
correlation to the increasing levels of urbanisation (Walker et al.,  2004).  
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Predisposition to breast cancer includes genetic factors (such as familial susceptibility), 
gender, age, exposure to radiation and other diseases of the breast (Turnbull and Rahman, 
2008; Cancer Genome Atlas, 2012). It has been predicted that, by the year 2030, the 
mortality rate of South African women with breast cancer will reach around 56.9% (Ferlay et 
al., 2010).  
 
The vast majority of malignant human tumours have been found to consist of cancerous 
epithelial cells along with a multitude of different cell types (such as fibroblasts, immune 
cells, adipocytes and normal non-cancerous epithelial cells), and of course, the components 
of the extracellular matrix (McAllister and Weinberg, 2010). Taken together, these 
components are collectively named the cancer microenvironment, or the stroma. Recent 
studies have alluded to the fact that all of the different cell types existing in the cancer 
microenvironment play an important role in the growth, survival and metastasis of the cancer 
cells within solid tumours (Quail and Joyce, 2013).  
 
The human breast can be described as consisting of mammary gland lobules, lactiferous 
ducts connecting the lobules, and stroma consisting of connective tissue, adipose tissue 
and a dense network of blood and lymph vessels (Badowska-Kozakiewicz et al., 2015). It 
has been found that the majority of breast cancers occur within the lactiferous duct tissue, 
however it is in fact possible for lesions to grow in all breast structures. Cancerous lesions 
within the lactiferous duct that do not infiltrate the surrounding tissue, have been described 
as non-invasive ductal carcinomas and account for approximately 20% of all breast cancers. 
Invasive ductal carcinoma of no special type are the most common form of invasive breast 
cancer, accounting for up to 80% of all cases (Badowska-Kozakiewicz et al., 2015). 
Chemotherapeutic agents (anthracyclines) used for breast cancer therapy have been found 
to be effective in treating patients diagnosed with breast cancer, however, they are cytotoxic 
to a wide assortment of systems in the body (Barrett-Lee et al., 2009). Resistance to cancer 
treatment therapies has become a prominent issue faced by patients, accounting for over 
90% of treatment failures (Coley, 2008), with a vast majority of sufferers experiencing a re-
occurrence of the disease with poor prognosis. Thus, there exists a serious requirement for 
novel strategies to overcome these problems and improve clinical outcomes and treatment.  
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1.2 Models Used to Study Breast Cancer 
1.2.1 Immortalised cell lines 
The bulk of our knowledge on breast cancer and breast cancer biology can be attributed to 
research done utilising breast cancer cell lines to investigate therapies, new therapeutic 
drugs or hormone treatments, as well as to gain a better insight into the mechanisms 
underlying tumour initiation and evolution of this relentless disease (Lacroix et al., 2004). 
Whether these cell lines are an accurate and realistic representation of cancerous tumours 
in vivo, and whether the molecular profiles of breast tumours are reflected in cell line models 
(Holliday and Speirs, 2011) remains a topic of debate among researchers, as it is somewhat 
unclear as to whether cultured cells are truly representative of in vivo conditions (Correa et 
al., 2009). Vargo-Gogola and Rosen described breast cancer as a collection of breast 
diseases rather than a single disease, having a diverse range of histopathologies along with 
both genetic and genomic variations and outcomes. They identified a major challenge facing 
breast cancer research being the availability of experimental models of the disease that 
accurately represent the multiple varieties of the disease  (Vargo-Gogola and Rosen, 2007). 
Most available lines have been derived from metastatic tumours, aspirates or pleural 
effusions, representing more aggressive behaviours and phenotypes, and are mostly 
genetically homogenous, converse to the heterogeneity of the in vivo tumour (Burdall et al., 
2003; Vázquez et al., 2004). The extent to which a single cell line can mirror the 
heterogeneity of clinical carcinoma samples has been questioned, as well as if an in vivo 
phenotype can be maintained in culture (Holliday and Speirs, 2011). Complex inter-
relationships existing in vivo are often lost when cell lines are cultured, with cells frequently 
found to be sensitive to culture conditions altering the cell’s phenotypes and resulting in the 
inappropriate activation of certain pathways, or altered differentiation (Holliday and Speirs, 
2011). Neve et al. suggested that no single cell line can be a true representation of the in 
vivo tumour cell population, yet a battery of cell lines could show the heterogeneity observed 
in primary breast cancer tissue (Neve et al., 2006). Based on this, it could be argued that 
future research studies should make use of additional methods or strategies to try and 
mitigate shortcomings of cell lines. Such methods could include injecting cells back into 
animals, as with xenografts (Kuperwasser et al., 2005; Stuelten et al., 2010), or changing 
and optimising the culture conditions with the additions of attachment-favouring products 
such as Matrigel,  promoting 3D culturing (Bergstraesser and Weitzman, 1993; Ip and Darcy, 
1996). Alternatively, protocols could include other models all together, such as primary cell 
models (S P Ethier et al., 1993; Speirs et al., 1998; Li et al., 1998). 
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Even with the metastatic nature of the cells, successful long-term culture has been limited, 
as it is probable that the cells undergo specific phenotype and genotype alterations in the 
simplified culture conditions when compared to in vivo cells (Burdall et al., 2003; Lacroix et 
al., 2004). Culture conditions used to propagate cell lines create vastly differing 
environments to the microenvironments within the breast tissue (Vargo-Gogola and Rosen, 
2007). It has also been identified that the same cancer cell lines cultured in different 
laboratories and/or under other conditions can evolve differently, giving rise to divergent 
sub-populations and preventing inter-laboratory comparisons of data on the same line 
(Lacroix et al., 2004). The metastatic foundation of most breast cancer cell lines also raises 
doubts as to the relationship of the lines to primary tumours, and it has been argued that 
most culturing conditions used for the establishing of the cell lines might eliminate some 
types of cancer cells initially present in the sample (Lacroix et al., 2004). 
 
Previous research however, suggests that breast cancer cell lines can likely reflect the 
features of the cancerous tumours from which they originate (Lacroix et al., 2004), and in 
many instances, remain powerful experimental and investigative tools (Holliday and Speirs, 
2011). Experiments performed on cell lines have established important principles, and 
allowed for the construction of useful hypotheses (Correa et al., 2009). A major benefit of 
using immortalised cell lines, is that they provide a ceaseless source of easily cultured, self-
replicating material with little to no contamination by fibroblasts or stromal cells, that can 
easily be grown and propagated over a long time (Burdall et al., 2003; Lacroix et al., 2004; 
Holliday and Speirs, 2011).  
  
Because of their ease of use, immortalised cancer cell lines will likely continue to be used in 
research as models for breast cancer. However, research findings suggest that the cell lines 
available might not be accurate representations of in vivo tumour cells, and the phenotype 
of the primary cells might alter significantly when interacting with surrounding tumour stroma 
in vivo (Lacroix et al., 2004). It is important for researchers to understand the shortfalls and 
to consider all limitations when designing experiments and interpreting experimental data, 
as relying on a single cell line could generate misleading data (Holliday and Speirs, 2011).  
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1.2.2 Isolated primary cells 
Successful isolation and culture of primary breast cancer cells provides an alternative model 
to immortalised cell lines, and is potentially of great importance for the establishment of a 
model of cells originating from an in vivo tumour for the advancement of our knowledge and 
understanding of breast cancer biology. As mentioned above, many investigative studies 
have made use of commercially available immortalised cell lines, however, recently it has 
come to light that these cell lines might not dependably display the true characteristics of 
the original tumour cells (Keller et al., 2010). Burdall et al. reported that the aggressive 
immortalised cell lines derived from tumour metastases, offer a bias toward more rapidly 
progressive and late stage cancer, rather than low grade and early stage disease. 
Accordingly, it could be argued that it is clinically more relevant to make use of cells isolated 
directly from a primary tumour as a more accurate representation of cancer pathophysiology  
(Burdall et al., 2003).  
 
The establishing and maintenance of isolated cells in primary culture as a more 
representative and viable in vitro model of breast cancer has been a major research target 
(Speirs et al., 1998). The advantage of this being that cells derived directly from tumour 
tissue offer a more accurate representation of the in vivo tumour, thereby furthering our 
understanding of cancer pathology, and allowing for characterisation of cell cultures which 
can be compared to the original tumour (Burdall et al., 2003). It is pertinent for researchers 
to select a cell culture model that accurately reflects as many of  the in vivo characteristics 
of the cells as possible, hence the essential need for a successful isolation and culturing 
protocol for primary cancer cells (Vu et al., 2015). 
 
Previous studies have been done to identify the optimal conditions for the procurement of 
primary breast cancer cells (Vu et al., 2015). It has been found that with isolation, many 
other cell types are often also present, such as connective-tissue fibroblasts, immune cells 
and vascular endothelial cells (Sung et al., 2007). Slow proliferation rates of isolated primary 
breast cancer cells often results in an overgrowth of these non-malignant cells, which 
threaten the successful culture and propagation of tumour cells (Dairkee et al., 1995; Speirs 
et al., 1998). Many attempts to isolate and culture cancer cells from breast tumour tissue 
have thus been largely unsuccessful due to this overgrowth of fibroblasts rapidly adapting 
to the in vitro conditions, and proliferating swiftly, outgrowing any epithelial counterparts 
Stellenbosch University  https://scholar.sun.ac.za
6 
 
(Freshney, 1985; Burdall et al., 2003; Lacroix et al., 2004). Amadori et al. were only able to 
report a success rate of 0.7% (Amadori et al., 1993), while Gazdar et al. obtained isolated 
cells from a mere 18 out of 177 cultures (Gazdar et al., 1998). Limitations and further barriers 
often encountered in the isolation procedure include low availability of human breast tumour 
tissue, the lack of consensus in literature regarding a successful, reproducible protocol for 
the isolation, cultivation and characterisation of the cancer cell population (Weigand et al., 
2016), as well as obtaining sufficient quantities of cancer cells in culture for molecular and 
cell biology studies (Speirs et al., 1998). Furthermore, there often also exists a lack of clear 
identification and morphological distinction between non-malignant and malignant cells in 
culture (Dairkee et al., 1995). 
 
The poor efficiency of the isolation procedure is often attributed to the technical difficulties 
associated with the extraction of viable tumour cells from the surrounding stromal tissue 
(Lacroix et al., 2004). However, Vázquez et al.  were able to derive and characterize three 
novel hormone responsive cell lines from human breast carcinomas through isolation and 
culture (Vázquez et al., 2004). Lacroix et al. reported that freshly isolated breast cancer cells 
can be considered to be representative of cancer cells in vivo (Lacroix et al., 2004). Although 
more technically challenging to establish, if properly characterized, isolated cells can offer a 
more clinically relevant model likely to provide more significant data (Burdall et al., 2003). 
However, it has been suggested that long-term culturing can alter the cancer cell’s 
properties (Lacroix et al., 2004). Although the limitations of primary culture exist with the 
afore-mentioned slow doubling times and poor characterisation due to rapid overgrowth of 
fibroblasts, when cultured over the short term, the cells appear able to maintain many 
characteristics associated with breast tumours (Speirs et al., 1998). There is little opportunity 
for the transformations frequently observed in long-term culture of immortalised cell lines, to 
take place when primary cells are maintained in culture for only a limited length of time. 
However, due to the loss of cell-cell interactions, the possibility does exist that the isolated 
cells may well behave differently under culture conditions in comparison to when forming 
part of the tissue in vivo (Burdall et al., 2003). 
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1.2.2.1 Primary cell isolation from excised tumour tissue  
In literature to date, there does not appear to be any general consensus on a single 
reproducible and successful method for primary cell isolation and propagation in culture. 
Many studies describe an isolation protocol requiring the mechanical disruption and 
enzymatic digestion of the tumour tissue (Burdall et al., 2003), with further differential 
centrifugation following the addition of collagenase for digestion. This allows for cell 
separation based on differing sedimentation rates (Emerman and Wilkinson, 1990; Speirs 
et al., 1996), and subsequent propagation of sufficient quantities of cells (Speirs et al., 1998; 
Loveday et al., 2002). Research published by Dairkee et al. describes a 6 hour partial 
enzymatic digestion with 66% of samples giving rise to tumour epithelial cells presenting 
with a proliferative capacity (Dairkee et al., 1997). Interestingly, the same research group 
had previously described an isolation protocol using a custom made sandwich model 
creating an hypoxic gradient whereby only malignant cells survived (Dairkee et al., 1995), 
however, further reported use of this technique is limited. 
 
In terms of sample collection, once patient consent has been obtained from breast cancer 
patients, tumour tissue is removed often by needle biopsy or through mastectomy surgery. 
When received in the laboratory following clinical and pathological testing, the tumour mass 
is often vastly reduced (Vázquez et al., 2004). Tissues are generally washed extensively in 
phosphate buffered saline (PBS) and subjected to disaggregation into fragments to remove 
any excess adipose and vascular material (Vu et al., 2015; Weigand et al., 2016), followed 
by the addition of collagenase and/or hyaluronidase for digestion, and overnight incubation 
on a rotor at 37°C (Speirs et al., 1998; Vázquez et al., 2004; Weigand et al., 2016). This 
digestion step preferentially disrupts the cancer cell’s contact with any stromal cells present, 
instigating release of single tumour cells while the remaining tumour epithelium remains 
intact. This allows for differential centrifugation and fractionation in later steps to successfully 
isolate the cancer cells for culturing (DeRose et al., 2013). In a previous argument by Li et 
al., it had been reported that approaches to the isolation of primary breast tumour cells 
dependent on the mechanical and/or enzymatic disaggregation and digestion of connective 
tissue, required large quantities (in excess of several grams worth) of tumour tissue. 
Furthermore, the cultures that have managed to proliferate using these techniques, are 
frequently slow-growing with a high occurrence of fibroblast overgrowth along with other 
breast tissue (Li et al., 1998). 
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Several studies have proceeded to characterise and plate the resulting fractions following 
digestion and a filtration steps, in a culture medium of Dulbecco’s Modified Eagle medium 
(DMEM) and HAMS-F12 with low (5%) serum and supplemented with growth factors, insulin 
and bovine serum albumin (BSA) and HEPES (Soule et al., 1990; Speirs et al., 1998; 
Vázquez et al., 2004; Ponti et al., 2005; Marsden et al., 2012; Weigand et al., 2016). 
  
However, since the culturing of cells isolated through protease digestion of solid tumours 
can encourage and increase the risk of overgrowth of any stromal cells and fibroblasts that 
might be present (Speirs et al., 1998; Loveday et al., 2002), there is a need for selective 
culture conditions allowing for the propagation of cancer cells only (Hass and Bertram, 
2009). Preferential growth of primary cancer cells is stimulated most often in serum-free, or 
low serum conditions permitting this selection (Emerman and Wilkinson, 1990). However, 
cells may still require a complex culture medium (including growth factors), and a reduced 
cell proliferation rate is frequently experienced (Vu et al., 2015). Although short term culture 
of isolated cancer cells can prove successful, it is still an imperfect model due to the nature 
of the mechanical and/or enzymatic digestion methods causing disruption to the normal 
tissue architecture and cell-cell interactions, which would normally occur in vivo (Burdall et 
al., 2003). In a protocol described by Hood et al., these functions and interactions can be 
maintained when a tissue slice (400 µm thick) from an excised tumour is placed in vitro for 
up to 6 days allowing cells to proliferate along with the adequate diffusion of nutrients from 
the surrounding culture medium (Hood and Parham, 1998). Further studies have also 
reported isolation techniques, whereby digestion with collagenase and differential 
centrifugation are not implemented. Hass et al., van Pham et al., and Vu et al. each describe 
protocols where tumour tissue samples were cut into fragments, washed with PBS and 
seeded directly onto uncoated culture dishes in serum-free growth medium with appropriate 
supplementations, and incubated at 37°C (Hass and Bertram, 2009; Van Pham et al., 2012; 
Vu et al., 2015). This approach led to the subsequent outgrowth of primary derived breast 
cancer cells spread out from the tumour fragments and forming tumour clusters, which were 
later separated and placed in a new culture dish to encourage the continual outgrowth of 
primary cancerous cells (Hass and Bertram, 2009). The success rate of further culture of 
the isolated primary breast cancer cells is greatly increased when using optimised growth 
media to enhance tumour cancer cell growth whilst preventing the rapid overgrowth of 
stromal cells and fibroblasts (Vu et al., 2015).  
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Following an isolation protocol, many studies make use of characterisation techniques to 
identify and confirm successful isolation and propagation of primary breast cancer cells. 
Techniques used include flow cytometry analysis using cancer specific cell surface markers 
CD44+/CD24- (Van Pham et al., 2012; DeRose et al., 2013; Vu et al., 2015), 
immunocytochemistry (Weigand et al., 2016), immunostaining, and polymerase chain 
reaction (PCR) (Ethier et al., 1993). In an effort to improve the success rate of primary breast 
cancer cultures, researchers have employed a number of approaches such as optimising 
the dissociation process of tumour tissue (Dairkee et al., 1997), improving the growth 
medium formulation (Band et al., 1990; Ethier et al., 1993) and simulating an in vivo 
microenvironment, in culture (Dairkee et al., 1995). 
 
1.2.2.2. Primary Cell Isolation through Fine Needle Aspiration (FNA) 
Fine needle aspiration (FNA), first reported to be used by Martin and Ellis in 1930 (Martin 
and Ellis, 1930), is a well-established, safe, minimally invasive, accurate technique to obtain 
samples from solid breast lumps, and is commonly used in the pathological characterization, 
evaluation and diagnosis of palpable and non-palpable lesions (Schmitt et al., 1995a; 
Schmitt et al., 1995b; Li et al., 1998; Rosa, 2008) . It is usually a fast technique, rarely 
presenting any complications, and commonly performed after the detection of a mass or 
lesion (Frable, 1983; Rosa, 2008). It is an inexpensive and relatively painless technique, 
and is advantageous in that it can be performed at the bedside of patients in outpatient 
clinics etc. (McLoughlin et al., 1978). Commonly, a fine 23-gauge needle attached to a 
syringe is used to remove cells from the tissue, referred to as a ‘pass’ (Figure 1.1). This is 
achieved by moving the needle back and forth through the tumour while pulling back on the 
syringe plunger to maintain suction, creating a pressure difference to draw cells into the 
needle (Li et al., 1998). FNA has become an important tool in clinical cytology and is 
frequently found to complement and supplement histology practices, being used extensively 
as a tool for obtaining samples from superficial organs of the body such as lymph nodes, 
breast tissue, thyroid and salivary glands for diagnostic purposes, in developed as well as 
developing countries (Das, 2003). 
 
The use of frozen sections of cancerous lesions has largely been replaced by FNA which 
has proven advantageous in providing assessment of hormonal status in patients, as well 
as many other significant biomarkers (Schmitt (a), Bento and Amendoeira, 1995; Schmitt 
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(b), Figueiredo and Lacerda, 1995). Two important factors which determine the cellular yield 
of the FNA are reported to be a) the skill of the individual performing the techniques, and 
more importantly, b) the cellularity of the malignant lesion. Furthermore, the number of actual 
viable proliferation competent cells present in the FNA sample, will determine whether 
propagation in culture will occur (Li et al., 1998). In addition to the detection of neoplasia 
through morphological analysis, cytological smears of breast cancer FNA samples have 
been used in independent research, through indirect immuno-localisation, towards 
outcomes such as the determination of estrogen and progesterone receptors (Skoog et al., 
1990), the expression of oncogene p53 (Lavarino et al., 1998) and the expression of the 
protein, erb-B2, also referred to as HER2 (Troncone et al., 1996). 
 
 
 
 
 
 
 
 
 
Figure 1.1 Cross section of a fine needle aspiration of a breast lump (Cancer Helpline, 2017). 
 
Since the FNA technique was implemented in the 1930’s (Martin and Ellis, 1930), it has 
been used predominantly as a diagnostics related technique. Aside from the advantages of 
patient diagnosis and prognosis, it has been proposed that FNA can be used to obtain 
samples of malignant cells from cancer patients for the purpose of research (Araujo et al., 
1999). It was suggested by Hammond et al., that it is possible to harvest tumour cells from 
small quantities of tumour material present in primary breast cancer FNA samples 
(Hammond et al., 1984). However, there exists in literature, a vast gap pertaining to this 
research idea, although two particular studies from the 90’s allude to the notion that cells 
obtained through FNA can be cultured and propagated in vitro for further research (Li et al., 
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1998; Araujo et al., 1999). Breast cancer cell lines have in the past been useful in the 
research of tumorigenicity, hormone responsiveness and drug-resistance as well as other 
aspects (Möbus et al., 1998).  However, the majority of in vitro breast cancer research 
investigations have been carried out on well characterised cell lines, whose phenotype as 
well as biological behaviour could be different to that of the primary cancer, as the cells are 
often derived from secondary metastases rather than the primary tumour itself  (Amadori et 
al., 1993; Siwek et al., 1998). Thus, there remains a need for the establishment of a cell 
model that retains the original tumour characteristics and can offer a better representative 
model for the study of hormone expression and neoplastic behaviours such as the 
progression and mechanisms involved in breast cancer (Araujo et al., 1999).  
 
It has been demonstrated, that primary breast cultures can be established from culturing 
material obtained through FNA (Li et al., 1998; Araujo et al., 1999), although there are 
several obstacles that interfere with and hinder isolation. Commonly, the presence and 
overgrowth of fibroblasts in the sample is a primary concern for all isolation techniques, as 
they are generally the first cell type to adhere to culture plates. This is especially true in the 
case of FNA sample collection (Gartner et al., 1996). Cleaning fibroblasts out of the sample 
is often tedious and time consuming (Amadori et al., 1993; Gartner et al., 1996), thus plural 
or visceral effusions, which have been commonly used to establish the majority of available 
breast cancer cell lines as cultures, prove far easier to establish (Siwek et al., 1998). 
Aspirates also frequently contain varying amounts of other contaminating cells, such as red 
blood cells, lymphocytes and mesenchymal cells (Li et al., 1998).  
 
In a study conducted by Li et al., FNA samples were collected from 25 patients. The samples 
were retrieved from tumours already excised from patients, prior to the specimen being cut 
open. A small, 23-gauge fine needle and syringe were used to aspirate the sample through 
continuous moving of the needle back and forth through the lesion while maintaining suction 
in the syringe by pulling back on the plunger. The aspirate was expelled into suitable 
transport medium and the process was repeated several times until a suspension containing 
visible fragments was obtained. The sample suspension was then centrifuged and the cell 
pellet re-suspended in suitable MCDB170 growth medium (supplemented with calcium, 
insulin, epidermal growth factor (EGF), hydrocortisone, bovine pituitary extract and fetal calf 
serum (FCS)), plated into culture dishes and maintained under standard conditions (37°C in 
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5% CO2) (Hammond et al., 1984). Differential trypsinisation was implemented to remove 
any contaminating fibroblasts only after the initial cell attachment and growth of the culture 
(Wolman et al., 1985). Cultures were passaged 3-7 times at sub-confluence using routine 
trypsinisation. It was found that cell proliferation was high during the first three sub-culturing 
cycles, with duplication time between 48-72 hours. In subsequent passaging, cell numbers 
appeared to increase more slowly, with a doubling rate of between 10 and 12 days. Through 
immunofluorescence, loss of heterozygosity (LOH) analysis and fluorescent in situ 
hybridisation (FISH) analysis, the researchers found they were able to expand viable cells 
from the FNA and obtain pure populations of cancerous epithelial cells presenting the same 
distinctive characteristics as that of the original tumour tissue, and in all cases, the 
phenotype of the cultures closely resembled the cancerous lesion from which they were 
derived.  
 
The objective of a similar study conducted by Araujo et al. was “to verify the potential role of 
FNA cytology in obtaining malignant cells from primary breast cancer, for the establishment 
of a primary breast cancer cell line” (Araujo et al., 1999). The study was conducted on four 
patients with the outcome of one successfully obtained primary cell line. FNA samples were 
collected under sterile conditions using a small, 23-gauge needle attached to a syringe. The 
material was then centrifuged, and the pellet washed and re-suspended in DMEM medium 
supplemented with HEPES, FCS, EGF and penicillin/streptomycin. The suspension was 
seeded into a 25 cm3 culture flask and cultured under standard conditions (37°C in 5% CO2). 
It took approximately one week for the cells to attach to the bottom of the cultures plate and 
to begin to proliferate. Cells were sub-cultured when a stage of confluence was reached and 
approximately 15 passages of sub-culturing occurred. It was reported that the cells 
appeared to reach confluence in more or less 2 weeks with a doubling time between 48-72 
hours. Growth kinetics, xenografts and immunocytochemistry analysis showed that the 
cultured cells established from the FNA sample presented with the same morphological 
characteristics as that of the original tumour. It was also concluded that only a small 
percentage of fibroblasts were present in the FNA sample and cancer cells appeared to 
represent the bulk of the tumour. This suggests that the use of the FNA technique to obtain 
malignant tumour cells for the purpose of laboratory culturing might be advantageous due 
to reduced risk for contamination of fibroblasts in culture. However, it is thought that the 
number of tumour cells present in the original FNA sample could play an important role in 
the success rate of establishing the primary culture (Araujo et al., 1999).  
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The use of FNA could prove to be a possible alternative in establishing a viable cell culture 
from a primary tumour, with no need for enzymes such as trypsin or collagenase for cell 
detachment from the surrounding stroma, as predominantly free, isolated cells can be 
obtained (Araujo et al., 1999). When performing an FNA, the bevelled tip of the needle easily 
shears through the tumour tissue, dislodging the less cohesive tumour cells, which are easily 
aspirated from the tissue and stromal elements. In this way, a more enriched sample is 
obtained that contains predominantly malignant cancer epithelium (Li et al., 1998). The afore 
mentioned studies show that relatively small numbers of cells within the FNA sample can be 
successfully propagated in culture, and could prove useful in research studies (Li et al., 
1998; Araujo et al., 1999). Regarding direct patient care, the existence of a strategy that can 
lead to an in-depth analysis of an FNA sample culture of a cancerous tumour, could be 
beneficial in the establishment of more effective patient specific therapeutic interventions 
that could potentially replace surgery or in the least, function as adjuvant therapy to surgical 
intervention (Li et al., 1998). However, minimal research has been conducted since these 
principle studies in the 1990’s possibly suggesting that the techniques and culture of primary 
FNA samples might not be as successful as hoped.  
 
1.3 The Effect of Hypoxia in Cancer 
A sufficient oxygen supply to the tissues is essential for the maintenance and proper 
functioning of cells, and to ensure appropriate energy reserves in the form of ATP 
(Badowska-Kozakiewicz et al., 2015). Hypoxia can be described as the reduction or 
deficiency of oxygen in tissues, with molecular oxygen levels reaching less than 2%. 
Moderate hypoxia is defined as tissue oxygen levels of 1.2%, while deep hypoxia or anoxia 
is defined as below 0.2%. Cells that are unable to adapt to the hypoxic environment and 
nutrient deprivation that often accompanies hypoxia, will likely undergo apoptosis and/or 
necrosis (O’Reilly, 1996). For cell survival to continue, cells are required to adapt to these 
new hypoxic conditions by making a switch to anaerobic metabolism, or to restore the 
appropriate levels of tissue oxygenation (Badowska-Kozakiewicz et al., 2015). Cells assume 
a range of responses in order to maintain a precise balance between the requirement of 
oxygen as an energy substrate of oxidative phosphorylation and metabolic reactions, and 
the intrinsic risk of possible oxidative damage to cellular macromolecules (Zhou et al., 2006; 
Ruan et al., 2009). Aside from the restoration of appropriate tissue oxygenation levels 
through increased angiogenesis (Strese et al., 2013), other mechanisms of adaptation and 
compensation include increased levels of lung ventilation, reduced blood viscosity, 
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decreases in the resistance of peripheral vessel, the redistribution of blood flow, and a switch 
to anaerobic metabolism, favouring glycolysis, facilitated through an increase in expression 
of glucose transporters (Semenza, 2003; Badowska-Kozakiewicz et al., 2015). With the 
adaptive shift from respiration to glucose metabolism, a decrease in intracellular pH follows 
due to the increase in production of lactic acid, leading to a state of acidosis (Zheng et al., 
2005; Badowska-Kozakiewicz et al., 2015). Acidosis during hypoxia is often thought to 
contribute to the susceptibility of cells to undergo apoptosis, with metabolically active cells 
found to be more prone to this demise than their silent counterparts (Zheng et al., 2005). 
Glycolysis and inhibition of apoptosis are therefore key regulators of cell survival, specifically 
in cancer cells (Park et al., 2015). In fact, the onset of hypoxia in the context of cancer, can 
also promote and facilitate cell proliferation through the provocation of adaptive responses, 
inciting a more aggressive tumour phenotype with often accompanying chemoresistance 
(Brown and Giaccia, 1998; Semenza, 2003; Zhou et al., 2006). These alterations may in 
turn contribute to an anti-apoptotic phenotype and tumour progression in the cancer 
environment, with an increase in invasion and metastasis contributing to an increase in cell 
survival (Semenza, 2003; Zhou et al., 2006; Strese et al., 2013).  
 
Cancerous tumours developing from epithelial tissue are characterised by growth and 
unrestricted replication with the potential to metastasise and infiltrate surrounding tissue 
(Vaapil et al., 2012). Regions of hypoxia are characteristic of the cancer microenvironment 
due to insufficient angiogenesis leading to a decrease in oxygen and nutrient supply, and 
ultimately to the subsequent stimulation of migration of endothelial cells to the region of 
tumour growth. This subsequently initiates disorderly angiogenesis which further impedes 
oxygen supply and contribute to persistently increasing hypoxia (Sorrentino and Carlo, 2009; 
Filho et al., 2010; Heddleston et al., 2010). Bousquet et al. proposed that a lack of oxygen 
to tissues can be seen as a hallmark of cancer, as it appears to be the driving force for 
malignant tumour progression with proteomic changes favouring cell survival under hypoxic 
conditions, leading to a more aggressive phenotype (Bousquet et al., 2015). Cells are able 
to adapt to the limited oxygen by slowing down cellular processes to preserve energy and 
by altering their metabolism to maximise energy gain (Carrer and Wellen, 2015). Sclerotic 
lesions developing in breast tissue are frequently poorly oxygenated and it has been 
hypothesised that hypoxia may play an important role in the cancerous transformation of 
cells in the hypoxic microenvironment (Vaapil et al., 2012). Growth arrest and/or necrosis 
occurs in the unvascularised regions when there is an insufficient supply of oxygen 
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(Tannock, 1968; Evans et al., 2001). In a review written by Badoswska-Kozakiewicz et al., 
it was discussed that due to factors such as poor vascularisation, limited oxygen supply with 
increased ischaemia, and large distances between cells, cancerous cells appear to be 
largely susceptible to increasing hypoxia and disease progression (Badowska-Kozakiewicz 
et al., 2015). Genetic defects in cell cycle checkpoints, as well as in DNA repair mechanisms, 
have been found to lead to genetic instability in cells, resulting in the progressive acquisition 
of several genetic, somatic and even epigenetic alterations promoting tumorigenesis 
(Hanahan and Weinberg, 2000). Hypoxia as a stress on the tumour microenvironment can 
provoke genetic instability through an increase in gene amplification, chromosomal 
rearrangement and the induction of intra-chromosomal fragile sites within cells (Coquelle et 
al., 1998; Bristow and Hill, 2008). It has also been reported that conditions of hypoxia can 
lead to the suppression of the expression of DNA mismatch repair genes, leading to an 
increase in the occurrence of mutagenesis (Bindra et al., 2007; Huang et al., 2007). These 
alterations cause cancer cells to adopt functional characteristics that oppose normal 
homeostasis such as facilitating a switch to a glycolytic metabolism, promoting the ability for 
unlimited replication potential, inducing irregular angiogenesis, resisting growth inhibitory 
factors, evading apoptosis, evading attacks from the immune system, promoting 
proliferation without exogenous growth factors, as well as invasion and metastasis 
(Hanahan and Weinberg, 2000; Bao et al., 2004) (Figure 1).  
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Figure 1.2 Adapted from Ruan et al, 2009. Hypoxia is associated with several aspects of tumorigenesis, 
including promoting a switch to glycolysis, the induction of angiogenesis, evasion of apoptosis, 
genomic instability, resistance to growth inhibitory factors, evasion of the immune system, unlimited 
replication potential, invasion and metastasis (Ruan et al., 2009).  
 
1.3.1 Hypoxia and HIF-1α 
Conditions of hypoxia have been found to lead to changes in gene expression, induction 
and suppression of specific genes, with hypoxia-inducible factor 1 (HIF-1) identified as the 
predominant transcription factor involved in the adaptation of cells to the hypoxic 
environment and the switch to anaerobic metabolism facilitating cell survival (Brahimi-Horn 
et al., 2007; Badowska-Kozakiewicz et al., 2015). This heterodimer is composed of one of 
three α-subunit isoforms, together with a single HIF-1β subunit, and is activated when the 
α-subunit is expressed or becomes stabilised under conditions of hypoxia (Kaelin, 2002; 
Pugh and Ratcliffe, 2003; Semenza, 2004). Kaelin et al. have reported that a decrease in 
the hydroxylation of Pro564/402 and Asn803 occurs with hypoxia, resulting in the 
stabilisation of HIF-1α and subsequent recruitment of transcriptional cofactors leading to the 
activation of HIF-1. Association of  the β subunit with HIF-1α thus activates HIF-1 and results 
in the expression of target genes (Kaelin, 2002). The discovery of HIF-1 has led to the 
identification of the molecular mechanisms involved in the adaptive responses of cells to the 
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changes in oxygenation of body tissues (Zhou et al., 2006). HIF-1 target genes include 
erythropoietin (EPO), VEGF, insulin-like growth factor 2 (IGF2) and transforming growth 
factor α (TGFα), all associated with pro-survival/proliferation, as well as cell death pathways 
(Semenza, 2003; Greijer and Wall, 2004; Brahimi-Horn et al., 2007). It has been reported 
that the hypoxia induced activation of HIF-1 plays a critical role in responses such as 
proliferation, angiogenesis, immunosurveilance, tumour invasion and survival (Ruan et al., 
2009). However, it plays an important further role in the maintenance of oxygen homeostasis  
(Kaelin and Ratcliffe, 2008), and as such is essential in systemic homeostasis (Badowska-
Kozakiewicz et al., 2015). The exact role of HIF-1 in cell adaptation and/or death is uncertain, 
since its activation has been shown to favour both pro-survival as well as pro-death 
pathways. Thus, there exists a paradox between the induction of both pro-survival and pro-
apoptotic genes as a consequence of HIF-1 activation under hypoxic conditions (Zhou et 
al., 2006). A balance between these activators and inhibitors is necessary for the regulation 
of either adaptation or apoptosis of cells in the growing tumour (Strese et al., 2013). 
 
It has also been suggested that secondary stressors, such as the progressively more acidic 
environment alongside genetic alterations, may play a role in the mechanism of action of 
HIF-1, mediating the susceptibility of cells to either adaptation and malignant progression, 
or alternatively to progress through hypoxia-induced cell death (Zhou et al., 2006). Only 
phosphorylated HIF-1α  is able to bind to HIF-1β under hypoxic conditions, while 
dephosphorylated HIF-1α preferentially binds to p53 to bring about pro-apoptotic responses 
(Suzuki et al., 2001). Thus the phosphorylation status of HIF-1α during hypoxia is key in 
determining whether apoptosis or proliferation is promoted (Semenza, 2003).  
 
In a normoxic environment, HIF-1α is typically unstable, difficult to detect, and earmarked 
for degradation by hydroxylation catalysed by prolyl hydroxylase (PHD) proteins, or, ‘oxygen 
sensors’ (Kaluz et al., 2008). Changes in the oxygen supply to the cells affects the enzyme’s 
activity, thus functioning as an oxygen sensor system (Ivan et al., 2001; Jaakkola et al., 
2001). Under conditions of hypoxia, PHD’s and factors-inhibiting-HIF-1 (FIH) are inactivated 
due to the absence of oxygen. HIF-1α is stabilised, and translocates to the cell nucleus 
where it forms a heterodimer with the HIF-1β subunit, and interacts with cofactors for binding 
to hypoxia-response elements (HRE) of promoter genes, fundamental in mediating systemic 
responses to hypoxia (Bertout et al., 2008; Chandel and Simon, 2008; Simon and Keith, 
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2008). Initial increases in levels of HIF-1α might be responsible for cell adaptation to 
hypoxia, with cancer cells favouring angiogenesis stimulation by vascular endothelial growth 
factor (VEGF) (Hicklin and Ellis, 2004), the inhibition of apoptosis (Zhou et al., 2006), 
adaptation to the increasing extracellular acidic pH (Cardone and Casavola, 2005), and the 
upregulation of proliferative proteins (Bogenrieder and Herlyn, 2003). An over expression of 
HIF-1 has commonly been associated with cancerous lesions with mean oxygen levels in 
tumour tissue presenting at approximately 10 mmHg while healthy, oxygenated tissue levels 
are around 63 mmHg (Cancer Genome Atlas, 2012). This reduced partial pressure of 
oxygen has been linked to the increase in expression of HIF-1 particularly, for example, in 
the pre-invasive high microvascular density stages of breast cancer, and may suggest a 
possible role of HIF-1 in cancer progression (Edge and Compton, 2010; Cancer Genome 
Atlas, 2012). It has been postulated that the overexpression of HIF-1 is linked to an 
increased risk of tumour invasion and metastasis with poor patient prognosis (Ruan et al., 
2009). HIF-1 induced angiogenesis has been implicated in tumour growth and metastases 
due to the associated increases in lactate production (from increased glycolysis) and 
overexpression of VEGF, leading to poor patient prognosis (Bos et al., 2003; Edge and 
Compton, 2010). A number of reports have thus supported the idea that hypoxia plays a 
predominantly pro-survival role in tumour tissue, with HIF-1α particularly exerting an anti-
apoptotic response (Zhang et al., 2004). Resistance to apoptosis induced by hypoxia has 
been linked to the development of chemo- and radiation resistance with an increase in 
invasive and metastasis potential (Hockel and Vaupel, 2001). Mechanistically, several 
factors have been reported to promote tumour metastases, induced by hypoxia, all of which 
are either directly or indirectly influenced by HIF-1 transcription regulators (Le et al., 2004; 
Chan and Giaccia, 2007; Vooijs et al., 2008; Lunt et al., 2009). Taking all the effects of HIF-
1 activation into account, it is perhaps not surprising that an increase in HIF-1α expression 
has been associated with an increase in patient mortality (Zhou et al., 2006).  
 
1.3.2 Metabolic Adaptations 
It is well known that normal, non-cancerous cells rely predominantly on mitochondrial 
oxidative phosphorylation as an efficient method of ATP production for metabolic processes, 
rather than glycolysis (Zheng, 2012). In contrast to this, under hypoxic conditions, cancer 
cells have been reported to preferentially switch their glucose metabolism from oxidative 
phosphorylation to oxygen independent glycolysis as a primary mechanism of ATP 
production, whereby components of the glycolytic pathway become up-regulated (Harris, 
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2002; Semenza, 2003; Brahimi-Horn et al., 2007; Denko, 2008). This adaptive shift to 
anaerobic metabolism is often regarded as an important hallmark of cancer cells under 
hypoxic conditions (Gatenby and Gillies, 2008). In 1926 Otto Warburg first described this 
inefficient pathway for the production of energy in cancer cells, which has been termed, the 
‘Warburg effect’. In his research, Warburg hypothesised that the cancer cell’s altered 
metabolism could be due to defective mitochondria, in turn affecting the cell’s ability to 
oxidize glucose to CO2 efficiently (Warburg et al., 1927). However, it has since been reported 
that the ability of cancer cell mitochondria to carry out oxidative phosphorylation is not 
defective. Instead, mitochondrial metabolism undergoes a reprogramming in order to better 
cope with the synthesis of macromolecules (Ward and Thompson, 2012). Recently, Lee et 
al. suggested that the cancer cells might have the inclination to preferentially produce energy 
through oxidative phosphorylation rather than increased glycolysis, but this is largely 
dependent on the surrounding conditions of the microenvironment (Lee and Yoon, 2015). 
This theory has been termed the ‘reverse Warburg effect’, and proposes that the oxygen 
deprived cancer cells stimulate an increase in aerobic glycolysis, with a subsequent increase 
in lactate production, in surrounding stromal cells which is then converted to pyruvate and 
utilized by the oxidative phosphorylation pathway in cancer cells. Thus, the stromal cells 
seem to ‘feed’ the cancer cells with pyruvate, thereby preventing the development of an 
acidic tumour microenvironment (Lee and Yoon, 2015). This concept advocates that both 
the surrounding stromal cells, as well as the cancer cells might have an influential role on 
the energy metabolism of each other, thus influencing cancer growth and progression. The 
understanding of the proposed mechanisms still remains unclear, however, Fiaschi et al. 
have reported that an increased production of ROS within the cancer cell environment in 
addition to the direct increase in aerobic glycolysis, can lead to the activation of HIF-1α and 
NFKβ, another important transcription factor (Fiaschi and Chiarugi, 2012), along with 
subsequent induction of oxidative stress and autophagy in the surrounding stromal cells and 
microenvironment (Pavlides et al., 2012). Taken together, these alterations contribute and 
ultimately lead to an increase in the production of metabolic substrates, such as lactate and 
ketones, which are shifted into cancer cells and utilized for their progression and survival 
(Anastasiou et al., 2011; Ros et al., 2012).  
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1.3.3 Cellular Signalling and Inflammation 
Cancer cells have also been found to be able to modify growth-inhibitory signalling events. 
Phosphatase and tensin homolog (PTEN), a tumour suppressor known to inhibit the 
phospho-inositol 3 kinase (PI3K) – protein kinase B (PKB) pathway which regulates cell 
survival and growth, is reported to be mutated, or even deleted in some forms of cancer, 
leading to the promotion of tumour growth and proliferation through HIF-mediated responses 
(Zundel et al., 2000; Harris, 2002). Related to this, several researchers have reported that 
the PI3K/PKB survival pathway is activated under conditions of hypoxia, thus promoting cell 
survival and proliferation in various cancer types (Song et al., 2005; Furuta et al., 2008; Wai 
and Kuo, 2008; Zeng et al., 2008; Walsh et al., 2009). 
 
Another potential role player in this setting is interleukin-32β (IL-32β), a pro-inflammatory 
cytokine, which has been associated with hypoxia. It has been shown that conditions of 
hypoxia play a role in its activation and over-expression in cancer. In this regard, hypoxia 
induced ROS has been shown to enhance IL-32β production (Park et al., 2013). In turn, IL-
32β enhances the migration and invasive potential of numerous tumour types, including 
breast cancer (Nishida et al., 2009; Nold-Petry et al., 2009; Sorrentino and Carlo, 2009; Tsai 
et al., 2014). Park et al. have reported that hypoxia-induced IL-32β also plays a role in the 
stimulation of glycolysis in hypoxia, mediated through the activation of lactate 
dehydrogenase (LDH), as well as the stimulation and activation of Src through the protection 
of its phosphorylation. This suggests that a hypoxia-ROS-IL-32β – Src-glycolysis interlinking 
pathway might be associated with the molecular regulation of cancer cell metabolism (Park 
et al., 2013; Park et al., 2015).  
 
1.3.4 Hypoxia Summary 
A review by Zhou et al. concluded that conditions of hypoxia appear to influence a wide 
range of molecular pathways to promote and facilitate adaptation of cells, apoptosis and 
chemoresistance. The responses of cells to hypoxia are determined through both pro- and 
anti-apoptotic factors, along with proliferative signals, a shifting in microenvironmental pH, 
as well as clonal selection. It has further been suggested that apoptosis may be initiated in 
conditions of severe and prolonged hypoxia/anoxia due to the presence of secondary 
stressors, such as acidosis, leading to the onset of apoptotic pathways. The development 
of chemoresistance and possibly clonal selection may occur in response to the opposing 
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signals delivered by pro-survival and pro-death pathways, leading to the selection of cells 
displaying a genetic or epigenetic growth advantage (Zhou et al., 2006). Vaapil et al. further 
concluded that conditions of hypoxia lead to a less differentiated phenotype in cells, and 
impairs cellular differentiation of non-malignant mammary epithelial cells by ‘trapping’ the 
cells in an undifferentiated, proliferative state increasing the risk of genetic alterations and 
mutations (Vaapil et al., 2012). 
 
Although hypoxia may prove toxic to both normal and cancerous cells, cancer cells appear 
to be able to undergo alterations permitting their adaptation and increasing their ability for 
survival and proliferation (Harris, 2002; Powis and Kirkpatrick, 2004). They are able to break 
the balance between pro- and anti-apoptotic factors, and continue to survive under adverse 
conditions such as hypoxic stress (Semenza, 2002; Bao et al., 2004; Blagosklonny, 2004). 
For critical understanding of cancer development and progression, it is important to 
understand the molecular mechanisms involved in the induction of cell death as well as 
cellular adaptations to such signals.  
 
1.4 Protein Phosphatase 2A (PP2A) in Cancer 
The transfer of phosphates between substrates is catalysed by the action of phosphatase 
and kinase enzymes. While the transfer of phosphate from ATP or GTP to a protein 
substrate is catalysed by protein kinases, protein phosphatases catalyse the transfer of the 
phosphate group from a phosphorylated protein to a water molecule (Cheng et al., 2011).   
Phosphorylation and dephosphorylation of proteins within the cell, are fundamental 
mechanisms employed for signal transduction and numerous other cellular functions, where 
the action of protein phosphatases and kinases encompass a broad substrate specificity in 
vitro, while performing specific and defined functions in vivo  (Sontag, 2001). Disturbances 
of the action of kinases and phosphatases within the cell due to either genetic and/or 
chemical factors, can thus yield a range of disease phenotypes, including that of cancer. 
Dysregulated phosphate-mediated signalling could lead to the deregulation of cell growth 
and adhesion, as well as gene expression, all of which are hallmarks of a transformed 
cellular phenotype, and could lead to progressive invasiveness and an increased cell motility 
in endothelial cells (Gabel et al., 1999; Sontag, 2001; Wang et al., 2004). Ruvolo et al. 
described the presence of pathway dysregulation in the cell as being much like a ‘switch’, 
whereby the activation of certain mutations can cause signalling to be stuck in the “On 
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position” leading to continual stimulation of proliferation and survival pathways, while 
alternatively the inactivation of certain phosphatases, such as PP2A, could be viewed as a 
defective “Off switch” again leading to the continued activation of these pro-survival 
pathways (Ruvolo, 2016). Abnormal activation or regulation of signal transduction pathways 
can thus play a role in transforming normal cells into malignant cells, promoting cell survival 
properties and leading to cellular resistance to potential drug therapies (Ruvolo, 2016).  
 
The ubiquitously expressed PP2A is one of the main serine/threonine (Ser/Thr) 
phosphatases in mammalian cells involved in the regulation of nearly all cellular activities 
including signal transduction, cell proliferation, apoptosis, cell division, survival, growth and 
development (Eichhorn et al., 2009; Danilo et al., 2013; Seshacharyulu et al., 2013). PP2A 
therefore plays an important role in the maintenance of cellular homeostasis. It has been 
found to be responsible for over 90% of all Ser/Thr activity within the cell, accounting for up 
to 1% of all cellular proteins (Eichhorn et al., 2009) and responsible for reversing the action 
of kinases in most major signalling pathways (Schönthal, 1998; Janssens and Goris, 2001; 
Sontag, 2001).  
 
1.4.1 Structure and Regulation of PP2A 
Structurally, PP2A is a multifarious hetero-trimer holoenzyme, composed of an active 
catalytic core dimer where the catalytic C subunit (PP2A-C) associates with the scaffold A 
subunit (PP2A-A, also known as PT65), with a regulatory B subunit binding to the AC core. 
Each subunit exists not as stable monomers, but rather in multiple isoforms, allowing for a 
structurally diverse enzyme (Mumby, 2007; Seshacharyulu et al., 2013; Kiely and Kiely, 
2015). Two isoforms (α and β) of the scaffold and catalytic subunits exist, whereas an ever-
growing number of regulatory B subunits are continually being discovered without being 
functionally redundant (Shu et al., 1997; Zhao et al., 1997; Sontag, 2001).  
 
Each of these subunits is responsible for different roles within the cell. The 36 kDa C subunit 
is the enzymatically active component and together with the A subunit, is responsible for 
dephosphorylation events (Eichhorn et al., 2009). The 60 kDa A subunit appears to function 
predominantly as a scaffold protein, assembling the different subunits into a single 
holoenzyme (Wong et al., 2010; Ruvolo, 2016). Thirdly, B subunits act as target modules, 
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providing distinct functional substrate specificity. These subunits control cellular localisation 
whilst displaying differential affinities for the core enzymes, competing for binding to the core 
and differentially replacing or exchanging one another in the PP2A complex (Sontag, 2001). 
The catalytic activity of PP2A is thus modulated through the binding of a regulatory B subunit 
to the AC core, the extent of which varies according to the type of subunit present, as well 
as the substrate available (Sontag, 2001). The association of the catalytic core with a wide 
variety of regulatory B subunits gives rise to the formation of different heterotrimeric PP2A 
holoenzyme complexes with diverse specificities (Eichhorn et al., 2009). It has been found 
that endogenous PP2A activity is modulated by the expression of regulatory B subunits 
(Garcia et al., 2000), as the B subunits influences the sub-cellular localization, as well as 
substrate selection of PP2A (Ruvolo, 2016). The over expression of mutant scaffold A 
subunits binding to catalytic C subunits but not to B, may lead to the dysregulation of 
intracellular PP2A (Ruediger et al., 1997). Thus, the regulation of PP2A is significantly 
affected by any changes occurring in the ratio of endogenous core enzymes to holoenzymes 
(Ruediger et al., 1997; Garcia et al., 2000).  
 
 
 
 
 
 
 
 
Figure 1.3 Adapted from Martin et al, 2010. PP2A structure and mechanisms of regulation  (Martin, 
Kettmann and Dequiedt, 2010) 
 
Post-translational modifications, such as phosphorylation or methylation, of proteins can 
influence the structure, charge and enzymatic activity of proteins to a great extent, thereby 
promoting differently modified proteins that display different activities (Nolan et al., 1964). 
Inappropriate regulation, or dysregulation, of reversible phosphorylation can therefore have 
a substantial effect on the responses of the cell to its surrounding environment (Eichhorn et 
Stellenbosch University  https://scholar.sun.ac.za
24 
 
al., 2009). Modifications of the catalytic core subunits of the PP2A enzyme complex, 
influences the binding affinity of regulatory B subunits, as well as the activity of the catalytic 
subunit itself, thereby modulating enzyme function (Janssens et al., 2008; Janssens and 
Rebollo, 2012).  
 
It has been argued that the phosphorylation of PP2A on both its Thr304 and Tyr307 residues 
shows an association with the inactivation of the enzyme, while reactivation occurs through 
dephosphorylation, including auto-dephosphorylation (Guo and Damuni, 1993; Brautigan, 
1995). In response to growth factors, PP2A can become transiently phosphorylated and 
thus, inactivated (Brautigan, 1995). PP2A actively dephosphorylates many kinases within 
the cell, and because resting levels of the enzyme’s activity is generally relatively high, it 
can be argued that the inactivation of PP2A might be a requirement for the activation of 
extra-cellular signal-related cascades (Sontag, 2001). Furthermore, Sontag et al. have also 
suggested that post-translational methylation of the catalytic C subunit greatly influences the 
ability of the regulatory B subunit to interact with the AC core, thus controlling the specificity 
of PP2A (Sontag, 2001).  
 
The activity and specificity of this heterotrimeric enzyme are highly regulated, and a growing 
amount of research points to PP2A as a tumour suppressor (Eichhorn et al., 2009). The role 
of methylation of PP2A remains poorly described in the context of cancer. In a study 
conducted by Du et al. it was reported that reversible methylation of the catalytic subunit of 
PP2A, regulates the enzymes activity. They further suggested that high glucose levels lead 
to significant increases in methylation of PP2A and that therapies inhibiting methylation also 
lead to inhibition of PP2A activity (Du et al., 2010). Another report by Israël et al. relating to 
Alzheimers disease, showed that a failure of PP2A methylation leads to the 
hyperphosphorylation of Tau protein and the formation of tangles in the brain (Israël and 
Schwartz, 2011). Methylation of PP2A and its regulation have remained elusive in literature 
and thus we aimed to investigate the effect of this post-translational modification of PP2A. 
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1.4.2 PP2A in Cancer 
The connection between PP2A and tumorigenesis has been strengthened through the 
discovery of mutations existing in genes encoding the scaffold A subunit of the enzyme in 
human breast carcinomas, however, neoplastic progression and cell invasiveness may also 
be promoted through mutations occurring in certain regulatory B subunits (Sontag, 2001). 
Interestingly, Ratnasinghe et al. found that the expression and activity of PP2A appears to 
be decreased in breast cancer cells presenting with drug-resistance (Ratnasinghe et al., 
1998). PP2A was first implicated as a tumour suppressor based on experiments conducted 
with the selective PP2A inhibitor, okadaic acid (OA), leading to tumour promotion (Bialojan 
and Takai, 1988). In later research, Schontal and colleagues showed that when mice were 
treated with OA, tumorous skin lesions developed due to the activation of several cancer 
promoting pathways (Schönthal, 2001). Dohoney et al. and Li and co-workers have also 
suggested that the direct dephosphorylation of the known tumour suppressor p53 at Ser37 
and Thr55 by PP2A, results in an increased stabilisation of p53 together with a subsequent 
increase in apoptosis following DNA damage (Dohoney et al., 2004; Li et al., 2007).  
 
1.4.2.1 The Effects of PP2A in Signalling 
Further data reviewed by Manning et al. have shown, that under normal cellular conditions, 
PP2A is found to actively inhibit the activity of PKB (also known as Akt), a Ser/Thr kinase, 
and known oncogene which has been implicated as a principal role player in a number of 
tumour promoting signalling pathways (Manning and Cantley, 2007). Under normal cellular 
conditions, PKB is tightly regulated by phosphorylation in order to regulate pro-survival 
pathways and control growth. However, this regulation has been reported to become de-
regulated in human cancers (Bellacosa et al., 1995; Carpten et al., 2007; Kuo et al., 2008).  
 
Abnormal RAS proteins have been found to facilitate uncontrolled cell division leading to the 
development of cancerous tumours (Mumby, 2007; Sablina et al., 2007).  PP2A is one of 
the intracellular regulators involved in the modulation of the activity of the RAS-RAF1-MAPK 
pathway (Ory et al., 2003; Kao et al., 2004; Adams et al., 2005). PP2A has been found to 
selectively target several kinases in this pathway, suggesting that the regulation of RAS-
RAF-MEK-ERK signalling by PP2A may be dependent on the context (Eichhorn et al., 2009). 
Downstream activation of the MAPK pathway correlates with dephosphorylation of RAF-1 
by PP2A, however, inhibition of B subunits or phosphorylation of PP2A has been found to 
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also result in the phosphorylation of ERK, downstream from RAF (Sontag et al., 1993; 
Sonoda et al., 1997). Supporting studies suggest that, while PP2A positively stimulates 
MAPK signalling at RAF1, there also exists a negative regulatory role for PP2A in this 
pathway (Wassarman et al., 1996). It has been found to inhibit several proteins in the RAF-
MEK-ERK pathway, including RAF, and the direct dephosphorylation of ERK by specific B 
subunits of PP2A leads to the inhibition of ERK activity (Eichhorn et al., 2009). The 
deregulation of PP2A in either the RAS-RAF-MEK-ERK pathways therefore appears to play 
a crucial role in the phenotypic cellular transformation to an oncogenic state (Eichhorn et al., 
2009).  
 
It is therefore clear that the deregulation of PP2A greatly contributes to cancer progression 
through the stabilisation of proto-oncogenes and destabilisation of tumour suppressors (i.e. 
p53), through the activation of protein kinases involved in mitogenic signalling (MAPK and 
PKB), and through the loss of signalling pathways focussing on promoting apoptosis 
(Eichhorn et al., 2009). The deregulation of PP2A in a number of signalling pathways can 
therefore lead to the promotion of tumorigenesis (Eichhorn et al., 2009).  
Endogenous tumorigenic inhibitors of PP2A, such as ‘endogenous inhibitor of PP2A 
(I2PP2A)’ and ‘cancerous inhibitor of PP2A (CIP2A)’ (also known as SET), have been found 
to play important roles in the survival of cancer cells and the development of drug resistance 
(Perrotti and Neviani, 2006; Danilo et al., 2013; Khanna et al., 2013). These inhibitors bind 
the phosphatase enzyme, diminishing its catalytic activity and leading to the promotion of 
malignant cell transformation through the suppression of PP2A (Ruvolo, 2016). Khanna  et 
al. have reported elevated levels of CIP2A in several cancers (Khanna et al., 2013), while 
others have demonstrated an association of CIP2A with a poor prognosis for solid tumours 
(Dong et al., 2011; Khanna et al., 2013; Barragán et al., 2015). It can be postulated that 
inhibitors of PP2A play an important role in mediating drug resistance in cancer cells, with 
CIP2A specifically promoting a resistance to doxorubicin, a known and popular therapeutic 
drug (Choi et al., 2011). The overexpression of I2PP2A has been found to increase the 
activation of ERK, thus supporting the notion of the antagonistic role of PP2A in the MAPK 
pathway (Al-Murrani et al., 1999; Härmälä-Braskén et al., 2003). High levels of this inhibitor 
observed in several human malignancies thus points to a conceivable role for the 
deregulation of PP2A by I2PP2A in cancer (Fornerod et al., 1995; Carlson et al., 1998). 
Therapeutic strategies aiming to suppress these inhibitors and re-activate PP2A are 
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continually being researched and developed to enhance possible future cancer therapies 
(Ruvolo, 2016). 
 
In this regard, sphingolipid second messenger molecules such as ceramide, have been 
associated with signalling leading to decreased proliferation and decreased survival, 
through the inactivation of I2PP2A and CI2PA/SET (Mukhopadhyay et al., 2009). This 
implies that ceramide-mediated apoptosis could possibly involve the reactivation of PP2A in 
some cancer types (Ruvolo, 2016). Evidence to support this exists whereby FTY-720, a 
sphingosine analogue has been shown to suppress CIP2A/SET and induce cell death 
through the re-activation of PP2A (Perrotti and Neviani, 2013; Cristóbal et al., 2014; Ciccone 
et al., 2015). 
 
Promotion of wide scale activation of cellular kinases through the suppression of PP2A can 
be achieved through targeting of the catalytic core (Ruvolo, 2016), and the loss or 
deregulation of specific PP2A holoenzymes can thus be argued to be a critical factor in cell 
transformation and cancer development (Eichhorn et al., 2009). Targeting PP2A through 
drug interventions can potentially show therapeutic benefits in some malignancies, though 
depending on the cellular context, the different PP2A isoforms can act as either tumour 
suppressors or promotors. These reported findings suggest the necessity for the strict 
regulation of PP2A activity, as dysregulated reduced activity leads to the promotion of 
cellular transformation, even though a minimal level of PP2A activity is necessary for normal 
cell survival (Ruvolo, 2016). 
 
1.5 Aims and Hypothesis  
The majority of research conducted has been performed on established, homogenous 
cancerous cell lines which do not provide an accurate representation of the in vivo tumour. 
With ethical clearance, we aimed to set up a cell culture model, for culturing primary breast 
cancer cells isolated through fine needle aspiration (FNA) from patients presenting with 
breast cancer at Tygerberg Hospital. Although it is clinically more relevant to use primary 
cultures of cancerous cells, limitations do exist. Cancerous cells present slow population 
doubling times with a finite lifespan, along with the possible contamination by fibroblasts and 
normal epithelial cells due to their heterogenic nature. The loss of cell-cell interactions in 
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culture may also lead to a change in behaviour of cells when compared to their responses 
as part of a tissue/organ (Burdall et al., 2003). As drug therapies are predominantly directed 
against primary tumours, it is still more relevant to establish a primary cell culture 
representative of the in vivo tumour (Burdall et al., 2003). A primary cell culture model will 
thus provide a useful tool for future research with a more accurate representation of cancer 
cells within the human body and characteristics comparable with the original tumour. In this 
study, we intended to build on the limited number of reports concerning primary cell isolation 
and culture by attempting to replicate these studies in the context of FNA.  
 
In the second half of the study, we aimed to investigate the effect that hypoxia has on PP2A 
within an immortalised breast cancer cell line, MDA-MB-231. As discussed above, malignant 
tumours are characterised by having areas of insufficient blood supply leading to hypoxia 
and nutrient deprivation to which cancer cells have been found to adapt (Vaapil et al., 2012; 
Carrer and Wellen, 2015). A potential role player in this adaptation is the major Ser/Thr 
phosphatase, PP2A, involved in the regulation of most cellular activities and therefore 
playing an important role in the maintenance of homeostasis (Eichhorn, Creyghton and 
Bernards, 2009; Danilo Perrotti and Neviani, 2013; Seshacharyulu et al., 2013). It has been 
implicated as a tumour suppressor in several forms of cancer, and its activity status and 
dysregulation have been linked to tumorigenesis (Eichhorn, Creyghton and Bernards, 2009). 
This study will therefore focus on determining the effect of chronic hypoxia and serum 
starvation on PP2A in cancer cells. The results generated will contribute to delineating the 
role of PP2A in this context, which could be of great interest as PP2A is a potentially drug-
able target.  
 
1.5.1 Aims 
1. To establish a primary cancer cell culture model using FNA as a method of cell 
sample collection. 
 
2. Once established, we aimed to investigate the effect of hypoxia on the primary cells.  
 
3. We also aimed to investigate the effect of hypoxia on protein phosphatase 2A (PP2A) 
expression, post translational modification and activity in a breast cancer cell line.  
 
Stellenbosch University  https://scholar.sun.ac.za
29 
 
1.5.2 Objectives 
1. To set up a pilot study for the isolation, culture and proliferation of cancer cells from 
fine needle aspirates obtained from apparent primary breast cancer lesions in 
patients presenting at the FNA clinic at Tygerberg Hospital.  
 
2. Compare frozen FNA samples with established primary cultures under normoxic 
conditions in order to determine the effect of in vitro culturing on the cancer cells. This 
will entail the comparison of each primary culture with its original FNA sample.  
 
3. Investigate the effect of hypoxia on the expression, post translational modification 
and activity of PP2A in an immortalised breast cancer cell line, MDA-MB-231. This 
will be achieved through Western blotting for the expression, phosphorylation and 
methylation of the catalytic subunit of PP2A (PP2A-C). PP2A activity will be 
measured through the incubation of immunoprecipitated PP2A with a fluorescent 
phosphatase substrate.  
 
4. Determine the sensitivity of both the primary, as well as the commercial breast cancer 
cell line to hypoxia through the measurement of ATP present in cells following 
hypoxia. A CellTitre Glo Cell viability assay kit will be used in this determination.  
 
1.5.3 Hypothesis 
Research has shown that cancer cells are able to adapt and survive under conditions of 
hypoxia and several studies have shown that the inhibition of PP2A, has been implicated in 
carcinogenesis and drug resistance, as well as in hypoxia (Ratnasinghe et al., 1998; 
Eichhorn et al., 2009).  
We therefore hypothesised that hypoxia would induce a decrease in PP2A activity, favouring 
the phosphorylation and activation of enzymes associated with survival and proliferation.  
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Chapter 2: Methods and Techniques 
 
2.1 Isolation and Culture of Primary Breast Cancer Cells 
With ethical clearance and approval from the Human Research Ethics Committee of 
Stellenbosch University, a pilot study with the aim of isolating and culturing cells from breast 
cancer carcinomas was conducted in collaboration with the Department of Pathology at 
Tygerberg Hospital. The inclusion criteria for the patients were: female patients below the 
age of 50 years, presenting with undiagnosed breast carcinomas, and who were radiation 
and/or chemotherapy naïve. The exclusion criteria included patients receiving and 
responding to cancer treatment, and patients older than 50. Patients were recruited from the 
Fine Needle Aspirate (FNA) clinic at Tygerberg Hospital. Samples were collected by trained 
nurses with the consent of the patient. This collection was the 3rd or 4th pass performed on 
the patients with initial passes used for hospital processing and pathological diagnosis. The 
FNA was expelled directly into 3 ml room temperature growth medium, consisting of 
Dulbeccos Modified Eagle Medium (DMEM) (Lonza, BE12-604F), supplemented with 10% 
fetal bovine serum (FBS) (Sigma F6178), 2 mM HEPES, 1 µg/ml Epidermal Growth Factor 
(EGF), and 1% Penicillin/Streptomycin solution (Sigma, P4333). Samples were maintained 
at room temperature and transported by foot (~15 minutes) back to the Medical Physiology 
laboratories of Stellenbosch University, adjacent to the hospital, where they were 
centrifuged at room temperature for 5 minutes at 500xg. The pellet of the first sample 
received was re-suspended in 5 ml of ‘TAC’ buffer (DeRose et al., 2013) containing 170 mM 
Tris (pH 7.4) and 150 mM Ammonium Chloride (pH 7.4), in order to lyse red blood cells 
present. The sample was incubated for 3 minutes in a water bath at 37°C, followed by 
centrifugation for 5 minutes at 500xg at room temperature. These steps were repeated, as 
many red blood cells remained in the pellet after the initial iteration. The pellet obtained was 
then re-suspended in 1 ml of warmed growth medium and seeded into one well of a 24 well 
plate, and incubated at 37°C in a humidified atmosphere with 5% CO2. On all samples 
received, growth medium was initially refreshed after ~4 days, to allow the cancer cells 
adequate time to attach to the surface of the culture plate. Thereafter, medium was 
refreshed every second day, with warmed phosphate buffered saline (PBS) used for 
washing steps. Sample 1 was left for the initial 4 days to allow for attachment, but 
unfortunately no cells appeared to attach to the culture plate after the first growth medium 
change. 
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Therefore, the second sample received from the FNA clinic was centrifuged as above and 
re-suspended directly into 1 ml warmed growth medium, seeded onto a 24 well plate and 
incubated. No attempt was made to lyse the red blood cells present in this sample. Initially, 
the presence of the red blood cells made visualisation of the cell population impossible, but 
after 3 days, growth medium was refreshed and from there onwards, cells were more clearly 
visible. Cells attached well and appeared to grow in number and size but never quite reached 
confluency over a 6 week period.  
 
The third and fourth samples collected were again centrifuged for 5 minutes at 500xg at 
room temperature. The pellet was re-suspended in 1 ml warmed growth medium and again 
seeded into wells on a 24 well plate and incubated. Then, after one hour, medium containing 
all unattached cells was removed from the wells and transferred to a clean, adjacent well on 
the plate. Fresh medium was added to the first well. This was repeated on the second well 
after a further hour. The rationale behind this was that fibroblasts attach fairly quickly to 
culture plates, and will hopefully remain in the first two wells so that the third well might 
contain cancer cells only. Gartner et al. observed that fibroblasts are generally the first cell 
type to adhere to culture plates (Gartner et al., 1996). Plates were incubated at 37°C in a 
humidified atmosphere with 5% O2 and 5% CO2. Cells were maintained in culture for four 
weeks. However, cells did not appear to grow prolifically, and the numbers of cells dwindled 
away until nothing was left.  
 
For samples five to nine, we reverted back to the protocol used on sample two, whereby 
samples were centrifuged immediately upon reception in the laboratory, followed by re-
suspension in 1 ml warmed growth medium, seeding onto 24 well plates and incubation as 
before, at 37°C in a humidified atmosphere under 95% O2 and 5% CO2. In some instances, 
some of the samples presented a gelatinous supernatant after centrifugation. This was 
collected and re-centrifuged, and the pellet generated was re-suspended in 1 ml growth 
medium and seeded onto the 24 well plate as well. In some cases, a sort of ‘tissue clump’ 
was visible floating in the supernatant. This was removed and disaggregated in a separate 
1 ml of growth medium and seeded separately onto the 24 well plate.  
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2.2 Culturing Immortalised Cell Lines 
A commonly investigated triple negative human breast cancer cells line, MDA-MB-231 
(PTEN wild type), was obtained through colleagues in the department of Physiological 
Sciences at Stellenbosch University. This cell line has been characterised by the lack of 
expression of estrogen receptors (ER), progesterone receptors (PR), as well as human 
epidermal growth factor receptor 2 (HER2) receptors, hence the term ‘triple negative’ 
(Holliday and Speirs, 2011), and has been shown to be rich in the expression of cell surface 
markers associated with mammary cancer stem cells such as CD44+ and CD24- (Prat et al., 
2009). These cells were seeded onto 100 mm cell culture plates, and maintained in a 
proliferative state through culture in high glucose (4.5 g/L) DMEM (Lonza, BE12-604F) 
supplemented with 10% FBS (Sigma F6178) and 1% penicillin/streptomycin solution 
(Sigma, P4333), at 37°C in a humidified atmosphere containing 95% O2 and 5% CO2. The 
use of adhesion factor to coat culture plates prior to culturing was not necessary as cells 
adhered well to the surface of the dishes.  
 
Culture medium was refreshed every 2-3 days and warmed phosphate buffered saline (PBS) 
used for washing steps. Cells were passaged at 70-80% confluency using a combination of 
trypsinisation (plates incubated at 37°C for 4 minutes in 0.25% trypsin), and cell scraping to 
lift cells from the base of the culture plates. Cell-trypsin suspensions were quenched in 
culture medium, centrifuged at 423xg for 4 minutes at 4°C, and re-seeded onto fresh culture 
plates. Cultures were maintained in this manner until enough plates were obtained for 
experimental protocols to proceed.  
 
2.3 Exposure of Cells to Hypoxia 
Once a sufficient number of plates of ~80% confluent cells were obtained, plates were 
washed with warmed PBS and exposed to varying lengths of hypoxia. Control plates 
received standard growth medium and were kept under standard culturing conditions 
(described above), while hypoxic experimental plates received growth medium with reduced 
serum (1% FBS), and were exposed to 4 minutes of hypoxic gas flow (0.5% O2, 5% CO2 
and 95% N2) (Afrox, 802732-RC-A) to displace O2, and sealed within an air-tight hypoxic 
chamber for the intended duration of hypoxia (Figure 2.1). Cobalt Chloride (CoCl2) (Sigma, 
C8661), a known chemical inducer of hypoxic-inducible factor (HIF-1), which is associated 
with hypoxia (Wu and Yotnda, 2011), was used as a positive control for the purposes of 
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Western Blotting and phosphatase assay experiments. 200 mM CoCl2 was added to positive 
control plates in standard growth medium, and all plates were then incubated at 37°C in a 
humidified atmosphere for the desired length of time.  
 
Hypoxia was initially measured over 72 hours, which was found to be too potent. As such, it 
was decided that varying time points should be investigated, namely 24, 48 and 72 hours. 
This was further revised to 2 hours, 4 hours, 6 hours and 8 hours.  
 
 
Figure 2.1 Billups-Rothenberg Inc. Modular Incubation Chamber (Hypoxic chamber) with rubber ‘O’ 
ring and metal sleeve for an air-tight seal. Culture plates are placed on the grid-trays and sealed inside 
the chamber, receiving hypoxic gas flow through the inlet valve.  
 
2.4 Western Blotting 
2.4.1 Lysate Preparation 
Following incubation, culture plates were placed directly on ice and cells were collected from 
the plates through scraping and centrifugation (423xg for 4 minutes at 4°C) to obtain cell 
pellets used for lysate preparation (on ice). Cell pellets were re-suspended in 300 µl ice cold 
lysis buffer (Table 2.1), with 0.5 mm zirconium beads and placed in a bullet blender 
homogeniser (Next Advance Bullet Blender) at 4°C for three cycles of 1 minute on speed 4, 
with 5 minutes rest between each cycle, for mechanical disruption. Samples were kept on 
ice for ~20minutes followed by re-centrifugation at 12074xg for 20 minutes at 4°C. 
Supernatants were removed, transferred to clean Eppendorf tubes and kept on ice. Protein 
concentrations were determined using the Bradford assay method (Bradford, 1976), and 
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sample lysates were prepared accordingly in Laemmli Sample buffer, boiled for 4.5 minutes 
and stored at -80°C until needed.  
 
Table 2.1: Components of the Lysis buffer used for the preparation of lysate samples for Western 
blotting. Buffer made up to 10ml with distilled water. 
Component Concentration 
Tris + 20 mM 
EGTA 1 mM 
EDTA 10 mM 
NaCl 150 mM 
β-glycerophosphate 0,93 mM 
Tetra sodium pirophosphate 3.76 mM 
Na3VO4 1 mM 
Leupeptin 0,01 µg/ml 
Aprotinin 0,01 µg/ml 
1%-Triton-X 1% 
PMSF 0,3 mM 
 
 
2.4.2 Protein Separation and Detection 
Proteins were separated through SDS-page electrophoresis using BioRad Criterion pre-cast 
4-20% gradient gels (Bio-rad, 5678095), and were resolved according to molecular weight. 
~30 µg of protein per sample was loaded into the gel along with a pre-stained molecular 
weight marker. Gels were run for 10 minutes at 100V, 200A, followed by 50 minutes at 200V, 
200A. Thereafter, proteins were transferred to an inert polyvinyl fluoride (PVDF) membrane 
via either a semi-wet TurboBlot system (7 minutes at 2.5A constant; up to 25V), or a wet 
tank-transfer system (35 minutes at 200V, 200mA). Membranes were briefly placed in 
methanol to fix proteins, allowed to air dry for 20 minutes, and then placed in 5% fat free 
milk (made in TBS-Tween) for at least an hour. The fat free milk acts as a blocking agent to 
minimise non-specific binding of antibodies. Membranes were then washed with Tris-
buffered saline (TBS)-0.1% Tween 20 solution with 4 quick hand washes, followed by three 
cycles of 10 minutes each. Thereafter, they were incubated at 4°C in primary antibody 
specific for the protein of interest (Table 2.2). Membranes were then re-washed in TBS-
Tween as before and further incubated for an hour at room temperature in an appropriate 
secondary antibody specific for the primary antibody used. A further washing step was 
performed followed by exposure of the membranes for protein detection using either a 
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ChemiDoc system in association with stain free technology (Biorad, 2017), or exposed and 
developed in a traditional dark room. Visualisation of the protein of interest was made 
possible through the chemiluminescence interaction between the Bio Rad ClarityTM ECL 
detection reagent (Bio-rad, 170-5061) and the anti-rabbit/mouse horseradish peroxidase 
conjugated secondary antibodies used.  
 
Bio Rad’s stain free imaging technology in association with imagers enabled with stain free 
detection capabilities, such as the ChemiDoc system, makes use of a trademarked tri-halo 
compound to enhance protein fluorescence of tryptophan amino acids within proteins, upon 
exposure to ultra-violet light. The proteins fluoresce directly within the gel upon 
photoactivation, allowing for immediate visualisation and imaging of proteins present on the 
gel and membrane at any stage during electrophoresis and blotting. Normalisation of the 
proteins can therefore be performed by measuring the total protein directly on the 
membrane, or ‘transfer image’, to obtain the total density of each lane. Specialised software 
then interprets the data in three dimensions and the total background is subtracted from the 
sum of the density of all the bands in each lane. In this way, total protein normalisation 
eliminates the need for immunodetection of housekeeping proteins for normalisation, along 
with staining with Ponceau, Coommassie or other dyes. It produces a much stronger signal, 
improves precision and reliability of Western blotting data, and stripping and re-probing 
steps can be circumvented, thus saving time (Bio Rad, 2017; Gilda and Gomes, 2013; 
Gürtler et al., 2013).  
 
Accordingly, bands generated using the ChemiDoc were analysed using Image Lab™ 
Software (Bio-Rad). Normalisation of ‘transfer images’ and exposed membranes using stain 
free technology, was used for the standardisation of protein loading. Normalisation of blots 
was expressed as pixel values which were then expressed relative to control. The resulting 
values were expressed as arbitrary units (AU) and used for final statistical analysis. 
Phospho-to-total and methyl-to-total ratios were calculated from pixel values of 
phosphorylation and methylation, divided by total pixel values and expressed relative to 
control, as arbitrary units. GraphPad Prism6 was used to conduct T-tests and 1-way 
Analysis of Variance (ANOVA) with Dunnett and Bonferroni post-hoc tests. Data was 
expressed as means ± SEM (standard error of the mean), with p≤0.05 considered 
statistically significant.  
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Table 2.2: Primary and secondary antibodies used for Western blotting 
Primary Antibodies Used Supplier  Code Secondary Antibody  
Total PP2A-C Cell Signalling 20385 Anti-Rabbit Conjugate 
Phosphorylated PP2A-C R&D Systems AF3980 Anti-Rabbit Conjugate 
Methylated PP2A-C Santa Cruz Sc81603 Anti-Mouse Conjugate 
Total PKB Cell Signalling 9272S Anti-Rabbit Conjugate 
Phosphorylated PKB Cell Signalling 4060S Anti-Rabbit Conjugate 
Total ERK Cell Signalling 9102S Anti-Rabbit Conjugate 
Phosphorylated ERK Cell Signalling 9101S Anti-Rabbit Conjugate 
HIF-1α Cell Signalling 14179S Anti-Rabbit Conjugate 
  
Secondary Antibodies Used Supplier  Code  
Anti-Rabbit Conjugate Cell Signalling 7074S  
Anti-Mouse Conjugate Cell Signalling 7076S  
 
 
2.5 Protein Phosphatase Assay 
2.5.1 Lysate Preparation 
Following hypoxic incubation as previously described, sample lysates were prepared in the 
same way as reported for Western blotting above, although the components of the lysis 
buffer differed (Table 2.3). Protein concentrations were determined using the Bradford assay 
method (Bradford, 1976), and sample lysates made up to a protein content of 400 µg/µl.  
 
Table 2.3: Components of the Lysis buffer used in the preparation of lysate samples for the protein 
phosphatase assay.  
Component Concentration 
Na3VO4 1 mM 
NaCl 150 mM 
HEPES 50 mM 
Glycerol  5 % 
Leupeptin 0,01 µg/ml 
Aprotinin 0,01 µg/ml 
β-mercaptoethanol  0.1 % 
Benzamidine 1,3 mM 
EDTA 0,01 µM 
PMSF 10 mM 
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2.5.2 Antibody Incubation 
10 µl PP2A-C antibody (Santa-Cruz, Sc-6110) was added to each sample. Samples were 
then incubated at 4°C, overnight in a rotating wheel.  
  
2.5.3 Bead Slurry Preparation 
An agarose bead slurry was prepared for a volume of 50 µl slurry needed per sample i.e. 
1.2 ml for 24 samples. 400 µl Agarose bead (Sigma, P2545) was added to each of three 
clean Eppendorf tubes, together with 1 ml lysis buffer (Table 2.3), and centrifuged at 4°C at 
12000xg for 45 seconds. The supernatant was then discarded and bead pellet re-suspended 
in 500 µl lysis buffer. This washing process was repeated three times where after slurries 
were left overnight at 4°C, ready to be used for immunoprecipitation.  
 
2.5.4 Immunoprecipitation 
Prepared bead slurries were gently vortexed to re-suspend all beads. Beads were all 
transferred to one single Eppendorf tube to ensure a consistent bead suspension, and the 
total volume of the tube was corrected to 1.2 ml with lysis buffer. 50 µl of well suspended 
bead slurry was added to each sample, which were then incubated for four hours at 4°C 
under continual agitation using a rotating wheel. Following incubation, samples were 
washed as before using prepared assay buffer (Table 2.4). The final bead pellet was re-
suspended in a volume of 150 µl assay buffer and assayed for PP2A activity in a 96 well 
plate using a DiFMUP assay.  
 
Table 2.4: Components of the assay buffer used during activity measurement of PP2A.  
Component Concentration 
HEPES + 50 mM 
MgCl2 5 mM 
β-mercaptoethanol  0.02 % 
BSA 1,5 µM 
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2.5.5 PP2A Activity Measurement: the DiFMUP Assay 
An EnzCheck® phosphatase assay kit was purchased from Molecular Probes (E12020). This 
kit is designed for use in a 96-well micro-plate for the continuous fluorescent assay of 
phosphatases with neutral, alkaline or moderately acidic pH optima. The substrate, 6,8-
difluoro-4-methylumbelliferyl phosphate (DiFMUP) is a fluorinated relative of 4-
methylumbelliferfyl (MUP) and is ideal for the continuous assay of phosphatases. The kit 
also contains 6,8-difluoror-7-hydroxy-4-methyl-coumarin, a reference standard for the 
generation of a standard curve. In this assay, DiFMUP is hydrolysed by any and all 
phosphatases to a product, DiFMU. Therefore, by measuring the increase in DiFMU 
associated fluorescence, one can estimate the phosphatase activity in the samples. In order 
to determine the activity of specific phosphatases, one has to either make use of specific 
phosphatase inhibitors, or enzyme purification (as with immunoprecipitation). 
 
50 µl of each immune precipitate sample was added, in duplicate, to wells of a 96-well micro-
plate, along with 50 µl 200 µM DiFMUP working solution. Blanks were set up to contain 50 
µl assay buffer (Table 2.4) with 50 µl DiFMUP, and a standard curve was prepared in 
duplicate through serial dilution of 6, 8-difluoror-7-hydroxy-4-methyl-coumarin (1.562-
100µM) (Table 2.5). The micro-pate was prepared under limited lighting to prevent, or at 
least minimise, degradation of the DiFMUP substrate, and fluorescence of the samples was 
measured every 5 minutes for a period of approximately two hours at a wavelength of 
355/450 nm, using a BMG Labtech FLUOstar Omega Plate reader at 37°C. Data generated 
was analysed with the aid of the Biostatistics Unit, Centre for Evidence-based Health Care 
at Stellenbosch University. Repeated measures ANOVA’s were performed with post-hoc 
Mann Whitney tests, and data presented as means ± SEM with p≤0.05 considered 
statistically significant. 
 
2.5.6 Confirmation of Immunoprecipitation 
To confirm that immunoprecipitation of PP2A had occurred, Western blotting was carried 
out as described above. 50 µl sample buffer (Laemmli buffer + Lysis buffer) was added to 
50 µl of immunoprecipitate sample. These were submitted to Western blotting alongside 
non-immunoprecipitated samples which were collected from the original lysates prior to 
immunoprecipitation. This was done to provide a comparison between immunoprecipitated 
and non-immunoprecipitated samples. Samples were run in 12% gels and transferred for 1 
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hour as described above. Membranes were probed for PP2A (cell signalling, 20385S) as 
well as PP1 (cell signalling, 25825), and were visualised using the Bio Rad ClarityTM ECL 
detection reagent and ChemiDoc System. 
 
2.6 Cell Viability Assay 
A CellTitre-Glo® luminescent cell viability assay kit was purchased from Promega (G755A). 
This kit is designed for use with multi-well plates, involving the addition of the CellTitre-Glo 
reagent directly to cells in culture. In this ATP activity assay, the generation of a stable “glow-
type” luminescent signal is brought about through the properties of a thermos-stable 
luciferase, with the simultaneous inhibition of the release of endogenous enzymes from cell 
lysis, such as ATPase’s, preventing any interference with accurate ATP measurement. 
Traditionally, firefly luciferase is used in these assays, however a unique and more stable 
mutant form of luciferase developed by Promega, selects for favourable characteristics to 
improve the performance of the ATP assay. The homogenous assay format involves the 
addition of the CellTiter-Glo® Reagent directly to cell line culture, resulting in cell lysis and 
the subsequent generation of a luminescent signal that is directly proportional to the amount 
of ATP present. Measurements of ATP thus provide an indication of viable and metabolically 
active cells present (Kangas et al., 1984; Gerhardt et al., 1991; Crouch et al., 1993; 
Promega, 2015) 
 
Figure 2.2 The luciferase reaction where luciferase catalyses the mono-oxygenation of luciferin in the 
presence of Mg2+, ATP and molecular oxygen (Promega, 2015). 
 
MDA-MB-231 cells were grown under standard culturing conditions as previously 
mentioned. Once 70-80% confluent, cells were divided in a ratio of 1:3 and seeded into four 
wells of two 96-well plates (control vs hypoxia). The control plate received two extra wells of 
cells for the purpose of a positive control, which entailed the incubation of the cells with 
distilled water for 2 hours. This positive control was not added to the hypoxic plate, as the 
hypoxic chamber could not be opened until the end of the desired incubation period. Cells 
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on the hypoxic plates received growth medium with reduced serum (1% FBS), and the plates 
were exposed to 4 minutes of hypoxic gas flow (0.5% O2, 5% CO2 and 95% N2) in a hypoxic 
chamber where after it was sealed with the hypoxic gas mixture inside (as described 
previously). Control, positive control and hypoxic (in the hypoxic chamber) 96 well plates 
were placed in an incubator at 37°C in a humidified atmosphere for the desired length of 
time. Varying time points were again investigated with hypoxic durations of 2 hours, 4 hours, 
6 hours and 8 hours. 
 
Following incubation, an ATP standard curve was prepared in duplicate on the control plate 
just prior to the addition of the CellTitre-Glo® reagent. A medium (2 µM) and a high (10 µM) 
concentration of the standard curve was added in duplicate to the hypoxic plate in order to 
be used as reference samples to facilitate comparison between the two plates. 10 µM ATP 
was prepared in standard growth medium (described previously), and serial dilutions were 
prepared on the 96 well plates (1 µM to 10 µM). 100 µl of the CellTitre-Glo® reagent was 
added to each well, where after the plates were exposed to vigorous shaking for two minutes 
followed by 10 minutes incubation at room temperature. Following this, a BMG Labtech 
FLUOstar Omega Plate reader was used determine the luminescence generated from each 
well. Data generated was analysed using GraphPad Prism6. Student T-tests were 
conducted and data was presented as means ± SEM with p≤0.05 considered statistically 
significant. 
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Table 2.5: 96 Well micro-titre plate layout used in the phosphatase assays. Rows A and B: Wells 1-7 represent standard curve concentrations (µM) prepared 
through serial dilutions; wells 9 and 12 represent blanks with assay buffer (AB). Rows D, E, G and H: DiFMUP substrate added to immunoprecipitate 
samples. C = control, +C = positive control, H = hypoxia.  
 
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A 1.562 3.125 6.25 125 25 50 100  
50ul AB 
+ 
DiFMUP 
  100µl AB 
B 1.562 3.125 6.25 125 25 50 100  
50ul AB 
+ 
DiFMUP 
  100µl AB 
C             
D 
50ul C1 
(2h)  
50ul C2 
(2h)  
50ul +C1 
(2h)  
50ul +C2 
(2h)  
50ul H1 
(2h)  
50ul H2 
(2h)  
50ul C3 
(4h)  
50ul C4 
(4h)  
50ul +C3 
(4h) 
50ul +C4 
(4h)  
50ul H3 
(4h)  
50ul H4 
(4h) 
E 
50ul C1 
(2h)  
50ul C2 
(2h)  
50ul +C1 
(2h)  
50ul +C2 
(2h)  
50ul H1 
(2h)  
50ul H2 
(2h)  
50ul C3 
(4h)  
50ul C4 
(4h)  
50ul +C3 
(4h) 
50ul +C4 
(4h)  
50ul H3 
(4h)  
50ul H4 
(4h) 
F             
G 
50ul C5 
(4h)  
50ul C6 
(4h)  
50ul +C5 
(4h) 
50ul +C6 
(4h)  
50ul H5 
(4h)  
50ul H6 
(4h) 
50ul C7 
(6h)  
50ul C8 
(6h)  
50ul +C7 
(6h)  
50ul +C8 
(6h)  
50ul H7 
(6h)  
50ul H8 
(6h)  
H 
50ul C5 
(4h)  
50ul C6 
(4h)  
50ul +C5 
(4h) 
50ul +C6 
(4h)  
50ul H5 
(4h)  
50ul H6 
(4h) 
50ul C7 
(6h)  
50ul C8 
(6h)  
50ul +C7 
(6h)  
50ul +C8 
(6h)  
50ul H7 
(6h)  
50ul H8 
(6h)  
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
42 
 
Chapter 3: Isolation and Culture of Primary Breast Cancer Cells: 
A Pilot Study 
 
3.1 Introduction 
Immortalised cell lines have been widely used in cancer studies for their ease of culturing 
self-replicating cells with minimal contamination from other cells and extended culturing 
capacity (Burdall et al., 2003; Lacroix et al., 2004; Holliday and Speirs, 2011). However, 
whether these cells can provide a true representation of cancer under in vivo conditions 
remains a topic of debate among researchers (Correa, Marshall and Burnier, 2009; Holliday 
and Speirs, 2011). Thus the establishment and use of successfully isolated and propagated 
primary cell cultures holds great allure as a research model more able to provide a closer 
representation of the in vivo tumour and microenvironment, as cells would be derived directly 
from tumour tissue (Speirs et al., 1998; Keller et al., 2010). Primary cell isolation and culture 
however, is not without its challenges. Studies have found a high prevalence of 
contamination from other cell types, such as fibroblasts, immune cells and connective tissue, 
that frequently overgrow cancer cells (Dairkee et al., 1995; Speirs et al., 1998; Sung et al., 
2007). Further challenges include a lack of consensus on a successful, reproducible 
isolation and culture protocol, acquiring sufficient quantities of cancer cells for molecular 
studies, and a lack of clear identification and morphological distinction between cancerous 
and non-cancerous cells in culture (Dairkee et al., 1995; Speirs et al., 1998; Weigand et al., 
2016). In previous studies, primary breast cancer cells have been isolated from highly 
metastatic pleural effusions, or from excised tumour tissue requiring mechanical 
disaggregation or enzymatic digestion for the detachment of cells from surrounding breast 
tissue. This has been found to encourage and increase the risk of overgrowth of 
contaminating cells (Siwek et al., 1998; Speirs et al., 1998; Loveday et al., 2002). The use 
of FNA as a means of primary cell sample collection for the purpose of in vitro culturing, has 
been proposed as an alternative, minimally invasive protocol able to collect tumour samples 
at an earlier stage, prior to metastasis and can be performed at the bedside of patients with 
a decreased risk of overgrowth of contaminating cells (McLoughlin et al., 1978; Li et al., 
1998; Araujo et al., 1999; Rosa, 2008). However, literature does not report on much work 
conducted on this proposal.  
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The aim of this pilot study was therefore to establish a successful isolation and primary cell 
culture model from samples collected by FNA from patients presenting with abnormal breast 
lumps or lesions. FNA is a well-established technique that is minimally invasive and safe, 
and is routinely used for the collection of tissue samples for the purposes of diagnosis and 
characterization of palpable and non-palpable lesions, commonly of the breast, lymph 
nodes, thyroid and salivary glands (Schmitt et al., 1995a; Schmitt et al., 1995b; Li et al., 
1998; Rosa, 2008). In this technique, a fine, 23-gauge needle attached to a syringe is used 
to remove cells from the tissue, referred to as a ‘pass’. This is achieved by moving the needle 
back and forth through the tumour while pulling back on the syringe plunger to maintain 
suction (Li et al., 1998).  However, very few cases have been documented where this 
technique has been used for the collection of samples for the purpose of cellular propagation 
in culture for research. Two particular studies from the late 90’s suggest that cells obtained 
through FNA can be cultured in vitro for further research (Li et al., 1998; Araujo et al., 1999). 
However, there is no consistent and definitive protocol for this approach and there still 
remains a need to establish a reliable primary cell model that retains the characteristics of 
the original in vivo tumour, offering a better representation of the progression and 
mechanisms involved in breast cancer (Araujo et al., 1999).  
 
In 1998, Li and colleagues developed a protocol whereby multiple FNA ‘passes’ were 
collected from each of 25 cancerous breast tumours already excised from patients until 
visible cell pellets were present. The samples then underwent centrifugation and 
tripsinisation to remove possible contaminating fibroblasts (Li et al., 1998). It was found that 
cell proliferation was initially rapid but doubling time slowed down after the first three sub-
culturing cycles. However, viable cancerous cells were obtained from the FNA samples 
presenting with characteristics and phenotype closely matching those of the original tumour 
(Li et al., 1998). A second study conducted the following year by Araujo et al. similarly aimed 
to substantiate the role of FNA sample collection as a means to obtain primary cancer cells 
with the purpose of establishing a primary breast cancer cell line in vitro. This study was 
conducted on four patients, with only one primary cell line successfully cultured. These FNA 
samples were collected as described in chapter 1, centrifuged and the pellets re-suspended 
in suitable medium and seeded directly onto culture plates. It was reported that cells 
attached to the bottom of the flasks within one week and that approximately 15 cycles of 
sub-culturing occurred producing cells with similar characteristics and morphology as the 
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original tumour, and only a small percentage of  contaminating fibroblasts was present 
(Araujo et al., 1999).  
 
These two studies both provided definitive success in their aim of culturing primary breast 
cancer cells from FNA samples, however, after 1999 no other reports were found of the 
usage of the FNA technique as a means of sample collection for the propagation and 
successful culture of primary breast cancer cells for research purposes. This led us to the 
decision to investigate this technique further and to examine whether in fact this technique 
does indeed have merit as a sample collection method for successful culture and 
propagation of primary cells in vitro, and if a successful primary cell model could be 
established.  
 
Unfortunately, due to time restraints and an unanticipated low number of suitable patients, 
only nine FNA samples were collected and maintained in culture. Of these nine samples, 
only one sample appeared to actually proliferate and progress through a sub-culture cycle, 
however, it was uncertain whether the proliferating cells were in fact cancer cells or 
contaminating fibroblasts as cells did not sufficiently increase in number to allow for 
characterisation through Flow Cytometry before dying off. We were not able to establish a 
successful culture from any of the samples collected and no definitive model has yet been 
established.   
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3.2 Methods, Materials and Results 
Due to the nature of this pilot study, this section will combine the methods and the results. 
As we were attempting to set up an isolation and culture technique, the protocol was 
adjusted based on results obtained with each sample, therefore it is in the interest of flow 
and understanding to merge the information. An overview schematic of the different sample 
processing is shown in Figure 3.7, however, indicating no obvious emerging patterns with 
the changes in protocols. 
 
With ethical clearance from the Human Research Ethics Committee (HREC) of Stellenbosch 
University, the pilot study was intended as a collaboration with the AIDS and Cancer 
Specimen Resource (ACSR) Biobank in conjunction with the department of Anatomical 
Pathology at Tygerberg Hospital, Cape Town, South Africa. The ACSR biobank nurses 
approached patients, visiting the Tygerberg Hospital FNA clinic who met the inclusion 
criteria, for their consent to donate a single FNA pass for the purpose of this research study. 
For this purpose the nurses made use of standard informed patient consent forms, approved 
by HREC (Addendum A). No samples were obtained without prior consent from each 
individual patient, and patients were only permitted to sign consent once it was determined 
that they fully understood and accepted the purpose of the study and their anticipated role. 
The inclusion criteria for suitable patients included females below the age of 50, who were 
chemo-and radiation therapy naïve. The study set out to obtain 15 FNA samples collected 
by trained nurses and then transported to the laboratories in the Division of Medical 
Physiology, Stellenbosch University, to optimise the protocol for successful isolation, 
propagation and culturing of cancerous cells present in the FNA samples. The protocol 
decided on was a combination of those described in previous FNA studies (Li et al., 1998; 
Araujo et al., 1999), as well as from studies on pleural effusions (Siwek et al., 1998) as a 
starting point. In all cases, the FNA samples were injected into 3ml suitable DMEM growth 
medium containing FBS, penicillin/streptomycin, HEPES and EGF, and transported to the 
laboratory for handling.  
 
Table 3.1 shows the age of the patients, the approximate number of days before the first 
growth medium change to allow cells to attach to the culture plate, the length of time the 
cells were maintained in culture, if a passage of the cells was possible and the official 
pathology diagnosis of each sample received. 
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Table 3.1 Collected FNA Sample Specifics 
 
Upon return to the laboratories in the Division of Medical Physiology, the first sample 
received from patient 1 was centrifuged for 5 minutes at 500xg at room temperature, where 
after the pellet was re-suspended in a lysis buffer, containing 170 mM Tris (pH 7.4) and 150 
mM ammonium chloride (pH 7.4) (DeRose et al., 2013), intended to lyse red blood cells. 
The sample was incubated for 3 minutes in a water bath at 37°C followed by re-centrifugation 
as before. This lysing step was repeated a second time before the cell pellet was re-
suspended in 1ml warmed growth medium and seeded into a well on a 24 well plate 
incubated at 37°C in a humidified atmosphere. Growth medium was refreshed after 3 days 
to allow time for cancer cells to attach to the culture plate. However, no cells were visible in 
culture after the medium change and we believe there were no cells left after the isolation 
procedure, to attach to the culture plate as the lysis buffer appeared to be too potent for the 
cells. No images were able to be taken as no cells were present in the well. 
 
Based on this result, the second FNA sample received was centrifuged as before, and 
merely re-suspended into suitable growth medium and allowed to incubate for the cells to 
attach. What appeared to be a ‘clump of tissue’ was observed to be floating in the 
supernatant after centrifugation. This was removed, manually dissociated with repeated 
suction through a pipette tip, re-suspended separately in growth medium and seeded onto 
Patient Age of 
Patient 
Days 
before 
1st 
medium 
change 
Length of 
time 
maintained 
in Culture 
Passage Pathology Diagnosis 
1 37 ~4 NA NA Breast Carcinoma:  Duct Carcinoma. ER+ PR+ C-erb- 
2 37 ~3 6 weeks 1 Breast Carcinoma:  Duct Carcinoma. ER+ PR- C-erb- 
3 42 ~3 3 weeks NA Breast Carcinoma. ER+ PR+ C-erb- 
4 44 ~3 2 weeks NA Breast Carcinoma:  Duct Carcinoma. ER+ PR+ C-erb 
2+ FISH requested 
5 31 ~4 3,5 weeks NA Breast Carcinoma:  Duct Carcinoma. 
6 32 ~3 1,5 weeks NA Breast Carcinoma ER- PR- C-erb- 
7 36 ~4 2 weeks NA Breast Carcinoma. ER- PR- C-erb+ 
8 43 ~4 2 weeks NA Breast Carcinoma:  Duct Carcinoma. ER+ PR+ C-erb- 
9 48 ~3 3 weeks NA Breast Carcinoma:  Duct Carcinoma. 
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the culture plate. After the first week in culture, cells appeared to have attached in both wells, 
however cells from the ‘tissue clump’ appeared more rounded and defined. Cells from the 
original sample suspension showed many small, round cells forming clusters and only a few 
larger, more rounded cells (Figure 3.1a). Over the course of approximately six weeks, only 
cells from the ‘tissue clump’ suspension appeared to grow in number and size, although the 
morphology of visible cells seemed to change (Figure 3.1b). After ~4 weeks, these cells 
were sub-cultured from one well on a 24 well plate, to a single 3.5 mm culture plate. 
However, the cells appeared branched and dendritic (Figure 3.2) thus leading to a suspicion 
of fibroblast contamination. Numbers of cells increased extremely slowly and began to 
dwindle off again before confluence was reached. After approximately 6-7 weeks cells were 
no longer present in culture.  
 
Figure 3.1 FNA sample 2 at ~1 week in culture: a) cells from sample pellet appearing rounded with a 
few spindle shaped cells and many smaller red blood cells; b) cells from disaggregated and re-
suspended ‘tissue clump’ appearing rounded and clustered together. Images taken with a 12 
megapixel iPhone 5S camera through the lens of a microscope (Zeiss, 476100-9901). Magnification = 
100x. 
a b 
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Figure 3.2 FNA sample 2 ‘tissue clump’ grown in culture after ~6 weeks. Long, spindly branches are 
visible with cells showing a flat and spread morphology. A Euromex DC.3000C CMEX camera 
microscope was used. Magnification = 100x. 
 
Because cell growth had been exceptionally slow and there was the suspicion of 
contaminating cells, it was decided to adjust the protocol for samples 3 and 4. These 
samples too presented with a similar ‘clump’ of tissue suspended in the supernatant 
following centrifugation. This was again removed, disaggregated and re-suspended in 
growth medium, separate to the cell pellet. However, the samples were then subjected to a 
‘differential’ seeding of cells into wells, followed by removal of medium and transferral to a 
new, clean well after one and two hours respectively, with the hope that fast attaching 
fibroblasts would attach to the initial wells within the first two hours leaving the third well 
expectantly free of fibroblast contamination, this based on reports by Gartner et al. (Gartner 
et al., 1996). The cultures were maintained for 2-3 weeks but cells from neither the original 
pellet resuspension, nor the ‘tissue clump’ appeared to proliferate or grow in size. Cells in 
the original pellet re-suspension were more rounded and appeared to clump together 
forming clusters (Figure 3.3). No ‘branched’ or ‘dendritic’ looking cells were observed as with 
sample 2, however, cells were very sparsely seeded with large distances between clusters, 
or sections of clusters.  
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While samples 3 and 4 remained in culture with no growth, it was decided to revert back to 
seeding the cells directly into one well for the next samples in the hopes of an increased 
yield of cells, with possible sub-culture cycles as seen with sample 2. Samples 5 to 9 were 
treated similarly to sample 2, whereby FNA samples received were centrifuged and the 
pellet re-suspended in growth medium and immediately seeded into wells of 24 well plates 
for culture. Following centrifugation, samples 6 and 7 presented a thick, gelatinous 
supernatant which was removed and re-centrifuged before both pellets from each sample 
were seeded as before. Cultures were maintained for ~1.5-3 weeks but no growth in number 
or size was recorded and no sub-culturing was possible. 
 
 
a b 
c 
Figure 3.3 FNA original pellet re-suspensions 
of samples 3 (a +b) and 4 (c.) maintained in 
culture for ~2-3 weeks. Cells appeared more 
rounded and formed clumps but did not grow 
in number or size before dying off.  
A Euromex DC.3000C CMEX camera 
microscope was used. Magnification = 100x. 
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Sample 5 again presented cells of a more ‘spindly’, flat, ‘dendritic’ appearance (Figure 3.4) 
as seen in sample 2 (Figure 3.2). Initially, cells appeared to attach well to the culture plate 
and an increase in cell numbers was observed, albeit slowly and reaching a plateau. 
However, by 3.5 weeks, cells were no longer visible in culture.  
Figure 3.4 Sample 5 maintained in culture for ~3.5 weeks. Cells again appeared branched and dendritic 
as seen in sample 2 but did not appear to proliferate. A Euromex DC.3000C CMEX camera microscope 
was used. Magnification = 100x. 
 
Samples 6 and 8 did not fare well at all (Figure 3.5). The protocol did not change, yet 
following the first growth medium change after 3 days, many red blood cells were still present 
in the culture wells. With subsequent medium changes, no cells appeared to have actually 
attached to the culture dish and the samples were discarded after 1.5-2 weeks. We 
speculate that it is possible we did not obtain enough tumour material in the FNA sample 
received to allow attachment and propagation of cells.  
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Figure 3.5 Many red blood cells initially visible in sample 6 (a) and 8 (b) following the first growth 
medium change after the first three days of culture. Thereafter, no cells appeared to have attached. A 
Euromex DC.3000C CMEX camera microscope was used. Magnification = 100x. 
 
Again, samples 7 and 9 were treated with the same protocol. Following the initial growth 
medium changes after 3-4 days, a few larger, round cells had appeared to attach to the base 
of the culture plates (Figure 3.6). Cells were very few in number with large distances 
between them. The cultures were maintained with regular growth medium changes for 2-3 
weeks but the cells did not appear to multiply in number or grow in size before eventually 
disappearing from culture.  
a b 
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Figure 3.6 A few, rounded cells from sample 7 (a + b) and sample 9 (c + d) appeared in culture for up 
to 2 weeks but there were no signs of growth in number or size over this duration. Cells eventually 
disappeared and were no longer visible on the culture plate. A Euromex DC.3000C CMEX camera 
microscope was used. Magnification = 100x. 
 
 
 
 
 
 
 
 
 
a b 
c d 
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Figure 3.7 Outline schematic of FNA sample processing 
FNA Sample collection at Tygerberg Hospital FNA Clinic: 3ml Growth medium (room temp) 
Samples transported to Stellenbosch University’s Medical Physiology Laboratories 
-Centrifugation (5 
mins, 500xg, room 
temp) 
-Resuspension in 
Lysis buffer (Tris + 
NH4Cl) 
-3 minutes in water 
bath (37°C) 
- Repeated 
 
 
-Centrifugation (5 mins, 500xg, room temp) 
-Pellet re-suspended in 1ml growth medium (37°C) 
-Seeded into well on 24 well plate 
-After 1 hr, medium 
with unattached 
cells transferred to 
new well 
 
-Repeated after a 
2nd hour 
-Spindly, dendritic 
shaped cells 
 
- Maintained in culture 
for ~6-7 weeks 
 
- 1 passage 
-Rounded cells 
forming small 
clusters 
 
-Very few cells  
 
- Maintained for 2-3 
weeks before 
disappearing 
 
-Spindly, dendritic 
shaped cells 
 
-Few cells 
 
-Maintained in 
culture for ~3.5 
weeks, with no 
growth 
 
-Many red blood 
cells after 1st 
medium change 
 
-No cells attached 
to plate 
 
-Samples 
discarded after 1.5-
2 weeks 
-Very few, larger, 
rounded cells 
 
- Maintained for 2-3 
weeks before cells 
no longer visible 
 
-No cells 
present after 
1st medium 
change 
(~3days) 
1 2 3 & 4 5 6 & 8 7 & 9 
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3.3 Discussion 
Nine women consented to donating a breast lump FNA sample to this research study for the 
setup of a primary cell culture in vitro model. These women ranged in age from 31 years to 
48 years old, having had no previous treatment or therapy for the lumps present in their 
breasts. The samples were collected, transported back to the laboratory at Stellenbosch 
University and seeded into culture dishes where we left cells on average, 3.6 days to attach 
to the culture plates. The length of time the cells remained in culture ranged from 
approximately two to six weeks, until no more cells were visible under a microscope. Of the 
nine samples collected, Sample 2 appeared to survive the longest and even progressed 
through a single sub-culture cycle, while in the other samples, cells were visible but no real 
growth or proliferation was observed contrary to expectations as set out by previous 
literature.  
 
It is a disappointment that only 9 out of the intended 15 samples were collected for this Pilot 
study, however a conclusion can be drawn from the culture of the 9 samples that we did in 
fact receive. As described in literature, the presence of contaminating fibroblasts in any 
primary sample is frequently a major stumbling block in the culture of these samples 
(Amadori et al., 1993; Gartner et al., 1996; Z Li et al., 1998). It had been our intention to 
characterise the cultured cell populations using Flow Cytometry to identify known, distinct 
breast cancer cell surface markers CD44Hi and CD24Low (Al-Hajj et al., 2003) and confirm 
whether the cultured populations were indeed cancerous. However, unfortunately due to 
such low numbers of cells in each culture, we were not able to perform characterisation 
analyses to confirm the cell types. We were therefore unable to definitively report whether 
the few cells we had seen in culture, were in fact cancerous breast epithelial cells or rather 
contaminating cells such as fibroblasts.  
 
Upon initial seeding and imaging of the samples, many presumably red blood cells were 
present in the culture plate wells, discernible by their distinguishing rounded and concave 
shape as seen in figure 3.5. These cells were washed away with each growth medium 
change to leave attached cells in the wells. The cells present in figures 3.2 and 3.4 (samples 
2 and 5 respectively) appear to have a similar morphology of spindly, almost dendritic shape, 
also appearing flatter and more spread out. In comparison, cells pictured in figures 3.3 
(samples 3 and 4) and figure 3.6 (samples 7 and 9), appear more rounded and forming 
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clumps. The differences in morphology of the cells is quite clear and we speculate whether 
the cells surviving in samples 2 and 5 might well be fibroblasts or pericytes described by 
Rønnov-Jessen and colleagues (Rønnov-Jessen et al., 1995), as a similar morphology can 
be observed. Interestingly, smaller, rounded clusters of cells were visible in samples 3 and 
4, more in keeping with the description of cancer cells as reported by Li et al. and Araujo et 
al. (Li et al., 1998; Araujo et al., 1999). These samples were subjected to centrifugation 
followed by differential seeding over two hours (see chapter 2). Again, we were unable to 
characterise these cells due to such few numbers and lack of proliferation in culture. 
Samples 7 and 9 were quite unsuccessful with very few cells visible on the surface of the 
culture plates. These cells appeared more rounded but disappeared relatively quickly with 
no proliferation observed at all. From the official pathology diagnoses received for each 
patient sample (Table 3.1), we were unable to draw any conclusions regarding possible 
trends with the associated cultures. However, patient 2 was diagnosed as having an 
estrogen receptor positive (ER+), progesterone receptor negative (PR-) and C-erb (also 
known as HER—2) receptor negative, ductal carcinoma. This hormone profile was different 
from the other 8 patients, and cells from this sample were cultured for the longest time, 
progressing through a sub-culturing cycle. As stated before however, we cannot know if 
these were in fact cancer cells or not, as no characterisation was possible. Further 
investigations are necessary to be able to draw conclusions from the pathological hormone 
profiles of the samples.  
 
In the study conducted by Li and colleagues on their 25 samples, it was reported that almost 
half of their cases showed vigorous growth, proliferating through 3-7 sub-culture cycles with 
a rapid initial doubling time every 48-72 hours which then slowed to every 10-12 days after 
the third passage. Of the remaining unsuccessful samples, 10 of the 25 showed no cellular 
attachment or growth and in three cases, although small clusters of cells were initially 
observed, no further appreciable growth was observed. Their explanation for these 
unsuccessful cultures of samples alluded to the possibility of an insufficient number of viable 
and/or proliferation-competent cells present in the FNA sample (Li et al., 1998). It is quite 
possible that we were also unable to attain sufficient amounts of viable epithelial cancerous 
cells in the samples.  
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Successful primary cultures have also been established through FNA sample collection from 
other cancerous lesions, such as thyroid tumours and uveal melanomas. Thyroid FNA 
samples were initially cultured in RPMI 1640 growth medium supplemented with gentamicin, 
penicillin, glutamine and 20% fetal calf serum (FCS) for 2 weeks,  followed by trypsinisation 
and then propagation in DMEM medium supplemented with penicillin/streptomycin, FCS 
and glutamine for 4-5 weeks, obtaining sufficiently high numbers of cells for experimental 
purposes (Antonelli et al., 2008). Uveal melanoma FNA samples were cultured in RPMI 
1640 supplemented with 5% FBS, penicillin/streptomycin and fungizone, grown to a 
minimum of 1 million cells for 2 weeks, thus maintaining a stable cell line (Correa, Marshall 
and Burnier, 2009). In both of these cases, successful primary cultures have been 
established from samples collected via the FNA technique confirming that the technique can 
be successful in these instances.  
 
Unfortunately, we were unable to match these results as all of our nine FNA samples failed 
to proliferate successfully in vitro, thus a primary breast cancer culture model was not 
established. We can only speculate at this point as to why this might be. As mentioned 
previously, it is possible that not enough viable cancerous material was present in each 
FNA. The growth medium we used was a combination of that stipulated in the two breast 
FNA articles from the 90’s, containing HEPES and epidermal growth factor as well as 
penicillin and FBS in a high glucose DMEM. For future samples it might be worth including 
insulin or other growth factors into the growth medium to promote growth of the cancer cells, 
or perhaps making use of RPMI 1640 growth medium as used by others in other tissues 
(Antonelli et al., 2008; Correa et al., 2009). Temperature fluctuations could possibly also 
play a role in the success of the culture. As the FNA samples are removed directly from the 
body which is at a temperature of approximately 37°C, having the growth medium and 
centrifugation steps at room temperature (~22°C) might influence the viability of the cells in 
the sample. Since maintaining cells at 37°C would logistically be very difficult, cooling cells 
to 4°C and keeping them on ice could possibly prove a better option for increasing cell 
viability. Future investigations could include a comparison of cold with room temperature 
handling of samples.  A further possible amendment to future studies would be to consider 
3D culturing with the addition of a suitable attachment matrix such as collagen or Matrigel® 
(Corning®), a solubilized basement membrane hydrogel, to coat the base of the culture plate 
(Bergstraesser and Weitzman, 1993; Ip and Darcy, 1996; Burdall et al., 2003). This is a 
variation in the protocol that we would have like to test, but unfortunately time did not allow 
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for it. Moving forward, for future investigations we would also like to include samples 
collected from solid tumour masses i.e. tissue slices from mastectomy surgeries, to possibly 
increase the number of viable cancerous cells in the sample and to optimise culturing 
conditions. Once this is established, we’d like to return to examining FNA sample collection.  
 
To conclude, although two studies from the 90’s have successfully shown that breast cancer 
samples collected through FNA can successfully be maintained and propagated in culture, 
and despite the fact that FNA sample collection has been used in other cancer research 
studies, for the establishment of successful primary cell lines, we were unable to definitively 
culture and propagate any of the nine breast cancer FNA samples we collected. Due to this, 
we were also unable to complete our second aim of investigating the effect of hypoxia on an 
established primary cell culture. Furthermore, we were not able to complete the objectives 
originally set out to compare frozen FNA samples with established primary cell cultures 
under normoxic conditions to determine the effect of in vitro culturing on primary cells, or to 
establish the sensitivity of the primary cells to hypoxia through the measurement of ATP 
present in cells.  
 
There is room for manipulation and improvement of the protocol used and with time, we 
would have liked to experiment with further amendments in order to achieve all of the original 
aims and objectives. However, this pilot study remains inconclusive with no successful 
primary cell culture model established.  
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Chapter 4: The Effect of Hypoxia on PP2A Activity, Expression 
and Post-translational Modification 
 
4.1 Introduction 
Signal transduction within cells is a process whereby components (typically receptors or 
enzymes) are required to initiate signalling, as well as inhibit the cascade when necessary. 
While previous research provides a wide and comprehensive understanding of a range of 
kinases associated with cellular function, much about the ‘brakes’ of signal cascades, the 
phosphatases, is yet to be understood (Haesen et al., 2014). It is speculated that 
phosphatases are less studied in comparison to kinases, as they are more challenging to 
work with (Ruvolo, 2016). Protein phosphatase 2A (PP2A) is a ubiquitously expressed 
protein Serine/Threonine phosphatase, initially described as a tumour suppressor, that is 
involved in the regulation of almost all cellular activities within the body, including signal 
transduction, cell proliferation, cell division, growth and development, apoptosis, and cell 
survival. It is therefore a key role-player in the maintenance of cellular homeostasis 
(Eichhorn et al., 2009; Perrotti and Neviani, 2013; Seshacharyulu et al., 2013). Previous 
studies have alluded to the fact that dysregulation, or abnormal inactivation of this 
phosphatase can lead to the transformation of cells with the development and progression 
of cancerous phenotypes, promoting cell survival (Gabel et al., 1999; Sontag, 2001; Ruvolo, 
2016).  
 
As discussed in chapter 1, conditions of decreased tissue oxygen, or hypoxia, have been 
identified as hallmark characteristics of most solid-tumour cancers, and is a state to which 
cancer cells are seen to adapt through different mechanisms of survival, promoting and 
facilitating cell proliferation, and provoking more aggressive tumour phenotypes (Semenza, 
2003; Zhou et al., 2006). In a review by Zhou et al., it was concluded that conditions of 
hypoxia appear to influence a wide range of molecular pathways to promote and facilitate 
adaptation of cells, apoptosis and chemoresistance. The responses of cells to hypoxia are 
determined through both pro- and anti-apoptotic factors, along with proliferative signals, a 
shift in microenvironmental pH, as well as clonal selection. They further suggested that 
apoptosis may be initiated in conditions of severe and prolonged hypoxia/anoxia due to the 
presence of secondary stressors such as acidosis leading to the onset of apoptotic 
pathways. The development of chemoresistance and possibly clonal selection may occur in 
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response to the opposing signals delivered by pro-survival and pro-death pathways, leading 
to the selection of cells displaying a genetic or epigenetic growth advantage (Zhou et al., 
2006). Hypoxia thus plays some role in whether proteins involved in signalling pathways 
become activated or inactivated, and the cascade of effects this has within the cell.  It is of 
importance to this study how the phosphatase PP2A specifically is affected by hypoxic 
conditions. 
 
Currently in literature there exists some degree of controversy surrounding the actual effect 
that hypoxia has on PP2A and its state of activation. Some studies have provided evidence 
that PP2A becomes activated under conditions of hypoxia, inhibiting cell growth and leading 
to arrest of the cell cycle in the G1/S phase allowing for prolonged survival of cells (Bando 
et al., 2003; Yung and Tolkovsky, 2003; Hofstetter et al., 2012). Other studies offer opposing 
evidence that PP2A is phosphorylated, becoming inactive during hypoxia, promoting 
activation of pro-survival/proliferation signal cascades and tumour formation (Mumby, 2007; 
Lin et al., 2012). In a review by Mumby et al. it was described that mechanisms involved in 
PP2A inhibition include the expression of SV40 small tumour antigen, the upregulation of 
the cancerous inhibitor of PP2A (CIP2A) and/or mutations leading to the inactivation of the 
scaffold subunit of PP2A. These all contribute to enhancing phosphorylation and activity of 
tumorigenic proteins, including PKB (Mumby, 2007). Chen et al. further reported, that 
suppression of the endogenous A scaffold subunit of PP2A promotes the activation of PKB, 
thus suggesting that the activation of the PI3K/PKB pathway contributes to cancerous cell 
transformation, triggered by the suppression of PP2A activity (Chen et al., 2005). When 
considering these opposing findings, one must however, take into account variations in the 
different research set ups, such as cancer types investigated, locations within the body, 
whether primary cells or immortalised cell lines were used, and the influence that various 
other signalling pathways may have on whether cells survive or progress through apoptosis. 
Regulation of the function of PP2A appears to be quite complex, involving post translational 
modifications of the subunits which make up PP2A, which in turn influences the activity and 
binding affinities of the catalytic and the B subunits, thereby modulating the function of the 
enzyme (Janssens et al., 2008; Janssens and Rebollo, 2012).  
 
We therefore set out to identify the effect of hypoxia on PP2A within the immortalised triple 
negative breast cancer cell line, MDA-MB-231. This cancerous line has been widely used in 
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breast cancer studies (Bando et al., 2003; Kang et al., 2003; Ameri et al., 2010; Xie et al., 
2016), and we anticipated that it would be a good breast cancer cell model to use for the 
purpose of our investigations. Our aim was to investigate the effect of hypoxia on PP2A 
activity and post-translational modification in the MDA-MB-231 cell line, with the objective of 
making use of Western blotting and phosphatase activity assays to accomplish this aim. 
ATP cell viability assays were performed to determine the effect of hypoxia on the cells. We 
hypothesised that hypoxia would lead to a decrease in PP2A activity, thereby favouring the 
phosphorylation and activation of pro-survival and proliferation associated enzymes.  
 
4.2 Methods and Materials 
4.2.1 Culturing immortalised cell lines  
The MDA-MB-231 triple negative breast cancer cell line (PTEN wild type), obtained from 
colleagues, was maintained in culture under standard conditions (37°C, 5% CO2) in DMEM 
growth medium supplemented with FBS and penicillin/streptomycin. Cells were passaged 
at ~80% confluence through a combination of trypsinisation and cell scraping, and growth 
medium was refreshed every second day, as described in chapter 2.  
 
4.2.2 Exposure of immortalised cell lines to hypoxia 
Once a suitable number of cell culture plates was obtained, hypoxic experiments were 
conducted over various time durations. Initially, 72 hours exposure to hypoxia was carried 
out but this length of time appeared to be too potent for the cells (cell numbers dwindled 
drastically) and was revised to investigating a time course of 24, 48 and 72 hours. The latter 
three time points were only tested once (n=1). The hypoxic duration was further revised to 
2 hours, 4 hours, 6 hours and 8 hours. Time exposure experiments for the initial 72 hours 
and the 2, 4, 6 and 8 hours were carried out on three separate days for each time point 
(n=3). Cells were used between passages 47-52. For the purposes of Western blotting and 
the phosphatase activity assays, control plates received standard growth medium 
(supplemented with 10% FBS), and positive control plates received further supplementation 
with 200mM CoCl2, a known inducer of HIF-1 (Wu and Yotnda, 2011). Hypoxic experimental 
plates received growth medium supplemented with 1% FBS and were subjected to 4 
minutes of hypoxic gas flow (described in chapter 2) in a sealed hypoxic chamber, followed 
by incubation in the chamber at 37°C in a humidified atmosphere for the varying time 
durations. 
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For the ATP cell viability assays, MDA-MB-231 cells were seeded and grown in two 96 well 
plates for each time point, namely one control plate and one hypoxic plate. Again, once 
~80% confluency, hypoxic experiments were carried out as described in chapter 2. 
Following hypoxic incubation, cells were harvested and the following primary end-points 
investigated: (1.) The expression, phosphorylation and methylation of the catalytic subunit 
of PP2A via Western blotting; (2.) PP2A activity; and (3.) cell viability. 
 
4.3 Western Botting  
4.3.1 Method Overview (described in detail in Chapter 2) 
Following incubation of cells for the different time points, cell lysates were prepared for the 
purpose of Western blotting as described in chapter 2. Protein determination of each sample 
was calculated using the Bradford assay method (Bradford, 1976) and samples were 
prepared accordingly in Leammlie sample buffer. Between 10-30µg of protein was 
calculated for each sample. Equal amounts of protein were loaded onto gels and used for 
each experimental run. 
 
Proteins within the samples were separated according to molecular weight using SDS-page 
electrophoresis on a pre-cast gradient gel (4-20%) as described in chapter 2. Proteins were 
transferred to an inert PVDF membrane followed by fixing of the proteins to the membrane, 
in methanol. 5% fat free milk was used for blocking of the membrane for at least one hour 
to minimise nonspecific binding of antibodies. Membranes were washed three times and 
were incubated at 4°C overnight, in the primary antibody of interest. For the initial 72 hour 
hypoxia experiments, membranes were probed for phosphorylated catalytic subunit of PP2A 
(PP2A-C) (R&D Systems, AF3989), methylated PP2A-C (Santa Cruz, Sc81603) and total 
PP2A-C (cell signalling, 20385), as well as total PKB/Akt (Cell Signalling, 9272S),  
phosphorylated PKB/Akt (Cell Signalling, 4060S), total ERK (Cell Signalling, 9102S) and 
phosphorylated ERK (Cell Signalling, 9101S). The revised time points of 24, 48 and 72 hours 
were probed for PKB/Akt (total and phosphorylated), HIF-1α (Cell Signalling, 14179S) and 
ERK (total and phosphorylated). Blotting for HIF-1α was introduced at this point to confirm 
that hypoxia had in fact been stimulated, since it is known that stabilisation and increase 
levels of HIF-1α has been associated with conditions of hypoxia (Kaelin, 2002; Semenza, 
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2004). The final revised time points of 2, 4, 6 and 8 hours were probed for PP2A (methylated, 
phosphorylated and total) as well as HIF-1α.  
Following overnight incubation, membranes were again washed as previously described in 
Chapter 2, and incubated at room temperature for an hour, in relevant secondary antibody. 
All antibodies were incubated in anti-rabbit conjugate secondary antibody (Cell Signalling, 
7074S), barring methylated-PP2A, which was incubated in anti-mouse conjugate secondary 
antibody (Cell Signalling, 7076S). Again, membranes were washed as before, and protein 
bands were detected using a ChemiDoc system in association with stain free technology 
(Biorad, 2017) through the chemiluminescence interaction between the Bio Rad ClarityTM 
ECL detection reagent (Bio-rad, 170-5061) and the anti-rabbit/mouse horseradish 
peroxidase conjugated secondary antibody used. 
 
Detectable bands were analysed using Image Lab™ Software (Bio-Rad), and normalisation 
of ‘transfer images’ and exposed membranes using stain free technology (see chapter 2) for 
the standardisation of protein loading. Paired t-tests were conducted for data generated from 
the initial 72 hours hypoxic experiments. One way ANOVA’s with Bonferroni and Dunnett 
post hoc tests were conducted for data generated from the revised time-course hypoxic 
experiments. Analysis was done using GraphPad Prism 6, and data expressed relative to 
control (as described in the text), as means ± SEM.  
 
4.3.2. Western Blotting Results 
Based on microscope observations, the initial hypoxic incubation period of 72 hours seemed 
to be too potent for the MDA-MB-231 cells as they appeared to be dying and unable to 
withstand such a length of hypoxic onslaught. Cell numbers appeared to have visibly and 
notably decreased in number following hypoxia, with the morphology of the cells appearing 
shrunken and small. Lysate samples were still prepared and run through SDS-page protein 
separation and detection techniques. PP2A-C (total, phosphorylated and methylated) was 
probed for, as the main protein of interesting in the experiment, however we also looked at 
PKB/Akt and ERK (total and phosphorylated) in order to identify if the cell’s survival 
pathways had in fact been affected. Further, HIF-1α was probed for as a confirmation that 
hypoxia had been simulated. These graphs provide a representation of what has occurred 
following 72 hours hypoxia (Figure 4.1-4.5).   
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Figure 4.1 Membrane showing total-PP2A bands and corresponding bar graph indicating control vs 
hypoxia with a significant decrease in tPP2A in the 72 hour hypoxic samples. C = Control; H = Hypoxia. 
* = p ≤ 0.05 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Membrane showing phosphorylated-PP2A bands after 72 hours of hypoxia, and 
corresponding bar graph indicating control vs hypoxia with no significant difference between the two. 
C = Control; H = Hypoxia.  
 
 
* 
H3 C3 H2 C2 H1 C1 
H1 C2 H2 C3 H3 C1 
36kDa 
36kDa 
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Figure 4.3 Western blot membrane of methylated-PP2A bands after 72 hour incubations with 
corresponding bar graph indicating control vs hypoxia, showing no significant difference. C = Control; 
H = Hypoxia 
 
 
 
Figure 4.4 Phospho-to-total and methyl-to-total ratios for control vs hypoxia conditions after 72 hours 
incubation. Neither ratio showed any significant difference, relative to control.  
 
 
A decrease in total PP2A (tPP2A) expression with hypoxia was significant following 72 hours 
hypoxia (Control: 1.00 ± 0.1426 AU vs hypoxia: 0.3513 ± 0.07558 AU; n=3; p≤0.05) (Figure 
4.1). However, blots analysed for the phosphorylation and methylation of PP2A (figures 4.2 
C1 H1 C2 H2 C3 H3 
36kDa 
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- 4.3) showed no significant changes with hypoxia relative to control. Furthermore, the 
phospho-to-total (p=0.0615) and methyl-to-total (p=0.9650) ratios further showed no 
changes following hypoxia.  
 
HIF-1α as well as survival proteins PKB and ERK were blotted for next to investigate whether 
hypoxia had in fact been induced, and what its impact was on the phosphorylation status of 
PKB and ERK following 72 hours hypoxia.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 Membrane showing HIF-1α bands and corresponding bar graph indicating control vs 
hypoxia with no significant difference, although an interestingly, and unexpected decrease in HIF-1α 
during hypoxia is observed.  
 
From visualising the membrane in Figure 4.5, one would expect to have seen a significant 
decrease in HIF-1α which was not observed using a T-test analysis. However, from 
literature, one would expect an increase in HIF-1 α. As can be seen from the patchy 
appearance of the blots, it could be that the binding of one of the antibodies was too weak 
or unreliable to generate consistent results. The resulting variations in the data could explain 
the lack of significance.  
 
 
 
120kDa 
C1 H1 C2 H2 C3 H3 
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Figure 4.6 Membrane showing total-PKB bands and corresponding bar graph, indicating control vs 
hypoxia with no significant increase during hypoxia. C = Control; H = Hypoxia. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7 Western blot and corresponding bar graph of phosphorylated PKB, showing a significant 
decrease with hypoxia. C = Control; H = Hypoxia. * = p≤0.05 
 
 
 
H1 C1 C2 H2 C3 H3 
* 
H3 C1 H1 C2 H2 C3 
60kDa 
60kDa 
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Figure 4.8 Phospho-to-total ratio of PKB showing a significant decrease with 72 hours hypoxia  
* = p≤0.05  
 
Blotting for PKB showed no significant changes in total PKB (tPKB) following 72 hours 
hypoxia (Figure 4.6), however, phosphorylation of PKB (pPKB) significantly decreased with 
hypoxia relative to control (control: 1.00 ± 0.1347 AU vs hypoxia: 0.3812 ± 0.1089 AU; n=3; 
p≤0.05) (Figure 4.7). Furthermore, the ratio of phosphorylation to total PKB (p/t PKB) 
following hypoxia was found to decrease significantly relative to control (control: 1.211 ± 
0.1820 AU vs hypoxia: 0.2088 ± 0.03583 AU; n=3; p≤0.05) (Figure 4.8).  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9 Membrane showing total-ERK bands at 42kDa and 44kDa, and corresponding bar graph 
indicating control vs hypoxia. No significant difference was observed. C = Control; H = Hypoxia. Data 
for ERK 42 and ERK 44 were combined in this analysis due to difficulties experienced in distinguishing 
between individual bands.  
C1 H1 C2 H2 C3 H3 
* 
42/44kDa 
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Figure 4.10 Membrane showing phospho-ERK bands 42kDa and 44kDa, and corresponding bar graph 
indicating control vs hypoxia. No Significant changes were observed between control and hypoxic 
samples. C = Control; H = Hypoxia.  
 
 
 
 
 
 
 
 
 
Figure 4.11 Phospho-to-total ratios for control vs hypoxia conditions. A significant decrease in the p/t 
ratio was found with hypoxia compared to control following72 hours hypoxia. * = p≤0.05 
 
 
Blots probing for ERK showed no significant changes in expression of total ERK (tERK) after 
72 hours hypoxia relative to control (Figure 4.9), and similarly, no changes were observed 
in phosphorylated ERK (pERK) relative to control either (Figure 4.10). However, a significant 
decrease in the phospho-to-total ratio was measured following hypoxia relative to control 
(control: 1.00 ± 0.1519 AU vs hypoxia: 0.3493 ± 0.05206 AU; n=3; p≤0.05), indicating that 
with hypoxia, a decrease in phosphorylation of ERK relative to the amount to total protein 
* 
C1 H1 C2 H2 C3 H3 
42/44kDa 
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was measured, in comparison to control (Figure 4.11). Our data therefore indicated that 72 
hours of hypoxia was associated with a reduction in the activation of the pro-survival 
pathways mediated by PKB and ERK.  
 
 
Following Western blotting of samples exposed to 72hours incubation, it was decided from 
the data obtained to revise the incubation period to a time course to include varying durations 
of incubation, namely 24hours, 48hours and 72hours. These were conducted only once (n 
= 1) before further revision. In this time course experiment, antibodies probed for included 
HIF-1α (to confirm hypoxia), PKB and ERK (both total and phosphorylated) in order to 
assess the possible effects of the incubation on the survival pathways of the cells. Blotting 
for PP2A was not included with these revised hypoxic durations as it was our intention to 
examine the effects of these hypoxic time points on the survival pathways, with the aim of 
selecting a time point for the investigation of PP2A.  
 
 
 
 
 
 
` 
 
 
 
 
 
Figure 4.12 Membrane and corresponding bar graph of HIF-1α normalised to 24 hour control, showing 
no significant differences between control and hypoxia following 24 and 48 hours. C = Control; H = 
Hypoxia. * = p≤0.05 
 
 
120kDa 
C24 H24 C48 H48 C72 H72 
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Figure 4.13 Western blotting membrane and corresponding bar graph of total-PKB, normalised to 24 
hour control. No significant difference detected between control and hypoxia for any of the three time 
points measured. C = Control; H = Hypoxia.  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.14 Exposed membrane and corresponding bar graph of phosphorylated PKB, normalised to 
24 hour control. No significant difference observed. C = Control; H = Hypoxia.  
60kDa 
H48 H72 C72 C48 C24 H24 
60kDa 
C24 H72 C72 H24 C48 H48 
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Figure 4.15 Phospho-to-total ratio of PKB, normalised to 24 hour control. No significant differences 
found between control and hypoxia exposed samples for each of the three time points measured.  
 
 
Following the analysis of the blots from the revised incubation times, it was observed that 
HIF-1α appeared initially to follow a downward trend at 24 and 48 hours (Figure 4.12). 
Although these changes were not statistically significant in comparison to control, it is still 
interesting to observe, especially since based on reports in literature, we expected to 
observe an increase in stability and expression of HIF-1α with hypoxia. An increase was 
seen following 72 hours, however this was still not significant. Similarly, analysis of the 
expression and phosphorylation of PKB showed no significant changes after hypoxic 
exposure relative to control (Figures 4.13 and 4.14). The ratio of phospho-to-total PKB 
further remained unchanged in all of the hypoxic time durations (Figure 4.15). 
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Figure 4.16 Exposed membrane with corresponding bar graphs for total ERK 42 and 44 respectively. 
Data was normalised to 24 hour control. C = Control; H = Hypoxia.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.17 Western blot membrane with corresponding bar graphs of phosphorylated ERK 42 and 
ERK 44, normalised to 24 hour control. A significant decrease in pERK was observed in 24 hours 
hypoxia compared to 24 hours control for both pERK 42 and pERK 44 respectively. C = Control; H = 
Hypoxia. * = p≤0.05 
42/44kD
* 
H72 C72 H24 C24 C48 H48 
* 
42/44kDa 
H72 C72 H24 C24 C48 H48 
Stellenbosch University  https://scholar.sun.ac.za
73 
 
 
Figure 4.18 Phospho-to-total ratio of ERK 42 and 44 respectively, normalised to 24 hour control. No 
significant difference found between control and hypoxia for the different time points examined.  
 
No changes in the expression of tERK were observed following any of the hypoxic time 
points (Figure 4.16), however, significant decreases in the phosphorylation of both pERK 42 
(control: 1.00 ± 0.1660 AU vs hypoxia: 0.4696 ± 0.09681 AU; n=3; p≤0.05) and pERK 44 
(control: 1.00 ± 0.1586 AU vs hypoxia: 0.4849 ± 0.03826 AU; n=3; p≤0.05) was observed 
following 24 hours hypoxia relative to 24 hour controls (Figure 4.17). For the analysis of the 
ratio of phospho-to-total ERK, data for 48 hours hypoxia was omitted from the graphs due 
to technical challenges with an anomaly in the gel, or the way in which the samples ran. This 
caused to too much variation in the data, leading to skewed and unrepresentative graphs. 
No significant changes in this ratio were observed following any of the hypoxic time points 
(Figure 4.18). 
 
These results prompted further revision of the hypoxic incubation times to include shorter 
durations. The lack of significant changes in PKB expression and phosphorylation along with 
the unanticipated HIF-1α trends led us to wonder whether the durations of hypoxic 
incubation were still too potent for the MDA-MB-231 cell. The significant decrease in 
phosphorylation ERK 42 and 44 following 24 hours hypoxia relative to control further 
suggested the possibility of shorter hypoxia times may be favourable. Moving forward with 
the experiments, the further revised hypoxic incubation times were thus implemented (2, 4, 
6 and 8 hours) and results plotted accordingly. Representative blots are shown in Figures 
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4.19- 4.24. Because the results obtained for HIF-1α thus far did not match expectations as 
reported in literature, such that HIF-1α expression and activity is increased with hypoxia 
(Kaelin, 2002; Semenza, 2004), CoCl2 was introduced in these experiments as a positive 
control for hypoxia (refer to chapter 2). It has been described in literature as a chemical 
inducer of the transcription factor, HIF-1α (Wu and Yotnda, 2011) thus all pathways and 
proteins downstream from HIF-1α that become activated during hypoxia, will also become 
activated with treatment with 200 mM CoCl2. Blots were normalised to 2 hour control and 
stain free technology was a control for loading. Each of these time points was repeated in 
triplicate on separate days (n=3) and the data averaged and subjected to 1-way ANOVA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.19 Individual graphs of HIF-1α with corresponding Western blot. Data was normalised to 2 
hour control and no significant changes were observed despite the visual trend of increased HIF-1α 
expression in positive control samples relative to control. C = Control; +C = Positive Control; H = 
Hypoxia. Numbers indicate time point measured, e.g. C2 = 2 hr control 
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Figure 4.20 Total PP2A protein expression across all four time points measured, normalised to 2 hour 
control. Despite a visual increase in hypoxia relative to control, no statistical differences were 
observed for PP2A expression. C = Control; +C = Positive Control; H = Hypoxia. Numbers indicate time 
point measured 
 
36kDa 
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Figure 4.21 Phosphorylated PP2A showed no statistically significant changes relative to control over 
any of the four time points. Data was normalised relative to 2 hour control. C = Control; +C = Positive 
Control; H = Hypoxia. Numbers indicate time point measured 
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Figure 4.22 Phospho-to-total ratio of PP2A expression across all four time points, expressed relative 
to 2 hour control.  
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Figure 4.23 Methylated PP2A expression showed no significant changes with hypoxia relative to 
control. Data was normalised to 2 hour control. C = Control; +C = Positive Control; H = Hypoxia. 
Numbers indicate time point measured 
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Figure 4.24 Methyl-to-total ratio of PP2A expression, normalised to positive control. No significant 
changes were observed for any of the time points measured.  
 
Following hypoxic incubation for 2, 4, 6 and 8 hours, Western blotting analysis indicated no 
significant changes in the levels of HIF-1α relative to control (Figure 4.19). Similarly, the 
expression, phosphorylation or methylation of PP2A remained unchanged following hypoxia 
relative to control, as did the ratios of phospho-to-total and methyl-to-total PP2A (Figures 
4.20-4.24). This suggests that hypoxia does not appear to have an effect on PP2A 
expression of post-translational modification.  
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Figure 4.25 Representative images of the MDA-MB-231 cells after 2 hours incubation: a) control cells 
(10% FBS), b) positive control (10% FBS + 200mM CoCl2), and c) hypoxic cells (1% FBS + 4mins hypoxic 
gas). A Euromex DC.3000C CMEX camera microscope was used. Magnification = 100x.  
 
 
 
 
 
 
 
 
 
 
Figure 4.26 Representative images of the MDA-MB-231 cells after 4 hours incubation: a) control cells 
(10% FBS), b) positive control (10% FBS + 200mM CoCl2), and c) hypoxic cells (1% FBS + 4mins hypoxic 
gas). A Euromex DC.3000C CMEX camera microscope was used. Magnification = 100x.  
 
 
 
 
 
a) b) c) 
a) c) b) 
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Figure 4.27 Representative images of the MDA-MB-231 cells after 6 hours incubation: a) control cells 
(10% FBS), b) positive control (10% FBS + 200mM CoCl2), and c) hypoxic cells (1% FBS + 4mins hypoxic 
gas). A Euromex DC.3000C CMEX camera microscope was used. Magnification = 100x.  
 
 
 
 
 
 
 
 
Figure 4.28 Representative images of the MDA-MB-231 cells after 8 hours incubation: a) control cells 
(10% FBS), b) positive control (10% FBS + 200mM CoCl2), and c) hypoxic cells (1% FBS + 4mins hypoxic 
gas). A Euromex DC.3000C CMEX camera microscope was used. Magnification = 100x.  
 
There appears to be no obvious visible difference in number or morphology of cells following 
hypoxic incubation and the addition of CoCl2 relative to control plates.  
 
 
 
 
a) b) c) 
a) b) c) 
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4.4 Phosphatase Activity Assay 
4.4.1 Method Overview (described in detail in Chapter 2) 
Following incubation of cells for the different time points, cell lysates were prepared for the 
purpose of the phosphatase activity assays as described in detail in chapter 2. Protein 
determination of each sample was calculated using the Bradford assay method (Bradford, 
1976) and samples were prepared to a protein concentration of 400µg/µl. 
 
The PP2A catalytic subunit was then isolated from these lysates using immunoprecipitation. 
Samples were incubated in a rotating wheel overnight at 4°C with PP2A-C antibody. 
Following this, 50µl of previously prepared agarose bead slurry was added to each sample 
with a further four hour incubation at 4°C in a rotating wheel. Samples were then washed 
and the bead-antibody pellet re-suspended in assay buffer (Table 2.4) and used to prepare 
96 well plates for the activity assay. An EnzCheck® phosphatase assay kit (Molecular 
Probes, E12020) was used for the detection of fluorescent product, correlating to the amount 
of phosphatase activity present and samples were measured every 5 minutes over a period 
of approximately 2 hours using a BMG Labtech FLUOstar Omega Plate reader. 
 
Data was analysed with the help of a biostatistician at the Stellenbosch University 
Biostatistics Unit, Centre for Evidence-based Health Care. Phosphatase assay experiments 
were repeated for each time point (2, 4, 6 and 8 hours respectively), 3 times over, on 
separate days (n=3). The rate of change for each group at each time point was measured 
as well as the time-by-group effect. A repeated measures ANOVA was conducted, however 
no significant differences were observed. Western blotting (as previously described) was 
carried out to confirm immunoprecipitation of PP2A in the samples, whereby non-
immunoprecipitated cell lysates were blotted against immunoprecipitate samples and 
membranes were probed for both total PP2A protein and protein phosphatase 1 (PP1). This 
was done to confirm that the immunoprecipitation was successful and per implication that 
the phosphatase activity measured was indeed primarily due to PP2A.  
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4.4.2 Phosphatase Activity Assay Results 
The degree of DiFMUP hydrolysis within the immunoprecipitated samples was measured 
over approximately 2 hours. The fluorescent signal detected thus provided an indication of 
the amount of phosphatase activity within each sample. Experiments were repeated three 
times for each hypoxic incubation period (2, 4, 6 and 8 hours) and averages used to plot 
graphs for the signal generation over time.  
 
Western blotting of immunoprecipitated samples was conducted to observe whether PP2A 
had in fact been successfully precipitated in the samples. Figure 4.29 shows the presence 
of PP2A in immunoprecipitated samples as well as present in non-immunoprecipitated 
samples prepared prior to immunoprecipitation. Blotting for PP1 was also carried out as a 
means to observe whether the activity measured in the assay was not contaminated by other 
major Ser/Thr phosphatases, such as PP1, suggesting that what was measured in the 
assay, was in fact, PP2A (Figure 4.30). Thus, successful immunoprecipitation was 
confirmed by the presence of PP2A but not PP1 in immunoprecipitate samples relative to 
non-immunoprecipitated samples. 
 
 
 
 
 
 
 
 
Figure 4.29 Representative Western blot of PP2A, confirming the immunoprecipitation of PP2A in 
samples used for phosphatase assay. Clearly visible bands present at 36kDa in immunoprecipitation 
samples. C = control samples, H = Hypoxic samples. 
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Figure 4.30 Representative Western blot showing the presence of PP1 in the non-immunoprecipitated 
samples but not in the immunoprecipitatied samples. C = control samples, H = Hypoxic samples. 
 
 
From the graphs in Figure 4.31, one can see that the signal generation over time, for each 
group and for each hypoxic incubation time, remained statistically constant with no 
significant differences found relative to control. 
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Figure 4.31 Average signal generation over time. Samples exposed to A) 2 hours hypoxia, B) 4 hours 
hypoxia, C) 6 hours hypoxia and D) 8 hours hypoxia respectively. (n=3). The distribution of absolute 
change is the same across the groups. ANOVA’s and Mann-Whitney post hoc tests confirmed no 
significant differences.  
 
The average velocity of the reactions was then calculated as the absolute change in signal 
generation over 115 minutes and expressed as fluorescent units (FU) per minute (Figure 
4.32). This was further analysed for each hypoxic incubation time point. 1-way ANOVA’s 
were conducted with Dunnett post hoc tests. The velocity of the reactions of hypoxic 
samples as well as positive control samples showed no significant changes from that of 
control for the 2, 4 and 8 hour hypoxic times, however a significant increase was observed 
in the positive control group following 6 hours hypoxia, relative to control (control: 134.7 ± 
33.74 AU vs positive control: 193.6 ± 35.31 AU; n=2; p≤0.05). However, for this time point, 
only 2 experimental sets of data were used (n=2) due to the third repeated experiment 
providing too little protein in the sample to enable immunoprecipitation experiments. 
Interestingly, following 8 hour hypoxia, there appears to be a visual increased rate of change 
in hypoxic samples relative to control, contrary to the trend observed in the previous three 
time points. However, this was not statistically significant (control: 102.2 ± 0.7696 AU vs 
hypoxia: 138.6 ± 50.82 AU; n = 2; p = 0.6018). Data for this time point was also constricted 
to two sets of experimental repeats as too little protein was present in cells of the third 
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repetition to allow for immunoprecipitation and assay. Thus, it is possible that with an n of 3, 
significant differences may have been observed after 8 hours hypoxia.  
 
 
 
 
 
Figure 4.32 Average velocity (change in signal generation over time) for each time point measured. A 
significant change was only observed at 6 hours for positive control relative to control. * = p≤0.05 
 
With the aid of the Biostatistics Unit, Centre for Evidence-based Health Care at Stellenbosch 
University, repeated measures ANOVA’s were conducted to determine the effect of time on 
each group. However, insufficient residual degrees of freedom were detected and thus no 
statistical conclusions could be drawn from the graphs (Figure 4.33 and 4.34). Because of 
this, data was pooled to possibly provide an indication of whether hypoxia in general, had 
any effect on the activity of PP2A. The slopes of the graphs of hypoxia vs control (Figure 
4.35) and positive control vs control (Figure 4.36) were compared; however, no statistical 
significance was found, indicating that regardless of the time intervention, hypoxia did not 
appear to have any effect in the rate of change of activity of PP2A over time. 
 
* 
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Figure 4.33 and 3.34 are representative comparisons of signal generation of the four 
different hypoxic incubation durations conducted. The trend is thought-provoking and could 
prompt the inclusion of longer hypoxic incubation periods, possibly 12 and/or 16 hours, for 
future experiments. Furthermore, an increase in n-number would be beneficial as well as 
possibly a comparison between the three different runs conducted on one single plate. This 
however, would be logistically challenging and would cost some experimental compromise.  
 
 
 
 
 
 
 
 
 
Figure 4.33 A representative comparison of the signal generation of the different hypoxic incubation 
times with corresponding controls. Fluorescence appears to increase over time. 
 
Figure 4.34 A representative comparison of the signal generation of the different incubation times for 
control and positive control samples.   
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Figure 4.35 A repeated measures ANOVA conducted for control groups vs hypoxia groups showed 
no significant differences between the groups over time. p=0.586  
 
 
Figure 4.36 A repeated measures ANOVA conducted for control groups vs positive control groups also 
showed no significant differences between the groups over time. p=0.381 
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From the data generated and the statistics performed, we saw that there appeared to be no 
association of phosphatase activity with an increase in hypoxic exposure relative to controls. 
The rate of change of controls, positive controls and hypoxic groups showed no differences 
and the effect of time within each group also confirmed that no significant changes occur 
within each group over time. We are thus compelled to accept the null hypothesis that 
hypoxia does not have an effect on PP2A activity.  
 
4.5 ATP Cell Viability Assay 
4.5.1 Method Overview (described in detail in Chapter 2) 
MDA-MB-231 breast cancer cells were seeded and grown in 96 well plates under standard 
conditions to a confluency of ~80% whereupon plates were exposed to varying lengths of 
hypoxic incubations as described in detail in chapter 2. Control cells were seeded onto 
separate 96 well plates and incubated at 37°C for the corresponding time points measured. 
A CellTitre-Glo® luminescent cell viability assay kit (Promega G755A) was used to measure 
the amount of ATP present in the wells, providing an indication of the degree of metabolic 
activity of the cells in each well. An increase in luminescent signal correlates to an increased 
level of ATP production indicating increased viability of the cells.  
 
100µl of the CellTitre-Glo® reagent was added to each well by hand and a BMG Labtech 
FLUOstar Omega Plate reader was used determine the luminescence generated from each 
well. Data generated was analysed using paired T-Tests on GraphPad Prism6 and 
presented as means ± SEM with p≤0.05 considered statistically significant. 
 
4.5.2 ATP Cell Viability Assay Results 
Figure 4.37 shows a representative control plate standard curve of ATP signal generation 
measured, and confirming the linearity of the measurements in this assay. We did not 
however make use of the standard curve to calculate ATP levels as our primary concern 
was the relative change, relative to control. The luminescent signal measured alone is 
sufficient in this regard. 
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Figure 4.37 Representative ATP standard curve indicating the linear measurement of ATP.  
 
Data collected from three separate runs of each time point (n=3) were analysed as averages 
of each run. Paired T-tests indicated that no significant changes in ATP levels were present 
in the hypoxic samples relative to control (Figure 4.38). However, when each repeated run 
for each time point for was analysed independently, an interesting visual trend of decreased 
ATP following 4 and 6 hour hypoxia relative to control were detected (Figures 4.39 and 4.40). 
Although no statistical conclusions can be drawn from this observation, it is still pertinent to 
note the degree of repeatability present. Four wells of cells per time point per run were 
measured for both hypoxic and control plates. These individual analyses provide clearly 
visible trends in the data which is lost due to too much variability when the data is pooled 
and expressed as averages for each time point.  
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Figure 4.38 Paired T-tests indicated no significant changes in ATP levels for hypoxia samples relative 
to control for each time point measured. (n=3). 
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Figure 4.39 Visual decreases in ATP observed in 
hypoxic samples relative to controls for each 
repeated experiment of the 4 hour time point. 
Measurements of each run were done in 
quadruplicated, respectively (4 wells of cells per 
plate).  
Figure 4.40 Visual decreases in ATP observed in 
hypoxic samples expressed relative to controls 
for each repeated experiment of the 6 hour time 
point. Measurements of each run were done in 
quadruplicated, respectively (4 wells of cells per 
plate).  
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It is thus important to note that consistent results were only observed following 4 and 6 hours 
hypoxia. This indicates that the data was more robust at these time points. To investigate 
the variability seen following 2 and 8 hours hypoxia, we would need to increase the n-number 
of the experiment.  
 
Although the above analyses of the individual runs showed notable and repeated visual 
changes, when pooled together, the variation in the data lead to a finding of no statistical 
significance as seen in Figure 4.38.  
 
4.6 Discussion 
Previous reports in literature have shown that cancer cells are able to adapt and survive in 
conditions of hypoxia, with several studies suggesting that the inhibition of PP2A has been 
implicated in carcinogenesis and drug resistance, as well as in hypoxia (Ratnasinghe, Phang 
and Yeh, 1998). This led to the formulation of our hypothesis that hypoxia would induce a 
decrease in PP2A activity, thereby favouring the phosphorylation and activation of enzymes 
associated with survival and proliferation.  
 
In a study conducted by Lin et al. involving tumour initiating or stem cell (TIC’s), it was 
reported that PP2A activity is suppressed in these TIC’s in a variety of cancers. Their 
experiments made use of TIC’s cultured in 1% oxygen for 2, 4 and 6 days. Analysis of 
apoptosis assays indicated a large degree of cell death accompanying hypoxia, while 
phosphatase activity assays and Western blotting for PP2A found a decrease in PP2A 
activity with an increase in PP2A phosphorylation following hypoxia. These results combined 
with their results from cell migration and invasion assays, PCR, and flow cytometry analyses, 
led to the conclusion that suppression of PP2A leads to independent cell growth and tumour 
formation, essential factors for tumour initiation. In essence, PP2A suppression may 
promote tumour initiation (Lin et al., 2012). In an earlier study conducted by Chen et al., 
mutations in the Aα subunit of PP2A were introduced to immortalised cells, which led to 
defects in its binding to the other PP2A subunits, thereby impairing PP2A activity. 
Suppression of the expression of this subunit favoured the activation of the PKB survival 
pathway promoting tumour formation. Immunoprecipitation with phosphatase activity 
assays, apoptosis analysis and proliferation assays showed that over-expression of Aα 
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mutations and suppression of PP2A phosphatase activity lead to enhanced tumour 
formation. The same researchers also investigated PKB phosphorylation in these cells and 
found increased levels of pPKB in the cells expressing the Aα mutations, however, increased 
levels of pPKB were not detected in wild type PP2A cells. The results from their experiments 
further identified that 50% suppression of endogenous PP2A lead to cancerous cell 
transformation, while further suppression of PP2A lead to cell cycle arrest and apoptosis 
(Chen et al., 2005).  
 
4.6.1 Western Blotting 
At the onset of this research project, it was decided to investigate a hypoxic incubation period 
of 72 hours based on previous studies that had conducted similar hypoxic experiments, 
some ranging from 6 hours incubation (Prior et al., 2014; Xie et al., 2016), to 18 hours (J. 
Park et al., 2015), 24 hours (Nagelkerke et al., 2013), 48 hours (Cronin et al., 2010) and 72 
hours (Ren et al., 2013; Bousquet et al., 2015). Some studies even went so far as to incubate 
cells for between 9-21 days of hypoxic exposure (Coyle, Izzo and Chu, 2009; Vaapil et al., 
2012). Thus we anticipated that after 72 hours of hypoxia, we would be able to measure 
some degree of the effect of hypoxia on PP2A. We made use of a hypoxic gas mixture of 
0.5% O2, 5% CO2 and the balance, N2, and cells were incubated at 37°C in a humidified 
atmosphere. However, after the 72 hour incubation period, cultures had decreased in cell 
numbers, with shrunken, smaller morphologies. Western blotting analysis for total PP2A 
(tPP2A) showed a significant decrease, while blots for phosphorylated PP2A (pPP2A) and 
methylated PP2A (mPP2A) showed no significant changes following hypoxia relative to 
control (Figure 4.1 – 4.4). The ratios p/t PP2A and m/t PP2A further showed no significance. 
We also blotted for HIF-1α as it is a known and predominant transcription factor involved in 
cellular adaptation to hypoxia (Brahimi-Horn et al., 2007; Badowska-Kozakiewicz et al., 
2015).  From the analysis we saw an unexpected decrease in HIF-1α in hypoxia relative to 
control (Figure 4.5). Although this decrease was not statistically significant, it was an 
interesting observation as reportedly, HIF-1α is stabilised, activated and elevated under 
conditions of hypoxia (Bertout et al., 2008; Chandel and Simon, 2008; Ruan et al., 2009). 
Variations in the data, temperature fluctuations as in the case of HIF-1α, or sub-optimal 
Western blotting and antibody binding may have had an influence over these results.  
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Pro-survival pathways such as that leading to the activation of PKB, have been reported to 
be activated in many types of cancers through either amplification of associated genes, or 
through mutations of components of the signalling pathways, disrupting normal signalling 
and favouring cell proliferation and survival (Nicholson and Anderson, 2002; Yung and 
Tolkovsky, 2003; Song et al., 2005; Furuta et al., 2008). Lawlor and Alessi described PKB 
as a critical role player in cancer progression, through the stimulation of cell proliferation 
along with the inhibition of proteins that mediate apoptosis (Lawlor MA, 2001). Under normal 
cellular conditions, PKB is tightly regulated in order to inhibit pro-survival pathways and 
retard growth, however, in human cancers, this regulation has been reported to become de-
regulated (Bellacosa et al., 1995; Carpten et al., 2007; Kuo et al., 2008). In its activated, 
phosphorylated state, PKB directly phosphorylates transcription factors controlling 
expression of pro-and anti-apoptotic genes, leading to the negative regulation of factors 
promoting death gene expression, as well as positively regulating factors that induce survival 
genes. This promotes the development of angiogenesis, neovascularization and evasion of 
apoptosis, ultimately promoting tumour progression (Nicholson and Anderson, 2002).  
 
The ubiquitously expressed phosphatase, PP2A, has been found to actively 
dephosphorylate and inhibit the activity of PKB for regulation of cell survival pathways 
(Manning and Cantley, 2007).  However, regulation of PP2A in hypoxia has been shown to 
be abnormal, or dysregulated, contributing to cancer progression through the transformation 
of cells and the upregulation of phosphorylated PKB and ERK alike (Eichhorn et al., 2009; 
Ruvolo, 2016). We therefore decided to further blot for total PKB (tPKB), phosphorylated 
PKB (pPKB), total ERK (tERK) and phosphorylated ERK (pERK) after 72 hours hypoxia to 
gain a better indication of the effect of hypoxia on whether the MDA-MB-231 cells were 
adapting to hypoxia, or were in fact dying. When analysed, the results showed a significant 
decrease in pPKB with hypoxia relative to control (Figure 4.7), as well as significant 
decreases in the phospho-to-total ratios of both PKB and ERK with hypoxia relative to 
control (Figures 4.8 and 4.11 respectively). This indicates that there is less phosphorylated 
(active) PKB and ERK in comparison to the amount of total protein present during hypoxia, 
and suggests that these survival proteins are possibly being inactivated through 
dephosphorylation.  This result was unexpected as we anticipated to find an increase in 
activation of PKB and ERK correlating with an increased inactivation of PP2A with hypoxia. 
This, along with the fact that cell numbers appeared to be decreasing after 72 hours of 
hypoxia, called into question whether the MDA-MB-231 breast cancer cells were in fact able 
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to adapt and survive under such a long and potent duration of hypoxia (0.5% O2 with 1% 
FSB).  
 
In a study conducted by Xie et al. also on MDA-MB-231 cells, they made use of hypoxic 
incubation times of 2, 6, 12, 24 and 48 hours and cells were exposed to 1% O2. They 
measured the effect of hypoxia on proliferation and found that growth curves of control vs 
hypoxia overlapped at 2, 6, 12, and 24 hours, but separated at 48 hours however, changes 
were not significant. Cell apoptosis was also measured with results indicating that a 
significant reduction of apoptotic cells was indicated after 48 hours hypoxia relative to 
normoxic counterparts. The same group also looked at the expression of stem cell markers, 
which was significantly increased after 48 hours hypoxia, as well as colony formation which 
also indicated increased rates at 48 hours of hypoxia. These results obtained by this 
research group all confirm the notion that hypoxia alters metabolic pathways and promotes 
cell survival with the inhibition of apoptosis (Xie et al., 2016). Although this study did not 
investigate signalling pathways as with this current study, the cell line used was the same 
and the hypoxic incubation times appeared to induce cellular changes within the cells.  
 
Our 72 hour data prompted the revision of our incubation periods to include 24 hours as well 
as 48 hours exposure to hypoxia in the experimental protocol. However, Western blotting 
for PKB and ERK along with HIF-1α saw no significant changes in phosphorylation states 
other than a decrease in pERK 42/44 after 24 hours hypoxia relative to 24 hour control 
(Figure 4.17). Total PKB and ERK levels showed no significant changes over the 24, 48 and 
72 hour experiments relative to control, with the phospho-to-total ratios similarly unchanged. 
HIF-1α again showed a decreasing trend following 24 and 48 hours hypoxia relative to 
control, however, an increase following 72 hours hypoxia was observed. This data however, 
was not statistically significant, although it was surprising and unexpected (Figure 4.12). 
Upon exposure to oxygen, HIF-1α is typically unstable, difficult to detect and rapidly 
degraded by hydroxylation (Kaluz et al., 2008). We speculate that we may have in fact lost 
most of the stable HIF-1α through degradation when cells were exposed to re-oxygenation 
upon opening of the hypoxic chamber. Care was taken to handle cells quickly and all 
experimental steps following incubation were carried out on ice to slow cellular metabolism 
and thereby slow the breakdown of this protein. However, the results shows a visual 
decrease after 24 and 48 hours hypoxia, which opposes the significant increases that were 
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expected based on literature (Zhou et al., 2006; Bertout et al., 2008; Chandel and Simon, 
2008; Ruan et al., 2009). The hypoxic gas mixture used for the experiments contained only 
0.5% O2, and the hypoxic chamber remained sealed with an air-tight rubber ‘o’-ring and 
metal sleeve (Figure 2.1), thus we are certain that our stimulation of hypoxic conditions was 
sufficient, and the results we have seen are due to reasons relating to cellular signalling or 
perhaps technical issues concerning the various steps of the lysate protocol and/or lysate 
handling and storage. Thus it is possible that we were not able to accurately measure an 
accumulation of the protein due to re-exposure of the cells to oxygen upon removal from the 
hypoxic chamber. However, for future studies and peace of mind, measuring the presence 
of oxygen within the hypoxic chamber using either a specialized probe or dye, would indeed 
be a very relevant and useful step in the protocol. This would also confirm whether the 
chamber was sealed correctly and if the gas flow time was sufficient. 
 
The revised time experiments (24, 48 and 72 hours) were only conducted once each (n=1) 
and are thus seen as purely observational data without statistical power. The trends show a 
loss of cells with hypoxia, as well as a decrease in activation (phosphorylation) of PKB and 
ERK at 72 and 24 hours respectively, which does not support the notion that these MDA-
MB-231 breast cancer cells are able to display resistance to hypoxia. And further revision of 
hypoxic incubation times was considered. 
 
In a recent study by Smith et al., the uptake of F-Fluorodeoxyglucose (FDG), a widely used 
PET tracer, was measured in breast cancer cells mediated via HIF-1α. FDG enters cells via 
glucose transporters (GLUT) which are frequently seen to be upregulated in cancer cells 
(Smith et al., 2013). Low oxygen levels further enhance FDG uptake in cultured breast 
cancer cells, thus in order to measure the uptake, hypoxia was stimulated for 1, 2, 4, 8, 16 
and 24 hours respectively. Their results showed that treatment with hypoxia rapidly induced 
HIF-1 proteins, peaking at between 1- 4 hours with levels increasing ~10 fold in MDA-MB-
231 cells. Increased FDG uptake was detected after a mere 1 hour hypoxic incubation and 
reached a maximum after 4 hours, thereafter decreasing to base line by 16 hours. The rapid 
increase and peak between 1-8 hours hypoxia is consistent with a similar study by Burgman 
et al. in 2001, also on breast cancer cells (Burgman et al., 2001). These results further 
suggest that shorter periods of hypoxic incubation appear to have a significant effect on 
some cellular signalling pathways, including that of HIF-1.  
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Taking into account that these studies made use of hypoxic incubation times far shorter than 
those previously used in this study, we decided to further re-adjust the project protocol to 
include 2, 4, 6 and 8 hours of hypoxia. These experiments were repeated three times for 
each time point (n=3). As these time points were decided on to focus on the aim of the 
project, namely PP2A, we did not continue blotting for PKB and ERK. Western blotting for 
tPP2A, pPP2A and mPP2A (Figure 4.20-4.24) showed no significant changes with hypoxia 
relative to control. Blots for HIF-1α (Figure 4.19) also showed no significant changes, 
however, the trend appears to now show an increase in the expression of HIF- α with hypoxia 
at 4, 6 and 8 hours, relative to control. Although not statistical, this trend is closer to what 
was initially expected. Furthermore, the positive control for HIF-1α follows an increasing 
trend with an increase in hypoxic incubation time, reaching a maximum after 4 hours. This 
does somewhat cast some doubt on the efficacy of our hypoxic intervention, although large 
variations do exists in the data. This could be contributed to the high instability of HIF-1α 
and the technical difficulties experienced in working with the enzyme due to rapid 
degradation upon re-oxygenation following hypoxic incubation. 
 
Figures 4.25-4.29 show images of MDA-MB-231 cells in culture under control (normoxia), 
positive control (supplementation with 200 µM CoCl2) and hypoxic (0.5% O2) conditions, for 
each time point. It can be seen that not much variation exists between number and 
morphology of cells for each condition. Experiments were conducted when confluency was 
estimated to be 70-80%, thus an amount of discrepancy may exist between plates of 
different experiments/time points due to human error on different days. Xie et al. noted that 
hypoxia could inhibit the growth of MDA-MB-231 cells very slightly, but this inhibition is not 
significant relative to control cells cultured under normoxia (Xie et al., 2016).  
 
From the analyses conducted above, there proved to be a surprising and unexpected lack 
of significant changes in PP2A, and unexpected decreases in phosphorylation of pro-
survival proteins PKB and ERK following 72 and 24 hours hypoxia respectively. There also 
appears to be no link or evidence suggesting an association between PP2A and the duration 
of hypoxia in the MDA-MB-231 breast cancer cell line, at least in our hands.   
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4.6.2 Phosphatase Activity Assay  
Results from the phosphatase assays (n=3) seemed to correlate to and confirm the results 
obtained from the Western blotting analysis of PP2A, that hypoxia did not show any 
significant effect on PP2A activity following 2, 4, 6 and 8 hours hypoxic incubation. 
Fluorescence was measured every 5 minutes over a period of 2 hours for both hypoxic and 
control cells for each of the four incubation times. One way ANOVA analyses showed that 
no significant changes were observed within each group (incubation time) for control vs 
hypoxia, thus no rate of change differences were observed. Phosphatase activity during 
hypoxia did not significantly increase over time, relative to control (Figure 4.29). The average 
velocity for each time point was also analysed and the only significant change observed was 
seen in positive control samples relative to control after 6 hours (Figure 4.30). The trends 
however, observed in Figure 4.31 (D), Figure 4.32, Figure 4.33 and Figure 4.34, indicated 
an increase in PP2A as hypoxia continues. This could suggest further investigations are 
needed with increased n-numbers, increased durations of hypoxia, or attempting a different 
approach to measuring PP2A activity. 
 
Western blots were performed with whole cell lysates alongside immunoprecipitated 
samples used in the phosphatase assay, probing for PP2A and PP1 respectively. Figure 
4.29 shows the representative blot for PP2A with clearly visible bands across the blot at 36 
kDa. This confirms the presence of PP2A in both the non-immunoprecipitated and the 
immunoprecipitated samples, indicating that the protocol had been successful. Blotting for 
PP1 as shown in Figure 4.30 served to prove that other phosphatases were not present in 
the immunoprecipitate and that the activity measured in the assay was not contaminated by 
other major Ser/Thr phosphatases. This suggests that the lack of change in PP2A activity 
between control and hypoxia is not due to errors in the protocol but more likely that in fact 
hypoxia is not influencing activation of the enzyme. However, as a significant decrease in 
PP2A activity during hypoxia was also not observed, it appears that hypoxia is not leading 
to the phosphorylation and inactivation of PP2A either. PP2A remains unaffected, converse 
to our original hypothesis. It is difficult to speculate as to why this is. A phosphatase activity 
assay conducted on glioblastoma multiforme-derived tumour stem-like cells by Hofstetter et 
al., showed that at 80% confluency, cells exposed to 6 hours of hypoxia (1% O2) or 200 µM 
CoCl2, exhibited significantly marked increases in PP2A activity (Hofstetter et al., 2012). We 
expected to observe some change in activity levels of PP2A, but instead it appears to remain 
similar to control conditions.  
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4.6.3 ATP Cell Viability Assay 
Paired T-tests of the results obtained from the ATP cell viability assay indicated that no 
changes in ATP levels were present following any of the hypoxic time points. However, a 
degree of variability existed within the data so it was decided to analyse each repeated run 
of the experiments individually to possibly find a trend. Notable decreases in ATP were 
consistently detected in hypoxic samples for each of the three repeated experiments of 4 
hours and 6 hours incubation respectively (Figures 4.39 and 4.40). The individual analyses 
pertaining to 4 hours and 6 hours hypoxia, provide a clearly visible trend in the sets of data 
which is lost due to too much variability when the data is pooled and expressed as averages 
for each time point (Figure 4.38).The fact that the same trends were measured on each of 
these individual runs for 4 hours and 6 hours, alludes to the robustness and the repeatability 
of the observations. This decrease in ATP at 4 hours and 6 hours, suggests that at these 
time points, cells are less metabolically active than their control counterparts, or that possibly 
there are less viable cells present.  Yung et al. found in their ATP analyses following oxygen 
and glucose deprivation that after the first 4 hours cells still contained approximately 50% of 
their initial ATP, however after 6 hours, only 8.5% of initial ATP levels remained. 
Interestingly, this loss in ATP was accompanied by a loss of phosphorylation of kinases ERK 
and PKB, however these decreases were concluded to be due to glucose deprivation rather 
than the lack of oxygen (Yung and Tolkovsky, 2003). From this we could speculate that as 
hypoxia progresses, the activity of the kinases decreases. From our results we observed no 
changes in PP2A, thus if the interaction between phosphatases and kinases is viewed as a 
‘balancing act’, then even though PP2A activity remained unchanged following hypoxia, it 
would appear that the ‘balance’ has shifted in favour of PP2A activity by virtue of a reduction 
in kinase activity. In our experimental protocol, cells were cultured in high glucose DMEM 
medium, which does not then explain the decreases in ATP levels in accordance with Yung’s 
results. The decrease in ATP could possibly be contributed to the Warburg effect where the 
adaptive shift from oxidative phosphorylation to use inefficient glycolysis, produces less ATP 
(Warburg et al., 1927). In a more recent study involving PP2A and hypoxia, it was found that 
PP2A mediates the decrease, or loss, of metabolic activity along with ATP production during 
hypoxia. Their conclusion was that hypoxia induced PP2A activity leading to cell cycle arrest 
and decreased ATP consumption, promoting tumour cell survival (Hofstetter et al., 2012). 
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4.6.4 Summary 
Although all of these results do not tie in with our initial hypothesis which states that we 
anticipated a decrease in PP2A activity, favouring the activation of pro-survival pathways, it 
is interesting to note that controversy over the role of PP2A in cancer exists in literature, and 
there are research groups who report opposing results and propose different conclusions 
as to its role during hypoxia. In an article published in 2012 by Hofstetter and colleagues, 
evidence suggests that hypoxia in actual fact may induce PP2A, rather than inhibit it, leading 
to cell survival through G1/S phase arrest of the cell cycle. Their research was conducted 
on glioblastoma multiforme-derived tumour stem-like cells, and hypoxia was stimulated with 
1% oxygen or the use of 200 µM CoCl2. Results showed that PP2A activity was positively 
correlated with increased HIF-1α expression, and that its activity was induced after 6 hours 
of hypoxia, leading to the mediation of G1/S phase growth inhibition and a reduction in the 
consumption of ATP. This hypoxia-induced PP2A activity therefore was seen to decrease 
the cells’ metabolic activity by limiting proliferation and enhancing survival under severe 
hypoxic conditions. Experiments were conducted with okadaic acid (OA), a specific inhibitor 
of PP2A, where it was shown that PP2A inhibition prevented this cell cycle arrest and 
allowed cells to continue to proliferate, depleting intracellular ATP levels and eventually 
progressing though apoptosis or necrosis  (Hofstetter et al., 2012). In 2015, Carrer and 
Wellen proposed that cells are able to adapt to hypoxia, or limited oxygen supply, by slowing 
down cellular processes thereby preserving energy by altering their metabolism to maximise 
energy gain (Carrer and Wellen, 2015). Studies prior to these have also alluded to the notion 
that growth arrest and/or necrosis occurs in unvascularised regions where an insufficient 
supply of oxygen is present (Tannock, 1968; Evans et al., 2001). These reports call into 
question whether our expectation of ‘adaptation to hypoxia’ was correct. We expected that 
cells would thrive with an increase in cell survival signalling, but perhaps adaptation could 
also include sections of the cell population dying off, while the remaining population slows 
down and only later emerges as resistant, more aggressive cells.  
 
Another earlier study by Yung and Tolkovsky in 2003 on astrocytes, had similar conclusions 
that in fact PP2A becomes activated during oxygen and glucose deprivation, thereby 
promoting the dephosphorylation and inactivation of survival proteins PKB and ERK. Their 
research showed that erasure of ERK and PKB phosphorylation, thereby inactivating these 
enzymes, is mediated through the activation of OA-sensitive phosphatases such as PP2A. 
This is manifested between 6 and 8 hours from the onset of oxygen deprivation, with a 
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parallel decrease in ATP. However, it was determined that it was the lack of glucose rather 
than the lack of oxygen that promoted the dephosphorylation of ERK (Yung and Tolkovsky, 
2003).  
 
These studies mentioned were conducted on a variety of tumours rather than solely on the 
breast so one could argue that the cellular signalling could substantially vary. However, the 
fact remains that there are conflicting reports as to the effect hypoxia has on PP2A and 
subsequently which signalling pathways become activated or inactivated. La Croix et al. also 
reported that the same cancer cell lines cultured in different laboratories and/or under 
several conditions can evolve differently, thus giving rise to divergent sub-populations and 
preventing inter-laboratory comparisons of data on the same cell line (Lacroix et al., 2004) 
 
From the Western blotting and phosphatase activity assay experiments, we have seen that 
PP2A activity did not appear to increase, nor did it decrease. The ATP results suggest that 
hypoxia is however affecting the cells, specifically at 4 and 6 hours, as ATP levels are 
decreased relative to control. These decreases however, are thus unlikely to be connected 
to PP2A activity, and it is more likely that some other signalling pathway within the cells has 
been affected rather than the PP2A. It is possible that there are contributing variables to our 
protocol that could be influencing the results, such as age of cells, passage number, 
robustness of these particular cells, genetic mutations inherent to this line or a number of 
other factors.  
 
In essence, we are investigating an in vivo problem using an in vitro cell line. Our central 
premise was that these MDA-MB-231 cells would adapt to the hypoxic conditions and 
continue to proliferate. Although the ATP assay that we conducted was a cell viability assay, 
with more time we would have liked to perform additional Propidium Iodide/ Annexin V 
staining to distinguish between apoptosis and necrosis. From this we would have been able 
to conclude whether cells were still very much present, just less metabolically active and 
producing less ATP, or in fact whether cell numbers had decreased due to cell death. The 
protein yields measured through Bradford assays (Bradford, 1976) following hypoxia for the 
purposes of Western blotting and the phosphatase assay, showed very little variation 
between time points. This suggests that cells exposed to hypoxia were still present in culture 
Stellenbosch University  https://scholar.sun.ac.za
104 
 
with similar protein yields relative to control cells. This could therefore propose that cells 
have not been lost to apoptosis or necrosis, but have rather gone into cell cycle arrest with 
decreased cellular metabolic demands. As mentioned, though this would need to be 
confirmed through further experimental assessment. Expanding on the hypoxic incubation 
periods to perhaps include 12, 16 and 32 hours might aid in further investigations, as well 
as making use of multiple cell lines for comparisons. The ATP data show that after 4 and 6 
hours of hypoxia, these cancer cells appear to already be producing less ATP, yet Western 
blotting data shows that although some degree of cell loss was experienced, there was a 
population of cells continuing to survive for up to 72 hours in hypoxia. This could indicate 
that a portion of the cells have adapted to the hypoxic conditions. From all the results 
obtained, there appears to be no link or evidence of association between PP2A and duration 
of hypoxia in this breast cancer cell line, and our initial hypothesis regarding the effects on 
PP2A was incorrect.  
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Chapter 5: Conclusion 
 
5.1 Establishing Primary Breast Cancer Cell Cultures 
Establishing successful primary cell cultures from breast cancer cells obtained through fine 
needle aspiration (FNA), retaining the characteristics of the original in vivo tumour, is a 
research goal that if achieved, could have numerous benefits for breast cancer research 
and clinical treatment. Advantages potentially include specific drug targeting and resistance 
management, the development of patient-specific therapies, as well as contributing to a 
broader understanding of the cellular functioning of cancer cells. In our pilot study we had 
hoped to be able to set up and institute such a primary cell model with the intention of 
comparing cultured cells to their frozen original un-cultured counterparts, and performing 
further hypoxic experiments on the cells. Apart from two prominent studies conducted in the 
late 90’s, not much work has been published referring to the successful set up of a primary 
cell model in this way, but based on these reports, we aimed to confirm and improve on 
these successful cell cultures.  
 
Our initial pilot study protocol included samples from 15 patients to set up the culturing 
technique. Unfortunately, we were only able to collect 9 FNA samples of the intended 15 
due to unforeseen waiting periods and time constraints. However, even with 9 primary 
samples, we were unable to successfully propagate cells in culture. Proliferating cells were 
observed in one of the cultures, however cells did not survive long, nor did the population of 
cells expand sufficiently for us to confirm whether they were in fact cancerous epithelial cells, 
or merely contaminating cells such as fibroblasts or pericytes (Rønnov-Jessen et al., 1995).  
 
5.1.1 Limitations and Future Directions 
Limitations of this study include the protocol design and the availability of patients. At the 
onset, we expected to receive patient samples on a regular and frequent basis, however, in 
reality, often weeks went by where no suitable patients visited the FNA clinic. We were 
therefore not able to collect all 15 samples. A second obstacle we did not anticipate was the 
length of time taken to obtain ethical clearance to begin sample collection. In this 2 year 
study, patient samples were only collected in the second half of the second year due to 
waiting periods connected to ethical approval, as well as the setting up of research 
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collaborations with the Department of Anatomical Pathology at Tygerberg Hospital. This 
meant that we did not have enough time to continue collection of samples before conclusion 
of the study. 
 
Regarding the actual protocol and handling of the samples, a further limitation was that 
samples were taken directly out of the body at 37°C, but our transport medium and 
conditions in the laboratory were at 22°C due to technical limitations. This change in 
temperature may or may not have affected the cells in the samples. In future, we would like 
to find a way of maintaining a constant 37°C at all times. However, keeping samples on ice 
and maintaining them at a low temperature could be an alternative approach, and could 
possibly serve to enhance the viability of the collected cells in the sample. Both of these 
temperature changes should be investigated to identify the optimal temperature range for 
successful, viable isolation.  
 
Contaminating cells within the FNA samples is also a limitation faced. Samples included 
many red blood cells which were difficult to remove without lysing cancer cells present. They 
also made visualisation of cultures impossible in the initial few days after seeding, due to 
the intense opaque red colouration of the growth medium. Thus we were unable to identify 
if cells had attached to culture plates and had to make estimations based on literature. 
Contaminating fibroblasts, mesenchymal cells and lymphocytes are a well-documented 
limitation in primary cell cultures, with their over growth commonly overwhelming and out 
numbering growth of cancer cells (Amadori et al., 1993; Gartner et al., 1996; Zheng Li et al., 
1998). However, this was not something that was struggled with in this study. In the majority 
of the cases, no cells appeared to grow for very long while in other cases, nothing grew at 
all. This then alludes to non-optimal culturing conditions, or it is possible that we did not 
receive enough cancerous material in the FNA samples we acquired. Li et al. also reported 
that the number of actual viable proliferation competent cells present in the FNA samples 
will determine whether propagation in culture will occur (Li et al., 1998).  
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For futures studies, it would be interesting to incorporate the use of a suitable attachment 
matrix such as collagen or a Matrigel® (Corning®) coating to the culture plates to determine 
if this could aid attachment of cancerous epithelial cells. Manipulations of the growth medium 
could also be implemented, possibly to include different growth factors such as estrogen 
and/or insulin, as well as varying percentages of FBS content. The use of RPMI 1640 growth 
medium instead of high glucose DMEM could also be tested. Furthermore, investigations 
including cells harvested from excised cancerous lesions obtained through surgery could 
prove beneficial in ensuring a greater number of cancerous cells are harvested per sample. 
 
If and when a primary model is established, we would like to continue our characterisation 
of the model by comparing primary cultured cells with their corresponding uncultured original 
sample as set out in our initial aims and objectives. In addition, we would like to assess the 
effects of hypoxia on these cells. We would like to even go so far as to investigate the 
specific protein profiles of these cultures to get a better idea of notable proteins that may or 
may not be up or down regulated in conjunction with culturing per se. Proteomic analysis 
could be used to identify adaptations in the cancer cells’ protein content due to in vitro 
culturing, as well as associated long term hypoxic culturing. Furthermore, identification and 
localisation of multiple proteins within samples, as well as determining the sensitivity of the 
cancer cells toward traditional therapies could be investigated. Introducing drug targeting 
and drug resistance studies to primary cultures would be a further advancement in the 
research which could add considerable value to the field of breast cancer.  
 
5.2 The Effect of Hypoxia on PP2A 
The effect that hypoxia has on PP2A in cancerous cells has led to much debate and 
controversy among researchers as different studies have concluded with quite different 
results. Several studies have proposed that PP2A becomes activated under conditions of 
hypoxia, inhibiting cell growth and leading to arrest of the cell cycle in the G1/S phase 
leading to prolonged survival of cells (Bando et al., 2003; Yung and Tolkovsky, 2003; 
Hofstetter et al., 2012). Other studies propose that PP2A is phosphorylated and inactivated 
during hypoxia, promoting  survival, proliferation and tumour formation (Mumby, 2007; Lin 
et al., 2012). The exact mechanisms involved are still poorly understood and the influence 
of other signalling pathways leads one to appreciate that cellular signal transductions do not 
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occur as stand-alone processes. There are many contributing pathways involved, 
sometimes bringing about unexpected effects. 
 
In this study, we hypothesised that hypoxia would induce a decrease in PP2A activity 
through an increase in its phosphorylation, bringing about the promotion of phosphorylation 
of pro-survival pathways. Our data suggests however, that PP2A activity was neither 
increased nor decreased. We observed a reduction in ATP at 4 hours and 6 hours that could 
indicate either a loss of cells, or that while cells are surviving, they may have reduced 
metabolic activity and are showing some degree of adaptation to hypoxia. However, further 
research is thus necessary to confirm this. 
 
From these results we are forced to reject our initial hypothesis and conclude that in our 
MDA-MB-231 breast cancer cell cultures, hypoxia does not seem to have an effect on PP2A 
and there appears no link or association between the two, contrary to those previously stated 
in literature.  
 
5.2.1 Limitations and Future Directions 
Limitations of this part of the study could be contributed to the setup of hypoxia. Oxygen 
levels were decreased to a mere 0.5% and it is possible that this severity of reduced oxygen 
could be too potent for this particular cell line. Hofstetter et al. suggested that in instances 
of severe hypoxia, cancer cells arrest in G1/S phase of the cell cycle (Hofstetter et al., 2012). 
Therefore, it is possible that the intensity of hypoxia in our experiments could have caused 
cells to enter cell cycle arrest which could be associated with the lack of any further PP2A-
associated responses to hypoxia.   
 
Cell robustness, age, passage number and associated possible genetic mutations of the cell 
line could all play roles in these hypoxic experiments. We are trying to investigate an in vivo 
phenomenon, making use of an in vitro cell line, as such, for future experiments it would be 
advantageous to investigate a range of different breast cancer cell lines for a better, more 
descriptive comparison of results. It could therefore be investigated whether results 
observed are the same in some, or none of the other cell types. This comparison would be 
of importance as the in vivo tumour microenvironment is largely heterogenous, thus if one 
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is able to observe repeated results in multiple cell lines, it would be a good indication of the 
conditions existing within the tumour cells.   
 
Furthermore, we would like to increase our hypoxic incubation times to include 12, 16 and 
36 hours of exposure. It is possible that the time points we measured may have been too 
short (2, 4, 6 and 8 hours), or alternatively, too long (48 and 72 hours). A wider variety of 
incubation times might give a better representation of the effect of hypoxia on cell signalling. 
It is interesting to note that the 72 hour data of the first revised time course experiments, did 
not mirror the data obtained from the initial 72 hour experiments. It is possible that we were 
too hasty in looking for an ideal time point. For further studies, it would be pertinent to 
conducted further experiments across these time points.  Regarding whether cells were 
surviving with a lowered metabolic demand, it would be preferential to include analyses 
using Propidium Iodide/Annexin V staining to confirm cell death within samples as the ATP 
assay that we conducted was merely a measure of cell viability, and not apoptosis as well. 
Obtaining new cells of a younger age having gone through fewer sub-culturing cycles, could 
also be advantageous as well as increasing the replication number of the experiments for 
robustness and reproducibility.  
  
This study has contributed further to the confusion surrounding the role of PP2A in hypoxia, 
however, some thought provoking trends were observed suggesting that extended future 
work is necessary. 
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Addendum A:  
PARTICIPANT INFORMATION LEAFLET AND CONSENT FORM 
TITILE OF RESEARCH PROJECTS: 
1. Proteomic investigation into the effect of hypoxic culturing on primary breast 
carcinoma cells.  
 
REFERENCE NUMBER: S16/03/048 
 
PRINCIPAL INVESTIGATORS:   
Dr Derick van Vuuren 
Miss Victoria Patten 
 
ADDRESS: 
Division of Medical Physiology, FISAN building, Tygerberg Campus, Francie van Zyl drive, 
Stellenbosch University, Bellville.  
 
CONTACT NUMBER:  
Dr Derick van Vuuren – 021 9389390 
 
 
 
Dear patient 
 
You are being invited to take part in our research study on breast cancer, and we would 
appreciate if you could take some time to read the information presented here, which will 
explain the details of this project.  Please ask the study staff or doctor any questions you 
may have about any part of this project that you may not fully understand as it is very 
important that you are fully satisfied and that you clearly understand what this research 
entails and how you could be involved.  Also, your participation is entirely voluntary and 
you are free to decline to participate.  Should you so decline, this will in no way affect you 
negatively by any means.  You are also free to withdraw from the study at any point, even if 
you do initially agree to take part. 
 
 
This study has been approved by the Health Research Ethics Committee at Stellenbosch 
University and will be conducted according to the ethical guidelines and principles of the 
international Declaration of Helsinki, South African Guidelines for Good Clinical Practice and 
the Medical Research Council (MRC) Ethical Guidelines for Research 
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What is the study all about and how can you help? 
 The study will be conducted at the department of Medical Physiology of Stellenbosch 
University, Tygerberg campus, and we are hoping to recruit approximately 50 
participants. 
 During your visit to the FNA clinic at Tygerberg Hospital, we would like to ask your 
permission to take 1 to 2 extra fine needle aspirates (FNA) when the nurses 
perform the routine diagnostic FNA procedures, to use in our research. We will use 
this aspirate to grow more cancer cells (if you do have cancer) that can be used in 
further research to assess variations in the proteins present within the cells, 
differences in molecular signalling as well as cell death processes.  
 For mastectomy patients, when the cancer tumour is removed from your breast 
during surgery, a biopsy (small piece of the tumour) is routinely taken by the surgeon 
to send to the pathologist for classification. For our study, we would like to ask 
your permission take a small piece of this tumour (already removed from you) 
to use in our research. We will use this tumour tissue to grow more cancer cells 
that can be used in further research to assess variations in the proteins present within 
the cells, differences in molecular signalling as well as cell death processes.  
 Cancer cells are able to adapt and thrive in hypoxic (reduced oxygen levels) 
conditions in the body. We would like to set up and characterise a primary cell culture 
model to investigate the effect of hypoxia on culturing cells and provide a useful tool 
for future research with a more accurate representation of cancer cells within the 
human body and characteristics comparable with the original tumour 
 
Why have you been invited to participate? 
 To make this study clinically significant, we need as many volunteers as possible to 
take part. We would like to ask your participation because either you have come to 
the FNA clinic with an undiagnosed lump in your breast, OR you have been 
diagnosed with breast cancer.  
 
What will your responsibilities be? 
 You will have no responsibilities during this project. 
 
Will you benefit from taking part in this research? 
 You will not benefit directly from this study, but future patients will benefit if this study 
is successful.  
 
Are there any risks involved in your taking part in this research? 
 The FNA will incur absolute minimal discomfort and risk. 
 Mastectomy patients: Taking part in this study will not induce any further risk apart 
from the usual risk factors involved in the mastectomy surgery.  
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Do you have to take part? 
 It is entirely your decision to take part in this research study or not, and it is completely 
acceptable if you decide to withdraw at any point during the study. The usual standard 
of care will apply to all patients. 
 
 
Who will have access to your medical records? 
 For us to make sense of our results, we will need to know how your cancer (if 
applicable) has been treated until now, and also what the diagnostic findings of the 
biopsy will be. All the information collected will be treated as confidential and 
protected. If it is used in a publication or thesis, the identity of the participant will 
remain anonymous. Only the researchers (Dr Derick van Vuuren, Professor A-M 
Engelbrecht and Ms V Patten) will have access to the information. 
 
What will happen in the unlikely event of some form of injury occurring as a direct 
result of your taking part in this research study? 
 
 The risk to patients receiving FNA is minimal. Taking part in this study will not induce 
any further risk outside of usual risk factors involved in FNA procedures. 
 For Mastectomy patients: Taking part in this study will not induce any further risk apart 
from the usual risk factors involved in surgery. No injury can occur as a direct result 
of taking part in this study. 
 
 
Will you be paid to take part in this study and are there any costs involved? 
 
No, you will not be paid to take part in the study. There will be no costs involved for you, if 
you do take part. 
 
 
Is there anything else that you should know or do? 
 Should you have any further queries about the study, or encounter any problems, 
please feel free to contact Dr Derick van Vuuren at tel 021-938 9390. 
 You can contact the Health Research Ethics Committee at 021-938 9207 if you 
have any concerns or complaints that have not been adequately addressed by your 
study doctor. 
 You will receive a copy of this information and consent form for your own records. 
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Declaration by participant 
 
By signing below, I …………………………………..…………. agree to take part in a research 
study entitled “Proteomic investigation into the effect of hypoxic culturing on primary breast 
carcinoma cells”.  
 
 
I declare that: 
 
 I have read or had read to me this information and consent form and it is written 
in a language with which I am fluent and comfortable. 
 I have had a chance to ask questions and all my questions have been adequately 
answered. 
 I understand that taking part in this study is voluntary and I have not been 
pressurised to take part. 
 I may choose to leave the study at any time and will not be penalised or prejudiced 
in any way. 
 I may be asked to leave the study before it has finished, if the study doctor or 
researcher feels it is in my best interests, or if I do not follow the study plan, as 
agreed to. 
 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2017. 
 
 
 
 ...............................................................  ............................................................. 
Signature of participant Signature of witness 
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Declaration by investigator 
 
I (name) ……………………………………………..……… declare that: 
 
 I explained the information in this document to ………………………………….. 
 I encouraged him/her to ask questions and took adequate time to answer them. 
 I am satisfied that he/she adequately understands all aspects of the research, as 
discussed above 
 I did/did not use an interpreter.  (If an interpreter is used then the interpreter must 
sign the declaration below. 
 
 
Signed at (place) ......................…........…………….. On (date) …………....……….. 2017. 
 
 
 
 ...............................................................  ............................................................. 
Signature of investigator Signature of witness 
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Declaration by interpreter 
 
I (name) ……………………………………………..……… declare that: 
 
 I assisted the investigator (name) ………………………………………. to explain 
the information in this document to (name of participant) 
……………..…………………………….. using the language medium of 
Afrikaans/Xhosa. 
 We encouraged him/her to ask questions and took adequate time to answer them. 
 I conveyed a factually correct version of what was related to me. 
 I am satisfied that the participant fully understands the content of this informed 
consent document and has had all his/her question satisfactorily answered. 
 
 
Signed at (place) ......................…...………….. on (date) …………....……………2017 
 
 
 
 ...............................................................  ............................................................. 
Signature of interpreter Signature of witness 
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Addendum B 
DEELNEMERINLIGTINGSBLAD EN -TOESTEMMINGSVORM 
 
 
TITEL VAN DIE NAVORSINGSPROJEK: 
 
Ondersoek na die effek van langtermyn hipoksiese blootstelling op die proteoom van 
primêre mammakarsinoom selle. 
 
VERWYSINGSNOMMER: S16/03/048 
 
HOOFNAVORSER:  
Dr Derick van Vuuren 
Mej Victoria Patten 
 
ADRES: 
Afdeling van Geneeskundige Fisiologie, FISAN gebou, Tygerberg kampus, Stellenbosch 
Universiteit, Francie van Zjil Rylaan, Bellville. 
 
KONTAKNOMMER: 
Dr Derick van Vuuren – 021 938 9390 
 
Beste Pasiënt 
 
U word versoek om deel te neem aan ’n navorsingsprojek wat handel oor borskanker.  Lees 
asseblief hierdie inligtingsblad op u tyd deur, aangesien die detail van die navorsingsprojek 
hierin verduidelik word. Indien daar enige deel van die navorsingsprojek is wat u nie ten 
volle verstaan nie, is u welkom om die navorsingspersoneel of dokter daaroor uit te vra.  Dit 
is baie belangrik dat u ten volle moet verstaan wat die navorsingsprojek behels en hoe u 
daarby betrokke kan wees.  U deelname is volkome vrywillig en dit staan u vry om 
deelname te weier.  U sal op geen wyse hoegenaamd negatief beïnvloed word indien u sou 
weier om deel te neem nie.  U mag ook te eniger tyd aan die navorsingsprojek onttrek, selfs 
al het u ingestem om deel te neem. 
 
Hierdie navorsingsprojek is deur die Gesondheidsnavorsingsetiekkomitee (GNEK) van die 
Universiteit Stellenbosch goedgekeur en sal uitgevoer word volgens die etiese riglyne en 
beginsels van die Internasionale Verklaring van Helsinki en die Etiese Riglyne vir Navorsing 
van die Mediese Navorsingsraad (MNR). 
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Wat behels hierdie navorsingsprojek en hoe kan u deelneem? 
 Die studie self gaan plaasvind by die departement van Geneeskundige Fisiologie  
van die Universiteit van Stellenbosch, op die Tygerberg kampus. Ons hoop om 
nagenoeg 50 deelnemers aan die projek te werf.  
 Ons wil graag u toestemming vra om 1 of 2 ekstra fynnaald aspirate (FNA) by 
u te versamel tydens die roetine diagnostiese FNA prosedures, waaraan u 
blootgestel gaan word tydens u besoek aan die FNA kliniek by Tygerberg hospitaal. 
Ons gaan hierdie aspiraat gebruik om meer kankerselle (indien u kanker het) te groei, 
wat ons dan sal kan gebruik in verdere navorsing aangaande verskille in die 
proteïene teenwoordig in die selle, verskille in hoe die selle aanpas by hul omgewing 
en ook seldood prosesse. 
 Vir mastektomie pasiënte, nadat die kankergewas chirurgies verwyder is vanuit u 
bors word die hele monster roetineweg deur die chirurg na ‘n patoloog gestuur vir 
evaluasie en klassifikasie. Vir ons studie wil ons graag u toestemming vra om ŉ 
2-3 mm dik snit van die gewas (wat reeds uit u bors verwyder is) te gebruik in 
ons studie. Ons gaan hierdie tumorweefsel gebruik om kankerselle in die 
laboratorium te groei, wat dan weer gebruik sal word vir verdere navorsing 
aangaande verskille in die proteïene teenwoordig in die selle, verskille in hoe die 
selle aanpas by hul omgewing en ook seldood prosesse. 
 Die weerstand van kankerselle teen anti-kanker medikasies speel ŉ belangrike rol in 
die oorlewing van tumorselle en beperk dus die effektiewe gebruik van hierdie 
medikasies. Ons stel belang in hoe kankerselle se metaboliese prosesse aanpas om 
uiteindelik by te dra tot hul weerstandigheid. Die uiteindelike doel is om hierdie 
prosesse te manipuleer sodat borskanker meer effektief behandel kan word. 
 
 
Waarom is u genooi om deel te neem? 
 Om hierdie studie klinies betekenisvol te maak het ons soveel as moontlik vrywilligers 
nodig om aan die studie deel te neem. Ons wil graag u deelname versoek omdat u 
óf die FNA kliniek besoek met ‘n ongediagnoseerde knop in u bors, óf u is 
gediagnoseer met borskanker. 
 
 
Wat sal u verantwoordelikhede wees? 
 U sal geen verantwoordelikhede tydens hierdie studie hê nie. 
 
 
Sal u voordeel trek deur deel te neem aan hierdie navorsingsprojek? 
 U sal nie direk voordeel trek deur u deelname aan hierdie studie nie, maar 
toekomstige pasiënte mag dalk wel bevoordeel word indien die studie suksesvol is.   
 
 
Is daar enige risiko's verbonde aan u deelname aan hierdie navorsingsprojek? 
 Die FNA gaan gepaard met minimale ongemak en risiko. 
 Vir mastektomie pasiënte: Deelname aan hierdie studie sal u nie blootstel aan enige 
addisionele risiko nie, buiten vir die gewone risikofaktore wat betrokke is by 
mastektomie chirurgie. 
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Watter alternatiewe is daar indien u nie instem om deel te neem nie? 
 U deelname aan hierdie studie is geheel en al u eie keuse. Dit is heeltemal 
aanvaarbaar indien u ter enige tyd tydens die studie besluit om u deelname te onttrek. 
Die gewone standaard van behandeling sal van toepassing wees vir alle pasiënte, 
ongeag deelname aan hierdie studie, al dan nie. 
 
 
Wie sal toegang hê tot u mediese rekords? 
 Om sin te maak van ons resultate sal ons moet weet hoe u kanker (indien van 
toepassing) tot op hede behandel is, asook die diagnostiese bevindings van die 
biopsie. Al die inligting wat ingesamel gaan word sal as konfidensieel hanteer word 
en sal ook beskerm word. Indien dit gebruik word in ‘n publikasie of tesis, sal die 
identiteit van die deelnemer anoniem bly. Slegs die navorsers (Dr Derick van Vuuren, 
Prof A-M Engelbrecht en Me Patten) sal toegang tot hierdie inligting hê.  
 
 
Wat sal gebeur in die onwaarskynlike geval van ’n besering wat mag voorkom as 
gevolg van u deelname aan hierdie navorsingsprojek? 
 Die risiko vir pasiënte op wie FNA uitgevoer gaan word is minimaal. Deelname aan 
hierdie studie gaan geen verdere risiko, buiten die gewone risikofaktore verwant aan 
FNA, tot gevolg hê nie. 
 Vir mastektomie pasiënte: Deelname aan hierdie projek gaan geen verdere risiko tot 
gevolg hê nie, buiten vir die standaard risikofaktore wat betrokke is by chirurgie. Geen 
besering kan plaasvind as ‘n direkte gevolg van deelname aan hierdie projek nie.  
 
 
Sal u betaal word vir deelname aan die navorsingsprojek en is daar enige koste 
verbonde aan deelname? 
 
Nee, u sal nie betaal word vir deelname aan die navorsingsprojek nie. U sal geen 
addisionele kostes aangaan indien u wel besluit om deel te neem aan die projek nie. 
 
 
Is daar enigiets anders wat u moet weet of doen? 
 
 U kan Dr Derick van Vuuren kontak by tel 021 938 9390 indien u enige verdere vrae 
het of enige probleme ondervind. 
 U kan die Gesondheidsnavorsingsetiek administrasie kontak by 021-938 9207 
indien u enige bekommernis of klagte het wat nie bevredigend deur u studiedokter 
hanteer is nie. 
 U sal ’n afskrif van hierdie inligtings- en toestemmingsvorm ontvang vir u eie rekords. 
Verklaring deur deelnemer 
 
Met die ondertekening van hierdie dokument onderneem ek, 
…….....................……….....……...……….., om deel te neem aan ’n navorsingsprojek 
getiteld  “Ondersoek na die effek van langtermyn hipoksiese blootstelling op die proteoom 
van primêre mammakarsinoom selle.” 
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Ek verklaar dat: 
 
 Ek hierdie inligtings- en toestemmingsvorm gelees het of aan my laat voorlees 
het en dat dit in ’n taal geskryf is waarin ek vaardig en waarmee ek gemaklik is. 
 Ek die geleentheid gehad het om vrae te stel en dat al my vrae bevredigend 
beantwoord is. 
 Ek verstaan dat deelname aan hierdie navorsingsprojek vrywillig is en dat daar 
geen druk op my geplaas is om deel te neem nie. 
 Ek te eniger tyd aan die navorsingsprojek mag onttrek en dat ek nie op enige 
wyse deur my ontrekking benadeel sal word nie. 
 Ek gevra mag word om van die navorsingsprojek te onttrek voordat dit afgehandel 
is indien die studiedokter of navorser van oordeel is dat dit in my beste belang is, 
of indien ek nie die ooreengekome navorsingsplan volg nie. 
 
 
Geteken te (plek) ..............................…………….. op (datum) …………....……….. 2017. 
 
 
 
 ...............................................................  ............................................................. 
Handtekening van deelnemer Handtekening van getuie 
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Verklaring deur navorser 
 
Ek (naam) …………………………………...……………… verklaar dat: 
 
 Ek die inligting in hierdie dokument verduidelik het aan 
…………………….............................................……….. 
 Ek hom/haar aangemoedig het om vrae te vra en voldoende tyd geneem het om 
dit te beantwoord. 
 Ek tevrede is dat hy/sy al die aspekte van die navorsingsprojek soos hierbo 
bespreek, voldoende verstaan. 
 Ek ’n tolk gebruik het/nie ’n tolk gebruik het nie.  (Indien ’n tolk gebruik is, moet 
die tolk die onderstaande verklaring teken.) 
 
 
Geteken te (plek) ..............................…………….. op (datum) …………....……….. 2017. 
 
 
 
 ...............................................................  ............................................................. 
Handtekening van navorser Handtekening van getuie 
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Verklaring deur tolk 
 
Ek (naam) …………………………………...……………… verklaar dat: 
 
 Ek die navorser (naam) ……….............................…………………. bygestaan het 
om die inligting in hierdie dokument in Afrikaans/Xhosa aan (naam van 
deelnemer) ……………………………......................... te verduidelik. 
 Ons hom/haar aangemoedig het om vrae te vra en voldoende tyd geneem het 
om dit te beantwoord. 
 Ek ’n feitelik korrekte weergawe oorgedra het van wat aan my vertel is. 
 Ek tevrede is dat die deelnemer die inhoud van hierdie dokument ten volle 
verstaan en dat al sy/haar vrae bevredigend beantwoord is. 
 
 
Geteken te (plek) .......................………….. op (datum) …………....………............ 2017. 
 
 
 
 ...............................................................  ............................................................. 
Handtekening van tolk Handtekening van getuie 
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Addendum C 
Phosphatase Assay Statistical Analysis Models  
     name:  <unnamed> 
       log:  C:\Users\tonyae\Documents\Stellenbosch\Consulting\Victoria Patten\6  
> feb 2018.log 
  log type:  text 
 opened on:   6 Feb 2018, 10:03:44 
 
. use "C:\Users\tonyae\Documents\Stellenbosch\Consulting\Victoria Patten\victoria 
>  long data.dta" 
 
. encode group, generate(group_n) 
 
. codebook group_n 
 
--------------------------------------------------------------------------------- 
group_n                                                               (unlabeled) 
--------------------------------------------------------------------------------- 
 
                  type:  numeric (long) 
                 label:  group_n 
 
                 range:  [1,3]                        units:  1 
         unique values:  3                        missing .:  0/864 
 
            tabulation:  Freq.   Numeric  Label 
                           288         1  Control 
                           288         2  Hypoxia 
                           288         3  Pos Control 
 
Multiple linear regression analysis using PP@A as the dependent variable and incubation 
time, measurement time, and group (hypox vs control) as independent variables and 
adjusting for the repeated measures over measurement time using clustered robust 
standard errors.  
Hypoxia vs control 
model 1 
no interaction term between time and group.  
only time is significant (p<0.001)meaning there was on average a 684 unit increase in 
PP2A with every 5 minute increase in measurement time. Incubation time did not affect 
PP2A nor did group.  
 
. regress PP2A i.Incubation  time  i.group_n if group_n<=2, vce(cluster id) 
 
Linear regression                               Number of obs     =        480 
                                                F(5, 19)          =      29.87 
                                                Prob > F          =     0.0000 
                                                R-squared         =     0.6196 
                                                Root MSE          =     3815.5 
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                                    (Std. Err. adjusted for 20 clusters in id) 
------------------------------------------------------------------------------ 
             |               Robust 
        PP2A |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
  Incubation | 
          4  |  -691.9705   2208.681    -0.31   0.757    -5314.794    3930.853 
          6  |  -1735.205   2138.998    -0.81   0.427    -6212.178    2741.769 
          8  |  -2136.194   2241.688    -0.95   0.353    -6828.102    2555.713 
             | 
        time |   684.3865   68.34555    10.01   0.000     541.3376    827.4354 
             | 
     group_n | 
    Hypoxia  |   1047.307   1469.445     0.71   0.485    -2028.277    4122.892 
       _cons |     567.72   1423.577     0.40   0.694    -2411.861    3547.301 
------------------------------------------------------------------------------ 
 
. gen timegroup = time* group_n 
model 2 
Interaction term between time and group.  
only time is significant (p=0.006)meaning there was on average a 569 unit increase in 
PP2A with every 5 minute increase in measurement time. Incubation time did not affect 
PP2A nor did group. THere was no interaction between time and group, therefore final 
model is model 1.  
 
. regress PP2A i.Incubation  time  i.group_n timegroup if group_n<=2, vce(cluster 
>  id) 
 
Linear regression                               Number of obs     =        480 
                                                F(6, 19)          =      25.82 
                                                Prob > F          =     0.0000 
                                                R-squared         =     0.6214 
                                                Root MSE          =     3810.2 
 
                                    (Std. Err. adjusted for 20 clusters in id) 
------------------------------------------------------------------------------ 
             |               Robust 
        PP2A |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
  Incubation | 
          4  |  -691.9705   2211.015    -0.31   0.758    -5319.678    3935.737 
          6  |  -1735.205   2141.258    -0.81   0.428    -6216.908    2746.499 
          8  |  -2136.194   2244.057    -0.95   0.353    -6833.059    2560.671 
             | 
        time |   569.5443    184.582     3.09   0.006     183.2097     955.879 
             | 
     group_n | 
    Hypoxia  |   90.28922   492.4886     0.18   0.856    -940.5012     1121.08 
   timegroup |   76.56145   135.6891     0.56   0.579    -207.4392    360.5621 
       _cons |   1046.229   1414.797     0.74   0.469    -1914.975    4007.433 
------------------------------------------------------------------------------ 
control vs pos control 
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model 1 
No interaction term 
only time is significant (p<0.001)meaning there was on average a 748 unit increase in 
PP2A with every 5 minute increase in measurement time. Incubation time did not affect 
PP2A nor did group.  
 
. regress PP2A i.Incubation  time  i.group_n  if group_n>1, vce(cluster id) 
 
Linear regression                               Number of obs     =        480 
                                                F(5, 19)          =      21.35 
                                                Prob > F          =     0.0000 
                                                R-squared         =     0.5540 
                                                Root MSE          =     4786.5 
 
                                    (Std. Err. adjusted for 20 clusters in id) 
------------------------------------------------------------------------------ 
             |               Robust 
        PP2A |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
  Incubation | 
          4  |  -867.8307   2831.739    -0.31   0.763    -6794.728    5059.067 
          6  |   -813.888   2715.079    -0.30   0.768    -6496.614    4868.838 
          8  |  -3056.063   2757.494    -1.11   0.282    -8827.563    2715.438 
             | 
        time |   748.4501   83.06968     9.01   0.000     574.5833     922.317 
             | 
     group_n | 
Pos Control  |   658.4974     1866.9     0.35   0.728    -3248.969    4565.964 
       _cons |      866.7   1941.428     0.45   0.660    -3196.755    4930.155 
------------------------------------------------------------------------------ 
 
Model 2 
Interaction term added 
No significant interaction between time and group, therefore revert to model 1.  
. regress PP2A i.Incubation  time  i.group_n timegroup if group_n>1, vce(cluster  
> id) 
 
Linear regression                               Number of obs     =        480 
                                                F(6, 19)          =      18.95 
                                                Prob > F          =     0.0000 
                                                R-squared         =     0.5547 
                                                Root MSE          =     4788.2 
 
                                    (Std. Err. adjusted for 20 clusters in id) 
------------------------------------------------------------------------------ 
             |               Robust 
        PP2A |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
  Incubation | 
          4  |  -867.8307   2834.731    -0.31   0.763     -6800.99    5065.329 
          6  |   -813.888   2717.948    -0.30   0.768    -6502.618    4874.842 
          8  |  -3056.063   2760.407    -1.11   0.282    -8833.661    2721.536 
Stellenbosch University  https://scholar.sun.ac.za
138 
 
             | 
        time |   619.5355   419.5653     1.48   0.156    -258.6248    1497.696 
             | 
     group_n | 
Pos Control  |   13.92409     579.36     0.02   0.981     -1198.69    1226.538 
   timegroup |   51.56586   165.8883     0.31   0.759    -295.6423     398.774 
       _cons |   1188.987   1744.681     0.68   0.504    -2462.673    4840.646 
------------------------------------------------------------------------------ 
 
. log close 
      name:  <unnamed> 
       log:  C:\Users\tonyae\Documents\Stellenbosch\Consulting\Victoria Patten\6  
> feb 2018.log 
  log type:  text 
 closed on:   6 Feb 2018, 10:13:06 
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